EOS Med Chem is serving more than 100 Pharma companies, we have the original Drug Discovery Compounds, Like Impurity, small molecule and inhibitor.
Impurity we keep stock more than 80000, most in stock, we are World Sole Original Supplier, Each impurity we could supply: Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA.
EOS Med Chem Quotation include: Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, COA, MSDS.
Contact:
EOS Med Chem, Medicinal Chemical is Big
執大象，天下往，往而無害，安平泰
Ms Nina
Youtube: https://youtu.be/r5cJdXKNXHk
Tel: 0086-531-69905422
SALE OFFICE: 16F, China Overseas Plaza, Jinan City, China
Ospemifene, CAS: 128607-22-7, stock: 7.9g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₃ClO₂.
4-(4-Butylphenylazo)phenol, CAS: 2496-21-1, stock: 6.3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₈N₂O.
4-(4-Carboxy-3-fluorophenyl)-2-fluorophenol, CAS: 1261981-84-3, stock: 3.3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₈F₂O₃.
Ospemifene O-β-D-Glucuronide, CAS: /, stock: 6.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₀H₃₁ClO₈.
Ospemifene-d4, CAS: /, stock: 9.3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₁₉D₄ClO₂.
3,4-Difluoro-1-nitrobenzene, CAS: 369-34-6, stock: 8.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₃F₂NO₂.
4-(4-Carboxy-3-fluorophenyl)-2-methoxyphenol, CAS: 1261990-34-4, stock: 4.1g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₁FO₄.
4-(4-Chloro-3-cyanophenyl)-2-methoxyphenol, CAS: 1261901-36-3, stock: 6.1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₀ClNO₂.
Ospemifene-d4, CAS: /, stock: 2.2g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₁₉D₄ClO₂.
4-(4-Chloro-3-cyanophenyl)phenol, CAS: 1261958-08-0, stock: 7g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₈ClNO.
4-(4-Chlorophenoxy)phenol, CAS: 21567-18-0, stock: 7.6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₉O₂Cl.
Vinyl Ospemifene, CAS: /, stock: 8.5g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₂O₂.
3-(4-Aminophenyl)-1,3-oxazolidin-2-one, CAS: 22036-26-6, stock: 7g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₀N₂O₂.
4-(4-Chlorophenyl)-2-fluorophenol, CAS: 1261944-84-6, stock: 9.3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₈ClFO.
4-(4-Cyanophenyl)-2-methylphenol, CAS: 460748-08-7, stock: 9g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₁NO.
4-(4-Ethoxy-2-methylphenyl)-3-fluorophenol, CAS: 1261998-20-2, stock: 1.4g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₅FO₂.
4-(4-Ethoxycarbonylphenyl)phenol, CAS: 50670-76-3, stock: 2.8g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₄O₃.
3-Acetyl-2-oxazolidinone, CAS: 1432-43-5, stock: 8.1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₇NO₃.
3-Acetyloxazolin-2-one, CAS: 60759-49-1, stock: 9.3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₅NO₃.
4-(4-Ethylphenyl)phenol, CAS: 21345-28-8, stock: 6.2g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₄O.
3-Acryloyl-2-oxazolidinone, CAS: 2043-21-2, stock: 8.4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₇NO₃.
4-(4-Ethylpiperazin-1-yl)phenol, CAS: 1086392-78-0, stock: 1.9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₈N₂O.
4-(4-Fluoro-3-methoxyphenyl)phenol, CAS: 64465-63-0, stock: 5.1g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₁FO₂.
3-Benzoyl-4-methyl-2-phenyl-5-oxazolidinone, CAS: 1260662-63-2, stock: 6.1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₅NO₃.
4-(4-Fluoro-3-methylphenyl)phenol, CAS: 64465-60-7, stock: 2.4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₁FO.
4-(4-Fluoro-3-trifluoromethylphenyl)phenol, CAS: 634192-41-9, stock: 2.6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₈F₄O.
4-(4-Fluorophenoxy)phenol, CAS: 1524-19-2, stock: 7.4g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₉FO₂.
4-(4-Fluorophenyl)-2-methylphenol, CAS: 22494-35-5, stock: 7.6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₁FO.
4-(4-Fluorophenyl)-3-fluorophenol, CAS: 349665-92-5, stock: 5.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₈F₂O.
4-(4-Fluorophenyl)phenol, CAS: 324-94-7, stock: 6.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₉FO.
3-Heptanoyl-4-(S)-isopropyl-oxazolidin-2-one, CAS: 145588-98-3, stock: 7.8g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₂₃NO₃.
3-Methyl-5-phenyl-2-oxazolidinone β-D-Glucuronide Triacetate (Mixture of Diastereoisomers), CAS: /, stock: 3.4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₇NO₁₂.
4-(4-Fluorophenylethynyl)phenol, CAS: 197770-48-2, stock: 6.6g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₉FO.
3-Nitro-2-oxazolidinone, CAS: 85430-60-0, stock: 3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃H₄N₂O₄.
4-(4-Hydroxy-3-methylbenzenesulfonyl)-2-methylphenol, CAS: 16346-97-7, stock: 1.6g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₄O₄S.
4-(4-Methoxycarbonylphenyl)phenol, CAS: 40501-41-5, stock: 6.3g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₂O₃.
3-Trimethylsilyl-2-oxazolidinone, CAS: 43112-38-5, stock: 9.9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₁₃NO₂Si.
4-(4-Methoxyphenyl)-2-methylphenol, CAS: 103594-29-2, stock: 4.9g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₄O₂.
4-(4-Methyl-1,3-thiazol-2-yl)phenol Hydrobromide, CAS: 1172835-03-8, stock: 7.2g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₉NOS • HBr.
3-[5-(1,5-Dioxo-5-(p-fluophenylpentyl]-4(S)-phenyl-2-oxazolidinone, CAS: 189028-93-1, stock: 5.7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₁₈FNO₄.
4-(4-Methylphenyl)phenol, CAS: 26191-64-0, stock: 3.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₂O.
4-(4-methylpiperazine-1-carbonyl)phenol hydrochloride, CAS: 1197232-18-0, stock: 10g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₆N₂O₂ • HCl.
3-[5-(4-Fluorophenyl)-5-hydroxy-1-oxopentyl]-4-phenyl-2-oxazolidinone, CAS: 439080-96-3, stock: 5.8g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₀FNO₄.
3-[5-(4-Methoxyphenoxy)-(2S)-2-methyl-1-oxobutyl]-(4S)-4-benzyl-2-oxazolidinone, CAS: /, stock: 4.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₇NO₅.
4-(4-Piperidinyl)phenol, CAS: 62614-84-0, stock: 7.1g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₅NO.
4-(4-Pyridinyl)aniline, CAS: 13296-04-3, stock: 2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₀N₂.
3-[5-(4-Methoxyphenoxy)-1-oxobutyl]-(4S)-4-benzyl-2-oxazolidinone, CAS: 1798827-54-9, stock: 3.3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₅NO₅.
4,5-Dimethyl-2-oxazolidinone, CAS: 58628-98-1, stock: 9.9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₉NO₂.
4-(4-Trifluoromethoxyphenyl)phenol, CAS: 173025-79-1, stock: 8.8g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₉O₂F₃.
4-(4’-Hydroxyphenyl)-2-butanone, CAS: 5471-51-2, stock: 8.6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₂O₂.
4,7-Dichloroquinoline, CAS: 86-98-6, stock: 7.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₅Cl₂N.
4-(2-Fluoro-4-nitrophenyl)morpholine, CAS: 2689-39-6, stock: 4.7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₁FN₂O₃.
4-(4’-Hydroxyphenyl)-2-butanone-d5, CAS: 182219-43-8, stock: 9.8g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₇D₅O₂.
4-(5,5-Dimethyl-1,3,2-dioxaborinan-2-yl)phenol, CAS: 1192765-29-9, stock: 3.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₅BO₃.
4-(4-Bromo-2-fluorophenyl)morpholine, CAS: 513068-89-8, stock: 7.7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₁BrFNO.
4-(4-Bromo-2-fluorophenyl)morpholine-d8, CAS: /, stock: 2.2g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₃D₈BrFNO.
4-(5-Amino-4H-1,2,4-triazol-3-yl)-2-chlorophenol, CAS: 1016534-61-4, stock: 4.1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₇N₄OCl.
4-(4-Fluorophenyl)-1,2,3,6-tetrahydropyridine Hydrochloride, CAS: 1978-61-6, stock: 8.2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₃ClFN.
4-(Aminomethyl)-2-oxazolidinone, CAS: 166395-15-9, stock: 3.2g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₈N₂O₂.
4-(5-Bromo-2-pyridinyl)phenol, CAS: 1032825-10-7, stock: 1.8g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₈NOBr.
4-(5-Butyl-1,2,4-oxadiazol-3-yl)phenol, CAS: 10185-79-2, stock: 9.6g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₄N₂O₂.
4-Ethynyl-2-oxazolidinone, CAS: 1087043-50-2, stock: 7.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: 111.1.
4-(5-Carboxy-2-fluorophenyl)phenol, CAS: 1181608-84-3, stock: 6.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₉FO₃.
4-(5-Cyano-2-fluorophenyl)phenol, CAS: 1261998-32-6, stock: 9.2g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₈FNO.
4-Methyl-2-phenyl-5-oxazolidinone, CAS: 70155-88-3, stock: 5.7g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₁NO₂.
5,5-Dimethyl-2-oxazolidinone, CAS: 1121-83-1, stock: 9.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₉NO₂.
4-(5-Cyclopropyl-1,2,4-oxadiazol-3-yl)phenol, CAS: 1038982-05-6, stock: 3.2g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₀N₂O₂.
4-(5-Formylthiophen-2-yl)-2-methylphenol, CAS: 1261976-11-7, stock: 7.7g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₀O₂S.
5,5-Dimethyl-2-pyrrolidone, CAS: 5165-28-6, stock: 7g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₁₁NO.
4-(5-Formylthiophen-2-yl)phenol, CAS: 893740-97-1, stock: 1.2g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₈O₂S.
4-(5-Methyl-1H-tetrazol-1-yl)phenol, CAS: 157124-41-9, stock: 8.8g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₈N₄O.
5-(3,4-Xylyloxymethyl)-2-oxazolidinone, CAS: 102871-73-8, stock: 1.9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₅NO₃.
5-(4’-Benzyloxyphenyl)-2-oxazolidone, CAS: 88693-98-5, stock: 8.5g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₅NO₃.
4-(5-Oxazolyl)phenol, CAS: 1128-71-8, stock: 8.4g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₇NO₂.
4-(6-Aminopyridin-3-yl)phenol, CAS: 96721-88-9, stock: 9.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₀N₂O.
4-(6-Methyl-1H-1,3-benzodiazol-2-yl)phenol, CAS: 113561-64-1, stock: 4.5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₂N₂O.
4-(Acetyloxy)-3-methoxybenzenethanol Acetate, CAS: 32022-28-9, stock: 9.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₆O₅.
5-Aminomethyl-2-oxazolidinone, CAS: 119736-09-3, stock: 7.6g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₈N₂O₂.
5-(3-Hydroxyphenyl)-3-methyl-2-oxazolidinone, CAS: 112710-46-0, stock: 9.1g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₁NO₃.
4-(Aminomethyl)-2-ethoxyphenol Hydrochloride, CAS: 105026-85-5, stock: 2.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₃NO₂ • HCl.
4-(aminomethyl)-3-methylphenol, CAS: 1243347-65-0, stock: 5.5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₁NO.
5-Bromo-2-(1H-tetrazol-5-yl)pyridine, CAS: 380380-60-9, stock: 1.1g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₄BrN₅.
4-(Aminomethyl)phenol Hydrobromide, CAS: 90430-14-1, stock: 5.8g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₉NO • HBr.
4-(Benzyloxy)-2-fluorophenol, CAS: 84352-10-3, stock: 5.4g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₁FO₂.
4-(Benzyloxy)-3-chlorophenol, CAS: 86902-27-4, stock: 2.9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₁O₂Cl.
4-(Benzyloxy)-3-fluorophenol, CAS: 81228-25-3, stock: 5.4g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₁O₂F.
5-Chloro-thiophene-2-carboxylic Acid, CAS: 799012-78-5, stock: 6.5g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₈ClNO₂S.
5-Chloromethyl-2-oxazolidinone, CAS: 22625-57-6, stock: 7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₆ClNO₂.
4-(Benzyloxy)-3-methylphenol, CAS: 100927-02-4, stock: 2.6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₄O₂.
5-Hydroxymethyl-3-(4-iodophenyl)-2-oxazolidinone, CAS: 84460-41-3, stock: 7.5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₀INO₃.
5-[(3-Benzoyloxy-9H-carbazol-4-yloxy)methyl]-3-[2-(2-methoxyphenoxy)ethyl]-2-oxazolidinone, CAS: 1796927-04-2, stock: 4g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₂H₂₈N₂O₇.
8-Methyl-1-oxa-3,8-diazaspiro[4.5]decan-2-one Hydrochloride, CAS: 01/10/5053, stock: 7.2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₅ClN₂O₂.
4-(cis-4-Hydroxycyclohexyl)phenol, CAS: 370860-74-5, stock: 3.1g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₆O₂.
4-(Cyclohexylamino)phenol, CAS: 10014-69-4, stock: 2.5g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₇NO.
4-(Difluoromethoxy)phenol, CAS: 87789-47-7, stock: 4.9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₆F₂O₂.
AMOZ-HN, CAS: 1347740-46-8, stock: 7.5g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₁N₃O₄.
AMOZ-HN-d5, CAS: /, stock: 8.5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₁₆D₅N₃O₄.
4-(Dimethylamino)phenol hydrochloride, CAS: 5882-48-4, stock: 3.5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₁NO • HCl.
4-(Dimethylaminomethyl)-6-fluoro-2-methoxyphenol, CAS: 103905-49-3, stock: 5.3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₄NO₂F.
AOZ-HN, CAS: 1367242-84-9, stock: 8.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₂N₂O₃.
4-(Hexyloxy)phenol, CAS: 18979-55-0, stock: 6.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₈O₂.
AOZ-HN-d4, CAS: /, stock: 3.2g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₈D₄N₂O₃.
4-(Imidazol-1-yl)phenol, CAS: 10041-02-8, stock: 7.9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₈N₂O.
Cell Sheet Migration Inhibitor, Locostatin, CAS: 133812-16-5, stock: 4.5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₅NO₃.
4-(Iodoacetylamino)phenol, CAS: 53527-05-2, stock: 8.7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₈INO₂.
4-(Iodoacetylamino)phenol-d6, CAS: /, stock: 3.5g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₂D₆INO₂.
cis-2-Butene-1,4-diol, CAS: 6117-80-2, stock: 5g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₈O₂.
4-(Methylamino)-3,5-xylenol, CAS: 6392-45-6, stock: 1.6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₃NO.
4-(Methylsulfinyl)phenol, CAS: 14763-64-5, stock: 2.9g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₈O₂S.
4-(Methylsulfonyl)-2-nitrophenol, CAS: 97-10-9, stock: 2.5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₇NO₅S.
4-(Methylthio)thiophenol, CAS: 1122-97-0, stock: 8.2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₈S₂.
4-(N-Acetyl)piperidinyl 2-(5-Methoxy)phenol Ketone, CAS: 64671-18-7, stock: 7.7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₉NO₄.
4-(N-Octyloxy)phenol, CAS: 3780-50-5, stock: 9.6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₂₂O₂.
4-(Pentafluorothio)phenol, CAS: 774-94-7, stock: 9.1g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₅OF₅S.
4-(Piperazin-1-yl)phenol Hydrochloride, CAS: 1175036-51-7, stock: 8.7g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₄N₂O • HCl.
4-(Pyridin-2-yl)phenol, CAS: 51035-40-6, stock: 2.4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₉NO.
4-(Pyridin-4-ylmethoxy)phenol, CAS: 1152564-20-9, stock: 4.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₁NO₂.
4-(Pyridin-4-yloxy)phenol, CAS: 103854-63-3, stock: 7.5g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₉NO₂.
4-(Pyrrolidin-1-yl)phenol, CAS: 1008-97-5, stock: 5.1g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₃NO.
Didesmethyl Zolmitriptan (90%), CAS: 139264-15-6, stock: 1.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₇N₃O₂.
Didesmethyl Zolmitriptan-d4, CAS: 1217853-52-5, stock: 7.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₃D₄N₃O₂.
4-(Pyrrolidin-2-yl)phenol Hydrobromide, CAS: 1197466-46-8, stock: 9.2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₃NO • HBr.
4-(tert-Butoxy)phenol, CAS: 2460-87-9, stock: 7.5g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₄O₂.
DL-Goitrin, CAS: 13190-34-6, stock: 3.1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₇NOS.
4-(tert-Butoxy)phenylboronic Acid, CAS: 176672-49-4, stock: 3.8g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₅BO₃.
4-(tert-Butyl)-2-iodophenol, CAS: 38941-98-9, stock: 2.2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₃OI.
4-(tert-Butyldimethylsiloxy)phenol, CAS: 108534-47-0, stock: 8.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₂₀O₂Si.
4-(tert-Butyldiphenylsilyl)hydroxy Propofol, CAS: 1246816-09-0, stock: 6g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₃₆O₂Si.
4-(tert-Butyldiphenylsilyl)hydroxy Propofol Tri-O-benzoyl-1-O-β-D-glucuronic Acid Methyl Ester, CAS: /, stock: 1.6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅₆H₅₈O₁₁Si.
4-(Trans-4-Ethylcyclohexyl)Phenol, CAS: 89100-78-7, stock: 7.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₂₀O.
(R)-N-Ethyl-N,N-dimethyl-2-(phenyl(o-tolyl)methoxy)ethanaminium Chloride, CAS: /, stock: 6.1g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₈ClNO.
(R)-Orphenadrine Citrate, CAS: 1202395-79-6, stock: 5.2g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₃₁NO₈.
(1R,2S,3S)-3-Chloro-5-(ethoxycarbonyl)cyclohex-4-ene-1,2-diyl Diacetate, CAS: /, stock: 1.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₇ClO₆.
4-(Trifluoromethoxy)-3-(trifluoromethyl)phenol, CAS: 120355-08-0, stock: 9.7g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₄O₂F₆.
4-(Trifluoromethoxy)phenol, CAS: 828-27-3, stock: 1.4g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₅F₃O₂.
1-[(2-Bromoethoxy)phenylmethyl]-2-methylbenzene-d4, CAS: /, stock: 6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₃D₄BrO.
(1R,5R,6R)-5-(1-Ethylpropoxy)-7-azabicyclo[4.1.0]hept-3-ene-3-carboxylic Acid Ethyl Ester, CAS: 204255-02-7, stock: 6.5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₂₃NO₃.
(1R,5R,6S)-Ethyl 5-Acetoxy-7-oxabicyclo[4.1.0]hept-2-ene-3-carboxylate, CAS: 347378-69-2, stock: 5.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₄O₅.
Furaltadone-d8, CAS: 1246832-89-2, stock: 7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₈D₈N₄O₆.
4-(Trifluoromethyl)phenyl β-D-Glucopyranosiduronic Acid, CAS: 176223-16-8, stock: 4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₃F₃O₇.
4-(Trifluoromethyl)thiophenol, CAS: 825-83-2, stock: 6.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₅F₃S.
2-(Di-o-tolylmethoxy)-N,N-dimethylethanamine Hydrochloride, CAS: 18483-53-9, stock: 2.7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₅NO • (HCl).
2-Methylbenzhydrol, CAS: 5472-13-9, stock: 3.1g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₄O.
(1R,5S,6R)-Ethyl 5-(Pentan-3-yloxy)-7-oxabicyclo[4.1.0]hept-3-ene-3-carboxylate, CAS: 347378-74-9, stock: 3.7g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₂₂O₄.
(1R,5S,6R)-Ethyl 5-(Pentan-3-yloxy-d5)-7-oxabicyclo[4.1.0]hept-3-ene-3-carboxylate, CAS: /, stock: 2.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₇D₅O₄.
Homomorpholine Hydrochloride, CAS: 178312-62-4, stock: 7.3g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₁₂ClNO.
4-(Trifluoromethylthio)phenol, CAS: 461-84-7, stock: 9.5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₅OF₃S.
Methyl(2-(phenyl(o-tolyl)methoxy)ethyl)carbamic Acid Ethyl Ester, CAS: /, stock: 4.6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₅NO₃.
N,N-Didemethylorphenadrine Hydrochloride, CAS: 17752-32-8, stock: 3.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₂₀ClNO.
(3R,4R,5R)-Ethyl 4-Acetamido-5-amino-3-(pentan-3-yloxy)cyclohex-1-enecarboxylate, CAS: 1402431-91-7, stock: 3.3g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₂₈N₂O₄.
(3R,4R,5S)-4-(Acetylamino)-5-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylic Acid Methyl Ester, CAS: /, stock: 9.6g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₂₆N₂O₄.
4-({[(1-Ethylpyrrolidin-2-yl)methyl]amino}methyl)phenol Dihydrochloride, CAS: 1235439-59-4, stock: 7.2g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₂₂N₂O • 2HCl.
4-Acetamidothiophenol, CAS: 1126-81-4, stock: 8.1g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₉NOS.
(3R,4S,5R)-Ethyl 5-Acetoxy-3-hydroxy-4-(pentan-3-yloxy)cyclohex-1-enecarboxylate, CAS: /, stock: 3.7g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₂₆O₆.
(3R,4S,5S)-3-(1-Ethylpropoxy)-4,5-dihydroxy-1-cyclohexene-1-carboxylic Acid Ethyl Ester, CAS: 1201685-71-3, stock: 4.1g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₂₄O₅.
4-Acetoxy-1-acetylamino-2-nitrobenzene, CAS: 2243-69-8, stock: 7.5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₀N₂O₅.
O-Demethyl-m-methyl Orphenadrine Citrate Salt, CAS: /, stock: 2.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₃₁NO₈.
(3R,4S,5S)-4-Azido-3-(1-ethylpropoxy)-5-[(methylsulfonyl)oxy]-1-cyclohexene-1-Carboxylic Acid Ethyl Ester + (3R,4S,5S)-5-Azido-3-(1-ethylpropoxy)-4-[(methylsulfonyl)oxy]-1-cyclohexene-1-Carboxylic Acid Ethyl Ester (Mixture of Isomers), CAS: /, stock: 1.3g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₂₅N₃O₆S.
(3S,4S,5R)-Ethyl 5-Acetoxy-4-((methylsulfonyl)oxy)-3-(pentan-3-yloxy)cyclohex-1-enecarboxylate, CAS: 347378-72-7, stock: 5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₂₈O₈S.
O-Demethyl-m-methyl Orphenadrine-d5 Citrate Salt, CAS: /, stock: 3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₆D₅NO₈.
Orphenadrine Citrate Salt, CAS: 4682-36-4, stock: 6.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₃₁NO₈.
(3S,4S,5R)-Ethyl 5-Acetoxy-4-hydroxy-3-(pentan-3-yloxy)cyclohex-1-enecarboxylate, CAS: 347378-70-5, stock: 8.7g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₂₆O₆.
Mephenoxalone, CAS: 70-07-5, stock: 5.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₃NO₄.
Mephenoxalone-d3, CAS: /, stock: 4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₀D₃NO₄.
4-Acetoxyphenol, CAS: 3233-32-7, stock: 8.8g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₈O₃.
4-Acetoxystyrene, CAS: 2628-16-2, stock: 1.7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₀O₂.
Orphenadrine N-Oxide, CAS: 29215-00-7, stock: 9.6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₃NO₂.
Orphenadrine-d3 Citrate Salt, CAS: 1185011-75-9, stock: 9.8g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₈D₃NO₈.
1,2-Dihydro-oseltamivir, CAS: 1052063-38-3, stock: 1.9g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₃₀N₂O₄.
Orphenadrine-d3 N-Oxide, CAS: 1329647-21-3, stock: 9.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₀D₃NO₂.
3,4-O-(Diethylmethylidene) Shikimic Acid Ethyl Ester, CAS: 943515-58-0, stock: 1.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₂₂O₅.
3-Des(1-ethylpropoxy)-3-(1-methylpropoxy) Oseltamivir, CAS: 1052063-37-2, stock: 5.5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₂₆N₂O₄.
N-(4-Nitrobenzenesulfonyl) N-Desmethyl Zolmitriptan, CAS: 1346602-02-5, stock: 3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₂N₄O₆S.
Tofenacin Hydrochloride Salt-d4, CAS: /, stock: 6.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₈D₄ClNO.
4-N-Desacetyl-5-N-acetyl Oseltamivir, CAS: 956267-10-0, stock: 6.9g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₂₈N₂O₄.
4-Allylphenol, CAS: 501-92-8, stock: 4.6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₀O.
4-Amino Propofol Hydrochloride, CAS: 100251-91-0, stock: 7.1g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₂₀ClNO.
4-N-Desacetyl-5-N-acetyl Oseltamivir Acid, CAS: 1391047-93-0, stock: 5.1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₂₄N₂O₄.
5-Azido Oseltamivir, CAS: 204255-06-1, stock: 6.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₂₆N₄O₄.
1-Methyl-L-4,5-dihydroorotic Acid, CAS: 103365-69-1, stock: 3.8g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₈N₂O₄.
N-Butyryl-4-(S)-phenylmethyl-2-oxazolidinone, CAS: 112459-79-7, stock: 8.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₇NO₃.
4-Amino-2,3-dichlorophenol, CAS: 39183-17-0, stock: 3.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₅Cl₂NO.
4-Amino-2,3-difluorophenol, CAS: 163733-99-1, stock: 4.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₅NOF₂.
5-Azido Oseltamivir-d3, CAS: /, stock: 7.7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₂₃D₃N₄O₄.
Butanal, CAS: 123-72-8, stock: 9.5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₈O.
2,4-Dihydroxypyrimidine-5-carboxylic Acid, Hydrate, CAS: 80106-50-9, stock: 1.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₃N₂O₂ xH₂O.
4-Amino-2,3-dimethylphenol, CAS: 3096-69-3, stock: 3.2g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₁NO.
4-Amino-2,5-difluorophenol, CAS: 120103-19-7, stock: 6.8g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₅NOF₂.
ent-Oseltamivir Phosphate, CAS: 1035895-89-6, stock: 4.9g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₃₁N₂O₈P.
Ethyl (3R,4R,5S)-4-N-Acetyl(1,1-dimethylethyl)amino-5-N,N-diallylamino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylate, CAS: 651324-07-1, stock: 5.2g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₄₄N₂O₄.
4,6-Dihydroxypyrimidine-2-carboxylic Acid, CAS: 5177-20-8, stock: 1.7g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₄N₂O₄.
N-Desmethyl Zolmitriptan, CAS: 139264-35-0, stock: 6.5g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₉N₃O₂.
N-Desmethyl Zolmitriptan-d3, CAS: 1217623-11-4, stock: 5.3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₆D₃N₃O₂.
4-Amino-2,5-dimethylphenol, CAS: 3096-71-7, stock: 3.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₁NO.
Ethyl (3R,4S,5S)-4,5-Epoxy-3-(1-ethylpropoxy)cyclohex-1-ene-1-carboxylate, CAS: 204254-96-6, stock: 4.4g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₂₂O₄.
Ethyl 3,4-O-isopropylideneshikimate, CAS: 136994-78-0, stock: 4.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₈O₅.
5-Bromohexahydro-2,6-dioxo-4-pyrimidinecarboxylic Acid, CAS: 58668-21-6, stock: 2.7g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₅BrN₂O₄.
5-Bromohexahydro-2,6-dioxo-4-pyrimidinecarboxylic Acid-15N2, CAS: /, stock: 2g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₅Br¹⁵N₂O₄.
5-Bromoorotic Acid, CAS: 15018-62-9, stock: 4.7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₃BrN₂O₄.
N-Desmethyl Zolmitriptan-d3 Hydrochloride, CAS: 1795786-26-3, stock: 3.4g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₇D₃ClN₃O₂.
3-Deschloro-3-hydroxy Ornidazole, CAS: 62580-80-7, stock: 4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₁₁N₃O₄.
4-Amino-2,6-dichlorophenol, CAS: 5930-28-9, stock: 7.4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₅Cl₂NO.
4-Amino-2,6-difluorophenol Hydrochloride, CAS: 220353-22-0, stock: 2.1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₆ClF₂NO.
N-Desacetyl 5-Azido Oseltamivir, CAS: 204255-04-9, stock: 2.1g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₂₄N₄O₃.
Oseltamivir, CAS: 196618-13-0, stock: 8.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₂₈N₂O₄.
5-Fluoroorotic acid, CAS: 703-95-7, stock: 1.5g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₃FN₂O₄.
5-Fluoroorotic Acid Hydrate, CAS: 207291-81-4, stock: 5.1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₃FN₂O₄ • xH ₂O.
4-Amino-2,6-dimethylphenol, CAS: 15980-22-0, stock: 4.5g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₁NO.
4-Amino-2,6-dimethylphenol Hydrochloride, CAS: 10486-48-3, stock: 1.9g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₁NO • HCl.
Oseltamivir 5-Desamino 5-(2-Formyl 5-Hydroxymethylpyrrol-1-yl), CAS: /, stock: 8.7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₃₂N₂O₆.
Oseltamivir Acid, CAS: 187227-45-8, stock: 8.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₂₄N₂O₄.
4-Amino-2-(5-methyl-1,3,4-oxadiazol-2-yl)phenol, CAS: 1091990-90-7, stock: 5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₉N₃O₂.
4-Amino-2-(methoxymethyl)phenol Hydrochloride, CAS: 135043-65-1, stock: 1.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₂ClNO₂.
Oseltamivir Acid Hydrochloride, CAS: 1415963-60-8, stock: 9.9g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₂₅ClN₂O₄.
Oseltamivir Acid Isopropyl Ester Phosphoric Acid, CAS: /, stock: 8.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₃₀N₂O₄•H₃PO₄.
5-Nitroorotic Acid, CAS: 17687-24-0, stock: 4.4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₃N₃O₆.
N-[2-(S)-Methyl-d3-butyryl]-4-(S)-phenylmethyl-2-oxazolidinone, CAS: 1073232-99-1, stock: 5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₆D₃NO₃.
4-Amino-2-bromo-6-chlorophenol, CAS: 1158322-54-3, stock: 9g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₅NOClBr.
4-Amino-2-bromophenol, CAS: 16750-67-7, stock: 2.1g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₆BrNO.
Oseltamivir Acid Methyl Ester, CAS: 208720-71-2, stock: 9.9g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₂₆N₂O₄.
Oseltamivir Acid Methyl Ester Phosphate Salt, CAS: /, stock: 9.7g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₂₉N₂O₈P.
Dihydroorotate Acid Methyl Ester, CAS: 23903-57-3, stock: 5.7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₈N₂O₄.
DL-Dihydoorotic Acid, CAS: 155-54-4, stock: 6.6g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₆N₂O₄.
Nifuratel, CAS: 4936-47-4, stock: 4.5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₁N₃O₅S.
4-Amino-2-chloro-3-fluorophenol, CAS: 1003710-18-6, stock: 7.2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₅NOFCl.
4-Amino-2-chloro-5-hydroxybenzenesulfonamide, CAS: 41606-65-9, stock: 7.9g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₇ClN₂O₃S.
Oseltamivir Acid Potassium Salt, CAS: 1363339-68-7, stock: 8.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₂₃KN₂O₄.
Oseltamivir citric acid Adduct, CAS: /, stock: 2.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₃₄N₂O₁₀.
Pseudoephedroxane, CAS: 16251-47-1, stock: 3.6g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₃NO₂.
Pseudoephedroxane-d3, CAS: 1329610-93-6, stock: 5.4g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₀D₃NO₂.
4-Amino-2-chlorophenol, CAS: 3964-52-1, stock: 2.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₆ClNO.
4-Amino-2-ethynylphenol, CAS: 1391053-48-7, stock: 3.9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₇NO.
Oseltamivir citric acid dehydrate, CAS: /, stock: 8.3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₃₂N₂O₉.
Orotic Acid Monohydrate, CAS: 50887-69-9, stock: 9.2g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₄N₂O₄•H₂O.
Orotic Acid Monosodium Salt, CAS: 154-85-8, stock: 5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₃N₂NaO₄.
R)-5-(2,2-Dimethyl-4H-1,3-benzodioxin-6-yl)-1,3-oxazolidin-2-one, CAS: 452339-73-0, stock: 9.8g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₅NO₄.
Oseltamivir Namino-fructosyl Conjugate, CAS: /, stock: 3.5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₃₈N₂O₉.
Oseltamivir Phosphate, CAS: 204255-11-8, stock: 3.2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₃₁N₂O₈P.
Orotic Acid-13C,15N2 Monohydrate, CAS: 1346602-15-0, stock: 1.8g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄¹³CH₄¹⁵N₂O₄•H₂O.
Orotic Acid-13C5 Monohydrate, CAS: /, stock: 4.6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: ¹³C₅H₅N₂O₅.
4-Amino-2-methoxyphenol, CAS: 52200-90-5, stock: 8.7g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₉NO₂.
Oseltamivir-13C2,d3 Acid, CAS: /, stock: 9.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂¹³C₂H₂₁D₃N₂O₄.
Oseltamivir-13C2,d3 Phosphate, CAS: /, stock: 2.7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄¹³C₂H₂₈D₃N₂O₈P.
Orotic Acid-15N Monohydrate, CAS: 1229646-87-0, stock: 4.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₆N¹⁵NO₅.
Orotic Acid-15N2 Monohydrate, CAS: 147687-63-6, stock: 9.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₆¹⁵N₂O₅.
4-Amino-2-methoxyphenol Hydrochloride, CAS: 4956-52-9, stock: 6.4g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₁₀ClNO₂.
Oseltamivir-d3, CAS: 1093851-61-6, stock: 1.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₂₅D₃N₂O₄.
Oseltamivir-d3 Acid, CAS: 1242184-43-5, stock: 9g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₂₁D₃N₂O₄.
Orotic Acid-15N2 Monosodium Salt, CAS: /, stock: 5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₃¹⁵N₂NaO₄.
Orotidine, CAS: 314-50-1, stock: 1g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₂N₂O₈.
Sutezolid, CAS: 168828-58-8, stock: 8.6g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₂₀FN₃O₃S.
4-Amino-2-[(diethylamino)methyl]phenol, CAS: 51387-92-9, stock: 3.1g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₈N₂O.
4-Amino-3,5-difluorophenol, CAS: 135086-76-9, stock: 6.8g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₅NOF₂.
Oseltamivir-d3 Phosphate, CAS: /, stock: 7.8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₂₈D₃N₂O₈P.
Oseltamivir-d5 Phosphate, CAS: /, stock: 8.2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₂₆D₅N₂O₈P.
Orotidine-15N2,13C, CAS: /, stock: 4.9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉¹³CH₁₂¹⁵N₂O₈.
Oxonic Acid -13C2,15N3 Potassium Salt Hydrate, CAS: /, stock: 6.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂¹³C₂H₄K¹⁵N₃O₅.
Tributylphosphine Oxide, CAS: 814-29-9, stock: 7.4g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₂₇OP.
4-Amino-3-(trifluoromethyl)phenol, CAS: 445-04-5, stock: 7.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₆NOF₃.
4-Amino-3-chlorophenol, CAS: 17609-80-2, stock: 8.5g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₆ClNO.
4-Amino-3-chlorophenol Hydrochloride, CAS: 52671-64-4, stock: 4.8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₆NOCl • HCl.
4-Amino-3-fluorophenol, CAS: 399-95-1, stock: 7.4g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₆FNO.
Thiomorpholine 1,1-Dioxide, CAS: 39093-93-1, stock: 4.9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₉NO₂S.
Toloxatone, CAS: 29218-27-7, stock: 4.7g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₃NO₃.
4-Amino-3-methoxyphenol, CAS: 61638-01-5, stock: 8.9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₉NO₂.
4-Amino-3-methylphenol, CAS: 2835-99-6, stock: 8.4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₉NO.
4-Amino-3-nitrophenol, CAS: 610-81-1, stock: 3.7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₆N₂O₃.
4-Amino-4’-hydroxydiphenylsulfone, CAS: 25963-47-7, stock: 2.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₁NO₃S.
Zolmitriptan, CAS: 139264-17-8, stock: 7.9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₂₁N₃O₂.
Zolmitriptan N-Oxide, CAS: 251451-30-6, stock: 8.6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₂₁N₃O₃.
Zolmitriptan-D6 (Major), CAS: 1217644-84-2, stock: 3.1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₅D₆N₃O₂.
Zolmitriptan-d6 N-Oxide, CAS: 1217618-32-0, stock: 8.9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₅D₆N₃O₃.
4-Aminocatechol, CAS: 13047-04-6, stock: 3.7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₇NO₂.
[4R-[3(2(S*),5(R*),4R]]-3-[2-[1-[3-[Bis(phenylmethyl)amino]phenyl]propyl]-5-hydroxy-1,3-dioxo-5-(2-phenylethyl)-6-octynyl]-4-phenyl-2-oxazolidinone, CAS: 188559-22-0, stock: 6.4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₈H₄₈N₂O₅.
[4R-[3(2S*,3S*),4R*]]-3-[3-[3-[Bis(phenylmethyl)amino]phenyl]-2-(2-methyl-1,3-dioxolan-2-yl)-1-oxopentyl]-4-phenyl-2-oxazolidinone, CAS: 188559-29-7, stock: 3.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₈H₄₀N₂O₅.
[R-(E)]-3-(1-Oxo-2-pentenyl)-4-phenyl-2-oxazolidinone, CAS: 188559-05-9, stock: 1.8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₅NO₃.
4-Aminophenyl α-D-Glucuronide, CAS: /, stock: 2.8g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₅NO₇.
[R-(R*,S*)]-3-[3-(3-Aminophenyl)-1-oxopentyl]-4-phenyl-2-oxazolidinone, CAS: 174590-39-7, stock: 7.8g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₂N₂O₃.
[R-(R*,S*)]-3-[3-[3-[Bis(phenylmethyl)amino]phenyl]-1-oxopentyl]-4-phenyl-2-oxazolidinone, CAS: 174590-40-0, stock: 9.5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₄H₃₄N₂O₃.
4-Aminophenyl β-D-Glucuronide Sodium Salt, CAS: /, stock: 7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₄NNaO₇.
4-Amyloxyphenol, CAS: 18979-53-8, stock: 7.7g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₆O₂.
4-(2-Aminoethyl)-2-methoxyphenol, CAS: 554-52-9, stock: 6.6g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₃NO₂.
4-Amino-2-nitrophenol, CAS: 119-34-6, stock: 4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₆N₂O₃.
4-Chlorothiophenol(4-Chlorobenzenethiol), CAS: 106-54-7, stock: 5.9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₅ClS.
4-Nitro-2-phenoxyphenol, CAS: 70995-08-3, stock: 1.1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₉NO₄.
4-[(5,6-Dihydro-4H-1,3-thiazin-2-yl)amino]phenol, CAS: 540771-32-2, stock: 1.4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₂N₂OS.
4-[[4-(Phenylmethoxy)phenyl]methyl]-phenol O-α-D-Glucuronic Acid Methyl Ester, CAS: /, stock: 1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₂₈O₈.
4-[[4-(Phenylmethoxy)phenyl]methyl]-phenol O-α-D-Glucuronic Acid Sodium Salt, CAS: /, stock: 3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₂₅NaO₈.
4-[[[1-(2-Fluorophenyl)cyclopentyl]amino]methyl]-2-[(4-methyl-1-piperazinyl)methyl]phenol Hydrochloride, CAS: 1700693-96-4, stock: 8.9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₃₂FN₃O • (HCl).
4-Benzyloxy-3-methoxyphenol, CAS: 40232-88-0, stock: 8.1g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₄O₃.
4-Benzyloxyphenyl 4-Hydroxyphenyl Sulfone, CAS: 63134-33-8, stock: 4.6g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₁₆O₄S.
4-Bromo-2,3,5,6-tetrafluorophenol, CAS: 1998-61-4, stock: 7g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆HOF₄Br.
4-Bromo-2,3-dichlorophenol, CAS: 1940-44-9, stock: 7.6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₃BrCl₂O.
4-Bromo-2,3-difluorophenol, CAS: 144292-32-0, stock: 9.8g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₃BrF₂O.
4-Bromo-2,3-dimethylphenol, CAS: 22802-37-5, stock: 5.9g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₉OBr.
4-Bromo-2,5-dichlorophenol, CAS: 1940-42-7, stock: 8.2g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₃BrCl₂O.
4-Bromo-2,5-difluorophenol, CAS: 486424-36-6, stock: 7.6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₃OF₂Br.
4-Bromo-2,5-dimethylphenol, CAS: 85223-93-4, stock: 5.5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₉BrO.
4-Bromo-2,6-bis(propan-2-yl)phenol, CAS: 03/03/2432, stock: 9.5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₇BrO.
4-Bromo-2,6-bis-hydroxymethyl-phenol, CAS: 6296-63-5, stock: 9.4g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₉BrO₃.
4-Bromo-2,6-di-tert-butylphenol, CAS: 1139-52-2, stock: 6.7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₂₁OBr.
4-Bromo-2,6-dichlorophenol, CAS: 3217-15-0, stock: 9.5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₃BrCl₂O.
4-Bromo-2,6-difluoro-3-methylphenol, CAS: 1365272-26-9, stock: 1.2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₅BrF₂O.
4-Bromo-2,6-difluorophenol, CAS: 104197-13-9, stock: 6.9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₃BrF₂O.
4-Bromo-2,6-diiodophenol, CAS: 15459-51-5, stock: 8.8g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₃OBrI₂.
4-Bromo-2,6-dimethylphenol, CAS: 02/05/2374, stock: 4.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₉BrO.
4-Bromo-2,6-dimethylphenol-d8 (Major), CAS: 1142096-13-6, stock: 3.3g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈HD₈BrO.
4-Bromo-2-(1H-pyrazol-3-yl)phenol, CAS: 99067-15-9, stock: 5.6g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₇N₂OBr.
4-bromo-2-(4-bromophenoxy)-Phenol, CAS: 880872-48-0, stock: 4.3g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₈Br₂O₂.
Metaproterenol Hemisulfate Salt, CAS: 5874-97-5, stock: 2.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₇NO₃•1/2H₂SO₄.
4-bromo-2-(4-bromophenoxy)-Phenol, CAS: 1087545-27-4, stock: 2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₈Br₂O₂.
4-Bromo-2-(hydroxymethyl)-6-methoxyphenol, CAS: 35090-64-3, stock: 7.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₉O₃Br.
Metaproterenol-d7 Hemisulfate Salt, CAS: 1346601-49-7, stock: 5.8g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₀D₇NO₃•1/2H₂SO₄.
4-Bromo-2-(isoxazol-5-yl)phenol, CAS: 213690-27-8, stock: 2.4g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₆NO₂Br.
4-Bromo-2-(trifluoromethoxy)phenol, CAS: 690264-39-2, stock: 2.5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₄O₂F₃Br.
4-Bromo-2-(trifluoromethoxy)thiophenol, CAS: 175278-15-6, stock: 5.7g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₄BrF₃OS.
4-Bromo-2-chloro-3-fluorophenol, CAS: 1233026-52-2, stock: 5.8g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₃BrClFO.
(2S)-(2S)-1-((2S,3S)-3-(3-methylhexyl)-4-oxooxetan-2-yl)tridecan-2-yl 2-formamido-4-Methylpentanoate, CAS: /, stock: 7.6g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₀H₅₅NO₅.
4-Bromo-2-chloro-5-fluorophenol, CAS: 1036383-21-7, stock: 4.5g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₃OFClBr.
4-Bromo-2-chloro-6-fluorophenol, CAS: 161045-79-0, stock: 7.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₃BrClFO.
(2S)-(2S)-1-((2S,3S)-3-(4-methylhexyl)-4-oxooxetan-2-yl)tridecan-2-yl 2-formamido-4-Methylpentanoate, CAS: /, stock: 4.7g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₀H₅₅NO₅.
4-Bromo-2-chloro-6-methylphenol, CAS: 7530-27-0, stock: 1.8g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₆OClBr.
4-Bromo-2-chloro-6-nitrophenol, CAS: 58349-01-2, stock: 9.1g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₃BrClNO₃.
(2S,3S,5S)-2-Hexyl-3,5-dihydroxyhexadecanoic Acid, CAS: 130793-30-5, stock: 4.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₄₄O₄.
(2S,3S,5S)-2-Hexyl-3,5-dihydroxyhexadecanoic Acid Sodium Salt, CAS: /, stock: 1.8g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₄₃NaO₄.
4-Bromo-2-chlorophenol, CAS: 3964-56-5, stock: 9.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₄BrClO.
4-Bromo-2-ethylphenol, CAS: 18980-21-7, stock: 5.4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₉BrO.
(2S,3S,5S)-2-Hexyl-3,5-dihydroxyhexadecanoic Acid-d13, CAS: 1217806-00-2, stock: 3.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₃₁D₁₃O₄.
4-Bromo-2-fluoro-6-(trifluoromethyl)phenol, CAS: 1224604-17-4, stock: 2.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₃OF₄Br.
4-Bromo-2-fluoro-6-iodophenol, CAS: 1228093-50-2, stock: 8.8g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₃OFBrI.
(3R,4R)-3-Hexyl-4-[(2S)-2-hydroxypentadecyl]-2-oxetanone, CAS: 1179806-74-6, stock: 8.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₄₆O₃.
4-Bromo-2-fluoro-6-nitrophenol, CAS: 320-76-3, stock: 7.8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₃BrFNO₃.
4-Bromo-2-fluorophenol, CAS: 2105-94-4, stock: 8.8g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₄BrFO.
(3R,4R,2’S)-3-Hexyl-4-(2’-benzyloxypentadec-1’-yl) Oxetan-2-one, CAS: /, stock: 9.6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₁H₅₂O₃.
(3R,4R,2’S)-3-Isopentyl-4-(2’-benzyloxypentadec-1’-yl)oxetan-2-one, CAS: /, stock: 5.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₀H₅₀O₃.
4-Bromo-2-fluorothiophenol, CAS: 174414-93-8, stock: 5.4g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₄FSBr.
4-Bromo-2-iodophenol, CAS: 207115-22-8, stock: 2.6g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₄BrIO.
(3S)-3-(Phenylmethoxy)-hexadecanal, CAS: 261927-83-7, stock: 3.1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₃₈O₂.
(3S,4S)-3-Hexyl-4-((S)-2-hydroxypentadecyl)oxetan-2-one, CAS: /, stock: 8.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₄₆O₃.
4-Bromo-2-methoxyphenol, CAS: 7368-78-7, stock: 5.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₇BrO₂.
4-Bromo-2-methyl-6-nitrophenol, CAS: 20294-50-2, stock: 2.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₆BrNO₃.
4-Bromo-2-methylphenol, CAS: 01/12/2362, stock: 6.4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₇BrO.
(3S,4S,2’S)-3-Hexyl-4-(2’-benzyloxypentadec-1’-yl) Oxetan-2-one, CAS: /, stock: 7.5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₁H₅₂O₃.
(3S,4S,2’S)-3-Isopentyl-4-(2’-benzyloxypentadec-1’-yl)oxetan-2-one, CAS: /, stock: 3.2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₀H₅₀O₃.
4-Bromo-2-nitrophenol, CAS: 7693-52-9, stock: 8.1g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₄BrNO₃.
4-Bromo-2-tert-butylphenol, CAS: 10323-39-4, stock: 5.8g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₃BrO.
(3S,4S,2’S)-3-Isopentyl-4-(2’-hydroxypentadec-1’-yl)oxetan-2-one, CAS: /, stock: 3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₄₄O₃.
4-Bromo-2-trifluoromethylphenol, CAS: 50824-04-9, stock: 8.3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₄BrF₃O.
4-Bromo-2-[(ethylamino)methyl]phenol, CAS: 42313-78-0, stock: 7.2g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₂NOBr.
4-Bromo-2-[(methylamino)methyl]phenol, CAS: 157729-23-2, stock: 5.4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₀NOBr.
4-Bromo-3-(trifluoromethoxy)phenol, CAS: 886499-93-0, stock: 2.6g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₄O₂F₃Br.
4-Bromo-3-(trifluoromethyl)phenol, CAS: 320-49-0, stock: 3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₄BrF₃O.
(S)-Methyl 3-(Benzyloxy)hexadecanoate, CAS: /, stock: 4.8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₄₀O₃.
4-Bromo-3-chlorophenol, CAS: 13631-21-5, stock: 4.2g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₄BrClO.
4-Bromo-3-dimethylaminomethylphenol, CAS: 848848-16-8, stock: 3.4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₂BrNO.
4-Bromo-3-fluoro-2-nitrophenol, CAS: 889939-22-4, stock: 8.1g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₃BrFNO₃.
4-Bromo-3-fluorophenol, CAS: 121219-03-2, stock: 8.6g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₄BrFO.
4-Bromo-3-methoxyphenol, CAS: 102127-34-4, stock: 3.6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₇BrO₂.
4-Methylhexanoyl-1H-1,2,3-benzotriazole, CAS: /, stock: 7.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₇N₃O.
4-Bromo-3-nitrophenol, CAS: 78137-76-5, stock: 5.5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₄BrNO₃.
4-Bromo-5-chloro-2-methylphenol, CAS: 1092460-50-8, stock: 3.1g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₆OClBr.
4-Bromo-5-chloro-2-nitrophenol, CAS: 65001-78-7, stock: 7.6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₃BrClNO₃.
4-Bromo-5-fluoro-2-methoxyphenol, CAS: 886510-25-4, stock: 1.2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₆O₂FBr.
Isopentyl (2R)-Orlistat Tetradecyl Ester, CAS: 1356019-68-5, stock: 8.2g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₀H₅₅NO₅.
4-Bromo-5-fluoro-2-nitrophenol, CAS: 1016234-87-9, stock: 1.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₃BrFNO₃.
4-Bromo-5-methyl-2-nitrophenol, CAS: 182500-28-3, stock: 4.7g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₆NO₃Br.
L-Valine Orlistat, CAS: 1243107-50-7, stock: 7.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₅₁NO₅.
4-Bromo-O-(t-butyldimethylsilyl)-2,6-dichlorophenol, CAS: 343564-38-5, stock: 1.9g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₇BrCl₂OSi.
Methyl (3S)-3-Hydroxyhexadecanoate, CAS: 76898-45-8, stock: 8g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₃₄O₃.
N-Deformyl-N-pivaloyl Orlistat, CAS: 1356017-35-0, stock: 3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₃H₆₁NO₅.
4-Bromophenol, CAS: 106-41-2, stock: 8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₅BrO.
4-Bromophenol-1,2,3,4,5,6-13C6, CAS: 1323940-38-0, stock: 7.1g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: ¹³C₆H₅BrO.
4-Bromophenol-2,3,5,6-d4, CAS: 152404-44-9, stock: 9.2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆HD₄BrO.
5,5’-(1,3-Propanediyl)bis[5H-dibenz[b,f]azepine], CAS: 62035-55-6, stock: 5.1g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₁H₂₆N₂.
(-)-2,2’-Methylenebis[(3aS,8aR)-3a,8a-dihydro-8Hindeno[1,2-d]oxazole], CAS: 175166-49-1, stock: 9.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₁₈N₂O₂.
4-Butylphenol, CAS: 1638-22-8, stock: 5.7g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₄O.
5-(3-Chloropropyl)-5H-dibenzo[b,f]azepine, CAS: 51551-40-7, stock: 2.7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₆ClN.
Opipramol, CAS: 315-72-0, stock: 9.9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₉N₃O.
(11β,16β)-11,21-bis(acetyloxy)-2’-methyl-5’H-pregna-1,4-dieno[17,16-d]oxazole-3,20-dione(Deflazacort Impurity), CAS: 710951-92-1, stock: 8.1g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₃₃NO₇.
(16β)-21-(Acetyloxy)-2’-methyl-5’H-Pregna-1,4-dieno[17,16-d]oxazole-3,11,20-trione, CAS: 13649-84-8, stock: 8.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₂₉NO₆.
4-Chloro-2,6-difluorophenol, CAS: 164790-68-5, stock: 9.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₃ClF₂O.
Opipramol-d4, CAS: 1215716-70-3, stock: 6.9g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₅D₄N₃O.
Opipramol-d4 Dihydrochloride, CAS: 1215716-70-3, stock: 3.8g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₇D₄Cl₂N₃O.
Orlistat L-Methionine, CAS: 1356354-38-5, stock: 9.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₅₁NO₅S.
(1R,3S)-3-Aminocyclohexanol, CAS: 1110772-22-9, stock: 1.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₁₃NO.
(1S,3R)-3-Aminocyclohexanol Hydrochloride, CAS: /, stock: 3.1g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₁₃NO • HCl.
4-Chloro-2-(1H-pyrazol-3-yl)phenol, CAS: 18704-67-1, stock: 9.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₇N₂OCl.
4-Chloro-2-(4-cyclopropyl-1,1,1-trifluoro-2-hydroxybut-3-yn-2-yl)phenol, CAS: /, stock: 2.8g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₀ClF₃O₂.
4-Chloro-2-(4-ethylpiperazine-1-carbonyl)phenol Hydrochloride, CAS: 1235438-79-5, stock: 8.5g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₇N₂O₂Cl • HCl.
4-Chloro-2-(isoxazol-5-yl)-5-methylphenol, CAS: 213690-32-5, stock: 9.1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₈NO₂Cl.
rel-(3R,4S)-3-Hexyl-4-[2-hydroxytridecyl]-2-oxetanone, CAS: 1795791-38-6, stock: 6.5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₄₂O₃.
(3aR,4R,6S,6aS)-4-[[(1,1-Dimethylethoxy)carbonyl]amino]-3-(1-ethylpropyl)-3a,5,6,6a-tetrahydro-4H-cyclopent[d]isoxazole-6-carboxylic Acid Methyl Ester, CAS: 229613-93-8, stock: 7.4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₃₀N₂O₅.
(3aR,4R,7aR)-3a,7a-Dihydro-2-methyl-4-[(1R,2R)-1,2,3-trihydroxypropyl]-4H-pyrano[3,4-d]oxazole-6-carboxylic Acid Methyl Ester, CAS: 1072449-83-2, stock: 2.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₇NO₇.
4-Chloro-2-(isoxazol-5-yl)phenol, CAS: 86176-56-9, stock: 3.3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₆NO₂Cl.
4-Chloro-2-(methyl-d3)phenol, CAS: 1407521-73-6, stock: 1.4g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₄D₃ClO.
Triphenylphosphine Oxide, CAS: 791-28-6, stock: 2.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₅OP.
Triphenylphosphine Oxide-d15, CAS: 54964-93-1, stock: 4.1g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈D₁₅OP.
(3aR,4R,7aR)-3a,7a-Dihydro-2-methyl-4-[(1S,2R)-1,2,3-tris(acetyloxy)propyl]-4H-pyrano[3,4-d]oxazole-6-carboxylic Acid Methyl Ester, CAS: 78850-37-0, stock: 9.8g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₃NO₁₀.
(3aR,4R,7aR)-3a,7a-Dihydro-4-[(S)-hydroxy[(4R)-2-oxo-1,3-dioxolan-4-yl]methyl]-2-methyl-4H-pyrano[3,4-d]oxazole-6-carboxylic Acid Methyl Ester, CAS: 1072449-84-3, stock: 7.9g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₅NO₈.
4-Chloro-2-(pyridin-3-yl)phenol, CAS: 1214337-83-3, stock: 1.9g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₈NOCl.
4-Chloro-2-(trifluoromethyl)phenol, CAS: 53903-51-8, stock: 1.2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₄OF₃Cl.
[3S-(3α,4α,6β)]-3-Hexyltetrahydro-4-hydroxy-6-undecyl-2H-pyran-2-one, CAS: 68711-33-1, stock: 3.1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₄₂O₃.
[S-(E)]-7-Heneicosen-10-ol, CAS: 68711-41-1, stock: 1.8g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₄₂O.
(3aR,4S,6R,6aS)-6-(N-Boc-amino)-3-(1-ethylpropyl)-3a,5,6,6a-tetrahydro-4H-cyclopent[d]isoxazole-4-carboxylic Acid Methyl Ester, CAS: 383910-24-5, stock: 1.5g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₃₀N₂O₅.
(3aS,4S,6R,6aR)-6-(N-Boc-amino)-3-(1-ethylpropyl)-3a,5,6,6a-tetrahydro-4H-cyclopent[d]isoxazole-4-carboxylic Acid Methyl Ester, CAS: 383910-25-6, stock: 5.6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₃₀N₂O₅.
4-Chloro-2-cyclohexylphenol, CAS: 13081-17-9, stock: 1.9g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₅OCl.
4-Chloro-2-fluoro-5-nitrophenol, CAS: 98404-02-5, stock: 7.9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₃ClFNO₃.
(3aS,4S,6R,6aR)-6-(N-Boc-amino)-3-(1-ethylpropyl)-3a,5,6,6a-tetrahydro-4H-cyclopent[d]isoxazole-4-carboxylic Acid Methyl Ester, CAS: 383910-22-3, stock: 9.4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₃₀N₂O₅.
(3R,4S,5R,6S)-1-Aza-4-hydroxy-5-formyl-6-isopropyl-3-methyl-7-oxabicycl[3.3.0]octan-2-one, CAS: 145452-03-5, stock: 8.8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₇NO₄.
4-Chloro-2-fluorophenol, CAS: 348-62-9, stock: 4.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₄ClFO.
4-Chloro-2-hydrazinylphenol, CAS: 23274-86-4, stock: 3.8g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₇ClN₂O.
(3R,4S,5S,6S)-1-Aza-5-carboxyl-4-hydroxy-6-isopropyl-3-methyl-7-oxabicyclo[3.3.0]octan-2-one, CAS: 145451-96-3, stock: 4.8g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₇NO₅.
4-Chloro-2-hydroxyphenylboronic acid pinacol ester, CAS: 1377503-12-2, stock: 8.7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₆BClO₃.
4-Chloro-2-iodo-6-methylphenol, CAS: 1257535-34-4, stock: 6.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₆OClI.
4-Chloro-2-iodophenol, CAS: 71643-66-8, stock: 6.5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₄OClI.
4-Chloro-2-isopropyl-5-methylphenol, CAS: 89-68-9, stock: 7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₃ClO.
(4R,4’R)-2,2’-(Propane-2,2-diyl)bis(4-phenyl-4,5-dihydrooxazole), CAS: 150529-93-4, stock: 2.2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₂N₂O₂.
4-Chloro-2-methoxyphenol, CAS: 16766-30-6, stock: 5.1g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₇ClO₂.
4-Chloro-2-methylphenol Sulfate Sodium Salt, CAS: /, stock: 6.8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₆ClNaO₄S.
4-Chloro-2-methylphenol-d3 Sulfate Sodium Salt, CAS: /, stock: 5.7g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₃D₃lNaO₄S.
4-Chloro-2-nitro-3-trifluoromethylphenol, CAS: 1192021-50-3, stock: 1.5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₃NO₃F₃Cl.
4-Chloro-2-nitro-5-trifluoromethyl-phenol, CAS: 1192021-48-9, stock: 1.8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₃NO₃F₃Cl.
(4S,4’S)-2,2’-(Pentane-3,3’-diyl)bis(4-benzyl-4,5-dihydrooxazole), CAS: 160191-64-0, stock: 3.8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₃₀N₂O₂.
4-Chloro-2-nitrobenzenediazonium Chloride, CAS: 119-09-5, stock: 2.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₃Cl₂N₃O₂.
4-Chloro-2-[(ethylamino)methyl]phenol, CAS: 1016500-71-2, stock: 9.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₂NOCl.
4-Chloro-2-[(methylamino)methyl]phenol, CAS: 38926-77-1, stock: 3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₀NOCl.
4-Chloro-3,5-difluorophenol, CAS: 03/03/2268, stock: 8.9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₃ClF₂O.
(4Z,10Z)-Tetradecadien-1-ol, CAS: /, stock: 2.5g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₂₆O.
(4Z,10Z)-Tetradecadienyl Acetate, CAS: 107433-75-0, stock: 3.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₂₈O₂.
4-Chloro-3-(trifluoromethoxy)phenol, CAS: 886500-85-2, stock: 8.9g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₄O₂F₃Cl.
4-Chloro-3-(trifluoromethyl)phenol, CAS: 6294-93-5, stock: 3.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₄ClF₃O.
(5R)-5-Hydroxy-3-oxo-6-(benzyloxy)-hexanoic Acid tert-Butyl Ester, CAS: 147849-63-6, stock: 4.3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₂₅O₅.
(6R,7R)-7-(4-Hydroxyisoxazole-3-carboxamido)-8-oxo-3-vinyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid, CAS: 1356842-10-8, stock: 5.1g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₁N₃O₆S.
4-Chloro-3-ethyl-5-methylphenol, CAS: 1125-66-2, stock: 5.4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₁OCl.
4-Chloro-3-ethylphenol, CAS: 14143-32-9, stock: 3.4g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₉OCl.
1,2,3,9-Tetrahydro-3-(1H-imidazol-1-ylmethyl)-9-methyl-4H-carbazol-4-one (Ondansetron Impurity G), CAS: 99614-03-6, stock: 8.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₇N₃O.
(6R,7R)-7-(4-Hydroxyisoxazole-3-carboxamido)-8-oxo-3-vinyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid tert-Butyl Ester, CAS: /, stock: 1.1g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₉N₃O₆S.
(8Z)-Dodecenyl Acetate, CAS: 28079-04-1, stock: 3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₂₆O₂.
4-Chloro-3-fluorophenol, CAS: 348-60-7, stock: 5.6g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₄ClFO.
4-Chloro-3-iodophenol, CAS: 202982-72-7, stock: 8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₄OClI.
1,2,3,9-Tetrahydro-9-methyl-3-methylene-4H-carbazol-4-one, CAS: 99614-64-9, stock: 7.9g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₃NO.
(βR)-β-Amino-3-chloro-4,5-dihydro-5-isoxazoleethanol (Mixture of Diastereomers), CAS: 1322622-94-5, stock: 9.5g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₉ClN₂O₂.
1,2,3,9-Tetrahydro-9-methyl-4H-carbazol-4-one, CAS: 27387-31-1, stock: 6g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₃NO.
1-Methylene Ondansetron, CAS: /, stock: 8.6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₁₉N₃O.
(R)-(+)-1-(2-Bromophenyl)ethanol, CAS: 76116-20-6, stock: 2.2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₉BrO.
4-chloro-3-[(4-ethoxyphenyl)methyl]-Phenol, CAS: 1408077-50-8, stock: 6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₅ClO₂.
3-Methylene-2,3-dihydro-1H-carbazol-4(9H)-one, CAS: /, stock: 6.7g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₁NO.
3-[(Dimethylamino)methyl]-1,2,3,9-tetrahydro-9-methyl-4H-carbazol-4-one Hydrochloride, CAS: 119812-29-2, stock: 4.9g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₂₁ClN₂O.
(R,S)-ATPA, CAS: 140158-50-5, stock: 8.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₆N₂O₄.
4-Chlorophenol, CAS: 106-48-9, stock: 3.4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₅ClO.
4-Chlorophenol-13C6, CAS: 475295-86-4, stock: 8.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: ¹³C₆H₅ClO.
3-[(Dimethylamino)methyl]-1,2,3,9-tetrahydro-9-methyl-4H-carbazol-4-one-d6 Hydrochloride, CAS: /, stock: 6.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₅D₆ClN₂O.
6,6’-Methylenebis[(3RS)-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-1,2,3,9-tetrahydro-4H-carbazol-4-one(Ondansetron Impurity B), CAS: 1076198-52-1, stock: 7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₇H₃₈N₆O₂.
4-Chlorophenol-d4, CAS: 344298-84-6, stock: 2.9g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆HD₄ClO.
6,6’-Methylenebis[(3RS)-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-1,2,3,9-tetrahydro-4H-carbazol-4-one-d6(Ondansetron Impurity B), CAS: /, stock: 3.6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₇H₃₂D₆N₆O₂.
6,6’-Methylenebis[1,2,3,4-tetrahydro-carbazol-4-one], CAS: 1216890-42-4, stock: 7.5g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₂₂N₂O₂.
4-Chloropyrocatechol, CAS: 2138-22-9, stock: 1.9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₅ClO₂.
4-Chlorotetrafluorophenol, CAS: 4232-66-0, stock: 2.5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆HOF₄Cl.
6-Hydroxy Ondansetron, CAS: 110708-17-3, stock: 3.1g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₉N₃O₂.
(S)-2,4-Diphenyl-4,5-dihydrooxazole, CAS: 475571-19-8, stock: 7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₃NO.
(S)-2-(2-Bromophenyl)-4-t-butyl-4,5-dihydrooxazole, CAS: 154701-60-7, stock: 7.8g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₆BrNO.
(S)-2-(3-Bromophenyl)-4-t-butyl-4,5-dihydrooxazole, CAS: 1291790-28-7, stock: 5.2g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₆BrNO.
7-Hydroxy Ondansetron, CAS: 126702-17-8, stock: 7.4g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₉N₃O₂.
(S)-2-(4-Bromophenyl)-4-t-butyl-4,5-dihydrooxazole, CAS: 1305322-94-4, stock: 3.9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₆BrNO.
(S)-2-Phenyl-4,5-dihydrooxazole-4-carboxylic Acid Methyl Ester (~60% ee), CAS: 78715-83-0, stock: 1.2g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₁NO₃.
4-Cyanophenol, CAS: 767-00-0, stock: 4.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₅NO.
4-Cyanophenol 2,3,5,6-d4, CAS: 1025089-21-7, stock: 8.2g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇HD₄NO.
N-Demethyl Ondansetron, CAS: 99614-14-9, stock: 9.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₇N₃O.
Ondansetron, CAS: 99614-02-5, stock: 5.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₉N₃O.
(S)-3-Hydroxypiperidine Hydrochloride, CAS: 475058-41-4, stock: 1.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₁₁NO•HCl.
4-Cyclobutylphenol, CAS: 10292-59-8, stock: 2.9g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₂O.
4-Cyclohexyl-benzenethiol, CAS: 18325-50-3, stock: 8.8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₆S.
Ondansetron Hydrochloride, CAS: 99614-01-4, stock: 9.3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₀ClN₃O.
Ondansetron Hydrochloride Dihydrate, CAS: 103639-04-9, stock: 6.3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₄ClN₃O₃.
4-Cyclohexylphenol, CAS: 1131-60-8, stock: 6.6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₆O.
Ondansetron-d3, CAS: 1132757-82-4, stock: 9.8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₆D₃N₃O.
Ondansetron-d3 Hydrochloride Salt, CAS: 1346605-02-4, stock: 9.5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₇D₃ClN₃O.
1,2-Benzisoxazole, CAS: 271-95-4, stock: 9.1g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₅NO.
1,2-Benzisoxazole-5-carboxylic Acid, CAS: 933744-95-7, stock: 3.5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₅NO₃.
4-Cyclopropylphenol, CAS: 10292-61-2, stock: 4.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₀O.
Tofenacin Hydrochloride Salt, CAS: 10488-36-5, stock: 1.7g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₂₂ClNO.
1,3-Dibromo-2-(difluoromethoxy)benzene, CAS: 1182728-50-2, stock: 8.5g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₄OF₂Br₂.
1,3-Oxazole-5-carbaldehyde, CAS: 118994-86-8, stock: 8.9g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₃NO₂.
4-Desulfo-4-hydroxy Picosulfate Monosodium Salt, CAS: 32500-19-9, stock: 4.2g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₄NNaO₅S.
1,2-Benzisoxazol-3-ylacetic Acid, CAS: 4865-84-3, stock: 7.2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₇NO₃.
1-(4-Hydroxyisoxazole)-carboxylic Acid, CAS: 178316-77-3, stock: 6.4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₃NO₄.
4-Desulfo-4-hydroxy Picosulfate Monosodium Salt-D13(mixture of D12/D13), CAS: /, stock: 5.4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₃D₁₃NNaO₅S.
4-Dimethylsulfamoylphenol, CAS: 15020-57-2, stock: 7.9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₁NO₃S.
1-(5-Methyl-1,2-oxazole-4-carbonyl)piperazine Hydrochloride, CAS: 1193387-26-6, stock: 1.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₃N₃O₂ • HCl.
4-Dodecyloxyphenol, CAS: 13037-87-1, stock: 2.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₃₀O₂.
4-Ethoxy-2,6-difluorophenol, CAS: 1017779-55-3, stock: 7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₈O₂F₂.
1-(Dimethyl-1,2-oxazole-4-sulfonamido)cyclopentane-1-carboxylic Acid, CAS: 1094472-05-5, stock: 8.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₆N₂O₅S.
1-Boc-4-isopropyl-4-piperidinecarboxylic Acid, CAS: 1093396-57-6, stock: 1.7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₂₅NO₄.
4-Ethoxyphenol, CAS: 622-62-8, stock: 3.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₀O₂.
4-Ethyl-2-(1-phenyl-1H-pyrazol-5-yl)phenol, CAS: 1202028-81-6, stock: 6.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₆N₂O.
1-Methyl-4-[4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)pyrazol-1-yl]piperidine, CAS: 1323919-64-7, stock: 8.2g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₂₆BN₃O₂.
1-Methyl-4-[4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)pyrazol-1-yl]piperidine-d3, CAS: /, stock: 6.6g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₂₃D₃BN₃O₂.
4-Ethyl-2-(1H-pyrazol-3-yl)phenol, CAS: 288401-59-2, stock: 2.5g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₂N₂O.
4-Ethyl-5-fluoro-2-methoxyphenol, CAS: 1065076-45-0, stock: 2.5g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₁O₂F.
1-Pentyne, CAS: 627-19-0, stock: 8.6g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₈.
1-Phenyl-1-cyclopropanecarboxylic Acid, CAS: 6120-95-2, stock: 5.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₀O₂.
4-Ethyl-5-fluoro-2-nitrophenol, CAS: 1089282-51-8, stock: 6.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₈NO₃F.
4-Ethylcatechol, CAS: 1124-39-6, stock: 1.9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₀O₂.
1-[4-(5-Fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethanone, CAS: 84163-10-0, stock: 3.1g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₅FN₂O₂.
11-epi Deflazacort, CAS: /, stock: 1.4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₃₁NO₆.
4-Ethylcatechol-d5, CAS: 1189508-64-2, stock: 5.8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₅D₅O₂.
4-Ethylguaiacol, CAS: 2785-89-9, stock: 7.3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₂O₂.
2,1-Benzisoxazole, CAS: 271-58-9, stock: 5.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₅NO.
2,1-Benzisoxazole-3-carboxylic acid, CAS: 642-91-1, stock: 7.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₅NO₃.
4-Ethylguaiacol-d5, CAS: 1219803-12-9, stock: 6.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉D₅H₇O₂.
4-Ethylphenyl Sulfate Potassium Salt, CAS: 1574285-06-5, stock: 9.8g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₉KO₄S.
2,2,2-Trifluoro-N-5-oxazolylacetamide, CAS: 110281-31-7, stock: 1.6g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₃F₃N₂O₂.
2,3-Dihydropyrazolo[5,1-b][1,3]oxazole-6-carboxylic Acid, CAS: 1239722-75-8, stock: 4.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₆N₂O₃.
4-Ethylphenyl-d4 Sulfate Potassium Salt, CAS: /, stock: 5.6g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₅D₄KO₄S.
4-Ethylphenyl-d9 Sulfate Potassium Salt, CAS: /, stock: 8.4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈D₉KO₄S.
2,4,4-Trimethyl-2-oxazoline, CAS: 1772-43-6, stock: 1.1g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₁₁NO.
2,4,5-Trimethyloxazole, CAS: 20662-84-4, stock: 8.2g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₉NO.
4-Ethylthiophenol, CAS: 4946-13-8, stock: 3g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₀S.
4-Fluoro-2-(1H-pyrazol-3-yl)phenol, CAS: 288401-64-9, stock: 1.1g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₇N₂OF.
2,4-Diaminophenol Dihydrochloride, CAS: 137-09-7, stock: 7.8g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₁₀Cl₂N₂O.
2,4-Dideoxy-6-O-(phenylmethyl)-L-threo-hexonic Acid tert-Butyl Ester, CAS: 215876-09-8, stock: 2.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₂₆O₅.
4-Fluoro-2-(trifluoromethyl)phenol, CAS: 130047-19-7, stock: 7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₄F₄O.
2,4-Diiodooxazole, CAS: 1037597-73-1, stock: 7.2g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃HI₂NO.
2,4-Dimethyl-1,3-oxazole-5-carbohydrazide, CAS: 89598-65-2, stock: 2.8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₉N₃O₂.
4-Fluoro-2-iodophenol, CAS: 2713-29-3, stock: 3.3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₄OFI.
2,4-Dimethyl-5-oxazolecarboxylic Acid, CAS: 2510-37-4, stock: 9.9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₇NO₃.
2,4-Dimethyloxazole, CAS: 01/05/7208, stock: 7g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₇NO.
4-Fluoro-2-methoxyphenol, CAS: 450-93-1, stock: 4.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₇FO₂.
4-Fluoro-2-methyl-5-nitrophenol, CAS: 122455-84-9, stock: 8.9g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₆NO₃F.
2,4-Diphenyloxazole, CAS: 838-41-5, stock: 9.1g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₁NO.
2,5,6-Trimethylbenzoxazole, CAS: 19219-98-8, stock: 8.2g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₁NO.
4-Fluoro-2-nitrophenol, CAS: 394-33-2, stock: 7.6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₄FNO₃.
2,5-Bis(5-tert-butylbenzooxazol-2-yl)thiophene, CAS: 7128-64-5, stock: 3.8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₂₆N₂O₂S.
2,5-Dichloro-1,3-benzoxazole, CAS: 3621-81-6, stock: 1.5g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₃NOCl₂.
4-Fluoro-2-[(1-phenyl-1H-pyrazol-4-yl)(2-phenylhydrazin-1-ylidene)methyl]phenol, CAS: 1006492-56-3, stock: 2.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₁₇N₄OF.
4-Fluoro-2-[(1E)-(hydroxyimino)methyl]phenol, CAS: 91407-40-8, stock: 8.9g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₆FNO₂.
2,5-Dichloroaniline, CAS: 95-82-9, stock: 6.3g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₅Cl₂N.
2,5-Dimethyl-1,3-oxazole-4-carboxylic Acid, CAS: 23000-14-8, stock: 5.8g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₇NO₃.
4-Fluoro-2-[(methylamino)methyl]phenol, CAS: 1363166-05-5, stock: 4.3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₀NOF.
4-Fluoro-3,5-dinitrophenol, CAS: 151222-64-9, stock: 8.5g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₃FN₂O₅.
2,5-Dimethylbenzoxazole, CAS: 5676-58-4, stock: 5.4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₉NO.
2,5-Diphenyloxazole, CAS: 92-71-7, stock: 9.4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₁NO.
4-Fluoro-3-methoxyphenol, CAS: 117902-15-5, stock: 4.9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₇O₂F.
2,6-Dichlorobenzoxazole, CAS: 3621-82-7, stock: 7.8g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₃Cl₂NO.
2,7A-Dimethyl-2,3,5,6-tetrahydro-[1,3]oxazolo[2,3-b][1,3]oxazole, CAS: 26562-68-5, stock: 5.8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₁₃NO₂.
4-Fluoro-3-methylphenol, CAS: 452-70-0, stock: 8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₇FO.
4-Fluoro-3-nitrophenol, CAS: 2105-96-6, stock: 8.9g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₄FNO₃.
2-(1-Chloroethyl)-1,3-benzoxazole, CAS: 1092286-05-9, stock: 6.4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₈NOCl.
2-(1-Chloroethyl)-4-ethyl-5-phenyl-1,3-oxazole, CAS: 1094382-58-7, stock: 8.1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₄NOCl.
4-Fluoro-3-trifluoromethylphenol, CAS: 61721-07-1, stock: 7.5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₄F₄O.
4-Fluorophenol, CAS: 371-41-5, stock: 5.9g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₅FO.
2-(1-Chloroethyl)-5-(3,4-dichlorophenyl)-1,3-oxazole, CAS: 1094318-44-1, stock: 4.7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₈NOCl₃.
2-(1-Chloroethyl)-5-(4-chlorophenyl)-4-methyl-1,3-oxazole, CAS: 1152541-88-2, stock: 3.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₁NOCl₂.
4-Fluorophenol-d5, CAS: 1219804-93-9, stock: 3.3g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆D₅FO.
4-Fluorothiophenol, CAS: 371-42-6, stock: 9.6g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₅FS.
2-(1-Chloroethyl)-5-phenyl-1,3-oxazole, CAS: 1094226-56-8, stock: 4.7g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₀NOCl.
2-(1-Naphthyl)-5-phenyl-1,3-oxazole, CAS: 846-63-9, stock: 8.2g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₁₃NO.
(4-Methoxy-3,5-dimethylpyridin-2-yl)methanol Hydrochloride, CAS: 96300-88-8, stock: 5.9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₄ClNO₂.
2-(1-Phenylcyclopropyl)-4-oxazolecarboxylic Acid, CAS: 1272947-00-8, stock: 1.4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₁NO₃.
2-(2,2,3,3-Tetramethylcyclopropyl)-oxazole-4-carbpxylic Acid, CAS: 1522198-99-7, stock: 6.8g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₅NO₃.
4-Hexylphenol, CAS: 2446-69-7, stock: 6.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₈O.
2-(2,4-Dichlorophenyl)oxazole, CAS: 1242336-71-5, stock: 6.9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₅NOCl₂.
2-(2-bromophenyl)-1,3-oxazole, CAS: 92346-48-0, stock: 4.6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₆BrNO.
(S)-5-Hydroxy Omeprazole, CAS: 196489-27-7, stock: 8.5g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₉N₃O₄S.
2-(2-Bromophenyl)-4-(chloromethyl)-1,3-oxazole, CAS: 1038295-04-3, stock: 8.6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₇NOClBr.
2-(2-Chloroethyl)-5-(3-nitrophenyl)-1,3-oxazole, CAS: 1094382-62-3, stock: 8.8g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₉N₂O₃Cl.
4-Hydroxy Clonidine Hydrochloride, CAS: 86861-28-1, stock: 6.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₀Cl₃N₃O.
4-Hydroxy Clonidine-d4, CAS: 1189988-05-3, stock: 2.4g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₅D₄Cl₂N₃O.
1,4-Dihydro-1-(5-methoxy-1H-benzimidazol-2-yl)-3,5-dimethyl-4-oxo-2-pyridinecarboxylic Acid Ammonium Salt, CAS: /, stock: 9.5g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₈N₄O₄.
2-(2-Hydroxyphenyl)benzoxazole, CAS: 835-64-3, stock: 1.5g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₉NO₂.
4-Hydroxy Mexiletine Hydrochloride, CAS: 123363-66-6, stock: 6.8g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₈ClNO₂.
1-Ethoxy-2-methyl-1-penten-3-one, CAS: 187222-11-3, stock: 3.2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₄O₂.
2-(2-Pyridyl)benzoxazole, CAS: 32959-62-9, stock: 7.8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₈N₂O.
2-(3-(Benzyloxy)-4,5-dimethoxybenzyl)-3-(phenylamino)acrylonitrile, CAS: /, stock: 4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₂₄N₂O₃.
Hydrolyzed Ombitasvir, CAS: /, stock: 7.1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅₀H₆₉N₇O₉.
4-Hydroxy Mexiletine-d6 Hydrochloride, CAS: 1330053-55-8, stock: 3.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₂D₆ClNO₂.
4-Hydroxy Ospemifene (Ospemifene Impurity), CAS: 128585-01-3, stock: 9.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₃ClO₃.
2,3,5-Trimethylpyridine, CAS: 695-98-7, stock: 1.3g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₁N.
2-(3-(Benzyloxy)-4,5-dimethoxybenzyl)-3-morpholinoacrylonitrile, CAS: /, stock: 5.6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₆N₂O₄.
Hydrolyzed Ombitasvir-d16, CAS: /, stock: 1.4g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅₀H₅₃D₁₆N₇O₉.
Ombitasvir, CAS: 1258226-87-7, stock: 8g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅₀H₆₇N₇O₈.
4-Hydroxy Propofol 1-O-β-D-Glucuronic Acid Methyl Ester, CAS: /, stock: 8.1g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₈O₈.
4-Hydroxy Propofol 1-O-β-D-Glucuronide, CAS: 114991-25-2, stock: 2.9g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₆O₈.
2,3,5-Trimethylpyridine N-Oxide, CAS: 74409-42-0, stock: 8.2g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₁NO.
2-(3-Bromophenyl)-4,5-dihydro-1,3-oxazole, CAS: 792913-45-2, stock: 1.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₈BrNO.
2-(3-bromophenyl)oxazole, CAS: 885274-35-1, stock: 7.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₆BrNO.
Ombitasvir-d16, CAS: /, stock: 8.1g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅₀H₅₁D₁₆N₇O₈.
4-Hydroxy Stiripentol, CAS: 58344-42-6, stock: 8.4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₂₀O₃.
4-Hydroxy Stiripentol-13CD3, CAS: 1346606-79-8, stock: 3.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃¹³CH₁₇D₃O₃.
2-(3-Chlorofuran-2-yl)-4,5-dimethyl-1,3-oxazole, CAS: 1235440-67-1, stock: 2.3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₈NO₂Cl.
2-(3-Phenyl-2,1-benzisoxazol-5-yl)-2H-tetrazole-5-carboxylic Acid, CAS: 951896-38-1, stock: 9.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₉N₅O₃.
4-Hydroxy Toremifene, CAS: 110503-62-3, stock: 1.2g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₂₈ClNO₂.
2,5-bis(Chloromethyl)-4-methoxy-3-methylpyridine, CAS: /, stock: 4.2g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₁Cl₂NO.
2,5-bis(Chloromethyl)-4-methoxy-d3-3-methylpyridine, CAS: /, stock: 4.4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₈D₃Cl₂NO.
2-(3-Phenyl-4,5-dihydroisoxazol-5-yl)acetic Acid, CAS: 6501-72-0, stock: 2.3g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₁NO₃.
2-(4-Aminophenyl)oxazole, CAS: 62882-11-5, stock: 2.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₈N₂O.
4-Hydroxy Triamterene, CAS: 1226-52-4, stock: 8.6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₁N₇O.
4-Hydroxy Triamterene Sulfate Potassium Salt, CAS: /, stock: 4.7g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₁KN₇O₄S.
2,5-Bis[(acetyloxy)methyl-4-methoxy-3-methylpyridine, CAS: 1391054-07-1, stock: 8.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₇NO₅.
2,5-Dihydroxymethyl-4-methoxy-3-methylpyridine, CAS: 120003-76-1, stock: 7.1g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₃NO₃.
2-(4-Aminophenyl)oxazole, HCl, CAS: 1351659-13-6, stock: 7.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₈N₂O • HCl.
2-(4-Bromo-Phenyl)-Benzooxazole, CAS: 3164-13-4, stock: 2.3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₈BrNO.
4-Hydroxy Triamterene Sulfate, Sodium Salt, CAS: 73756-87-3, stock: 1.1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₀N₇NaO₄S.
4-Hydroxy Triamterene Sulfate-d4, Sodium Salt, CAS: /, stock: 8.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₆D₄N₇NaO₄S.
2-(Chloromethyl)-3,5-dimethylpyridine Hydrochloride, CAS: 73590-93-9, stock: 3.8g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₁Cl₂N.
2-(Chloromethyl)-4-methoxy-3,5-dimethylpyridine, CAS: 84006-10-0, stock: 9.4g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₂ClNO.
2-(4-bromophenyl)-1,3-oxazole, CAS: 176961-50-5, stock: 1.4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₆BrNO.
4-Hydroxy Triamterene-d4 Hydrochloride, CAS: /, stock: 8.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₈D₄ClN₇O.
4-Hydroxy Xylazine, CAS: 145356-32-7, stock: 9.5g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₆N₂OS.
2-(Chloromethyl)-4-methoxy-3,5-dimethylpyridine Hydrochloride, CAS: 86604-75-3, stock: 4.9g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₃Cl₂NO.
2-Acetoxymethyl-5-hydroxymethyl-4-methoxy-3-methylpyridine, CAS: 120003-77-2, stock: 6.7g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₅NO₄.
2-(4-Bromophenyl)-5-chloro-1,3-benzoxazole, CAS: 122351-86-4, stock: 9.1g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₇NOClBr.
2-(4-Chlorophenyl)oxazole-4-carboxylic Acid, CAS: 1065102-51-3, stock: 8.8g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₆NO₃Cl.
4-Hydroxy-2-(trifluoromethyl)phenylboronic Acid Pinacol Ester, CAS: 1029439-76-6, stock: 5.4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₆BF₃O₃.
2-(4-Fluorophenyl)oxazole, CAS: 885268-39-3, stock: 2.7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₆FNO.
2-(4-Piperazin-1-yl-phenyl)-benzooxazole Dihydrochloride, CAS: 1187927-94-1, stock: 1.1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₇N₃O • 2HCl.
4-Hydroxy-3,5-dimethoxybenzyl Alcohol, CAS: 530-56-3, stock: 4.1g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₂O₄.
2-Chloromethyl-4-methoxy-3,5-dimethyl-6-hydroxypyridine, CAS: /, stock: 9.6g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₂ClNO₂.
2-(5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-3-yl)oxazole, CAS: 1201644-46-3, stock: 1.4g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₇BN₂O₃.
2-(5-Bromopyridin-3-yl)-1,3-benzoxazole, CAS: 1160274-30-5, stock: 2.4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₇N₂OBr.
2-Chloromethyl-4-methoxy-3,5-dimethylpyridine 1-Oxide, CAS: 848694-10-0, stock: 2.2g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₂ClNO₂.
2-Hydroxy-5,6-dimethyl-3-pyridinecarbonitrile, CAS: 72716-80-4, stock: 2.1g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₈N₂O.
2-(5-Methyl-2-phenyloxazole-4-yl)ethanol, CAS: 103788-65-4, stock: 3.9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₃NO₂.
3,5-Dimethyl-2-(ethoxycarbonyl)-4-pyrone, CAS: 187222-13-5, stock: 7.9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₂O₄.
2-(Azidomethyl)-6-chloro-1,3-benzoxazole, CAS: 1158199-79-1, stock: 9.1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₅N₄OCl.
2-(Bicyclo[3.1.0]hexane-6-yl)-4-ethoxy-oxazole 4-Carboxylic Acid(endo/exo Mixtures), CAS: /, stock: 2.2g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₅NO₄.
3,5-Dimethyl-2-pyridinemethanol, CAS: 202932-05-6, stock: 7.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₁NO.
2-(Bromomethyl) Oxazole, CAS: 1065073-35-9, stock: 8.7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₄BrNO.
Homoharringtonine, CAS: 26833-87-4, stock: 4.5g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₉H₃₉NO₉.
4-Hydroxy-3-methoxy-β-nitrostyrene, CAS: 6178-42-3, stock: 9.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₉NO₄.
4-Hydroxy-3-methoxybenzenepropanol, CAS: 2305-13-7, stock: 7.6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₄O₃.
3,5-Dimethyl-2-pyridinemethanol Hydrochloride, CAS: 70580-28-8, stock: 1.4g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₂ClNO.
4,5’-Di(desmethyl) Omeprazole, CAS: /, stock: 5.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₅N₃O₃S.
2-(Bromomethyl)benzo[d]oxazole, CAS: 73101-74-3, stock: 2.7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₆BrNO.
2-(But-1-yl)-5-nitro-1,3-benzoxazole, CAS: 886360-98-1, stock: 9.1g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁ H₁₂ N₂ O₃.
Homoharringtonine-13C,d3, CAS: 1217626-64-6, stock: 8.9g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈¹³CH₃₆D₃NO₉.
4,5’-Di(desmethyl) Omeprazole Sulfide, CAS: 176219-12-8, stock: 8.7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₅N₃O₂S.
2-(Chloromethyl)-1,3-benzoxazole, CAS: 41014-43-1, stock: 4.6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₆NOCl.
2-(Chloromethyl)-5-(2-methoxyphenyl)-1,3-oxazole, CAS: 1094452-07-9, stock: 1.7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₀NO₂Cl.
4-Hydroxy-3-methyoxybenzyl Alcohol, CAS: 498-00-0, stock: 5.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₀O₃.
4-Acetyloxy Omeprazole, CAS: 1246814-65-2, stock: 9.8g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₉N₃O₄S.
4-Acetyloxy Omeprazole Sulfide, CAS: 1359829-71-2, stock: 5.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₉N₃O₃S.
2-(Chloromethyl)-5-(2-methylphenyl)-1,3-oxazole, CAS: 1094226-45-5, stock: 3.5g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₀NOCl.
4-Hydroxy-3-nitrophenylboronic Acid Pinacol Ester, CAS: 1072945-08-4, stock: 9.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₆BNO₅.
4-Acetyloxy Omeprazole Sulfone, CAS: 1391054-80-0, stock: 9.6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₉N₃O₅S.
2-(Chloromethyl)-5-(3-fluorophenyl)-1,3-oxazole, CAS: 1152546-37-6, stock: 5g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₇NOFCl.
2-(Chloromethyl)-5-(3-methoxyphenyl)-1,3-oxazole, CAS: 1094226-46-6, stock: 2.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₀NO₂Cl.
4-Hydroxy-clomiphene, CAS: 79838-51-0, stock: 4.8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₂₈ClNO₂.
4-Hydroxy-detomidine, CAS: /, stock: 6.9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₄N₂O.
2-(Chloromethyl)-5-(ethanesulfonyl)-1,3-benzoxazole, CAS: 1018186-60-1, stock: 5.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₀NO₃SCl.
2-(Chloromethyl)-5-cyclopropyl-1,3-oxazole, CAS: 1225058-34-3, stock: 4.6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₈NOCl.
2-(Chloromethyl)-5-methyl-1,3-benzoxazole, CAS: 41014-44-2, stock: 6.2g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₈NOCl.
2-(Chloromethyl)-5-nitro-1,3-benzoxazole, CAS: 119198-10-6, stock: 4g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₅N₂O₃Cl.
2-(Furan-2-yl)-5-(piperazin-1-yl)-1,3-oxazole-4-carbonitrile, CAS: 1000932-90-0, stock: 4.8g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₂N₄O₂.
2-(Hydroxyimino)-3-oxo-pentanedioic Acid 1,5-Diethyl Ester, CAS: 996-75-8, stock: 7.9g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₃NO₆.
2-(Methylthio)benzo[d]oxazole, CAS: 13673-62-6, stock: 5.5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₇NOS.
2-(N-(2-Methoxyethyl)-3,5-dimethylisoxazole-4-sulfonamido)acetic Acid, CAS: 1033194-58-9, stock: 8.4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₆N₂O₆S.
4-Hydroxybenzamidine, Hydrochloride, CAS: 38148-63-9, stock: 5.8g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₉ClN₂O.
4-Desmethoxy-4-nitro Omeprazole Sulfone, CAS: 1076199-93-3, stock: 8.9g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₆N₄O₅S.
4-Hydroxy Omeprazole Preparation Kit, CAS: 301669-82-9, stock: 3.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₇N₃O₃S.
2-(p-Tolyl)benzoxazole, CAS: 835-71-2, stock: 7.4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₁NO.
2-(Piperidin-4-yl)benzo[d]oxazole, CAS: 51784-03-3, stock: 7.3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₄N₂O.
4-Hydroxybenzenesulfonic Acid (85%), CAS: 98-67-9, stock: 3.4g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₆O₄S.
4-Hydroxybenzenesulfonic Acid Sodium Salt, CAS: 825-90-1, stock: 7.8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₅NaO₄S.
4-Hydroxy Omeprazole Sulfide, CAS: 103876-98-8, stock: 4.4g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₇N₃O₂S.
2-(tert-Butyl)-6-chloro-N-methoxy-N-methylbenzo[d]oxazole-7-sulfonamide, CAS: 1206896-20-9, stock: 1.3g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₇N₂O₄SCl.
2-(Thiophen-2-yl)-1,3-oxazole-5-carboxylic Acid, CAS: 106833-80-1, stock: 3.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₅NO₃S.
4-Hydroxy Omeprazole Sulfone, CAS: 1346600-70-1, stock: 5.1g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₇N₃O₄S.
4-Methoxy-2,3,5-trimethylpyridine, CAS: 109371-19-9, stock: 7.4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₃NO.
2-(Tributylstannyl)-1,3-benzoxazole, CAS: 105494-68-6, stock: 1.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₃₁NOSn.
Dioctyltinmercaptide, CAS: 15571-58-1, stock: 6g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₆H₇₂O₄S₂Sn.
Tetraoctyltin, CAS: 3590-84-9, stock: 6.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: (C₈H₁₇)₄Sn.
4-Methoxy-6-[[(5-methoxy-1H-benzimidazol-2-yl)thio]methyl]-5-methyl-3-pyridinemethanol, CAS: 103876-99-9, stock: 6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₉N₃O₃S.
2-(Trifluoromethyl)-1,3-oxazole-4-carboxylic Acid, CAS: 1060816-01-4, stock: 9g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₂NO₃F₃.
2-Amino-1-[4-(trifluoromethoxy)phenyl]ethanone, CAS: 1092443-01-0, stock: 7.2g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₈F₃NO₂.
4-Hydroxybenzyl Isothiocyanate, CAS: 2086-86-4, stock: 3.8g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₇NOS.
Trichlorooctyl-stannane, CAS: 3091-25-6, stock: 5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₇Cl₃Sn.
2-Amino-4-(benzyloxy)phenol, CAS: 102580-07-4, stock: 2.8g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₃NO₂.
Trichlorooctyl-stannane-d17, CAS: /, stock: 7.4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₃D₁₄Cl₃Sn.
2-Amino-4-fluorophenol, CAS: 399-97-3, stock: 7.9g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₆NOF.
2-Amino-4-methylamino-5-(3,4,5-trimethoxybenzyl)pyrimidine, CAS: 92653-78-6, stock: 4.5g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₂₀N₄O₃.
4-Hydroxyphenyl 4-Isopropoxyphenyl Sulfone, CAS: 95235-30-6, stock: 9.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₆O₄S.
5-Acetoxymethyl-2,3-dimethyl-4-chloropyridine, CAS: 1159976-97-2, stock: 5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₂ClNO₂.
5-Acetoxymethyl-2,3-dimethyl-4-chloropyridine N-oxide, CAS: 1159976-98-3, stock: 8.7g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₂ClNO₃.
2-Amino-4-oxazolecarboxylic Acid Ethyl Ester, CAS: 177760-52-0, stock: 5.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₈N₂O₃.
2-Amino-5-benzoxazolecarboxylic Acid Methyl Ester, CAS: 56388-02-4, stock: 1.8g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₈N₂O₃.
4-Hydroxyphenyl 4-Isopropoxyphenyl Sulfone-d7, CAS: /, stock: 3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₉D₇O₄S.
5-Acetoxymethyl-2,3-dimethyl-4-nitropyridine-1-oxide, CAS: 120003-74-9, stock: 5.5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₂N₂O₅.
5-Acetoxymethyl-2,3-dimethylpyridine, CAS: 1159976-99-4, stock: 9.3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₃NO₂.
2-Amino-5-chlorobenzoxazole (Zoxazolamine), CAS: 61-80-3, stock: 7.6g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₅ClN₂O.
2-Amino-5-cyclopropyl-oxazole, CAS: 1297941-53-7, stock: 6.5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₈FO₂.
4-Hydroxyphenylacetic Acid, CAS: 156-38-7, stock: 9.6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₈O₃.
5-Acetoxymethyl-2,3-dimethylpyridine N-oxide, CAS: 1159977-00-0, stock: 3.8g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₃NO₃.
2-Aminobenzoxazole, CAS: 4570-41-6, stock: 4.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₆N₂O.
2-Aminooxazole, CAS: 4570-45-0, stock: 3.2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃H₄N₂O.
4-Hydroxyphenylacetic Acid, CAS: 100287-06-7, stock: 1.6g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₂D₆O₃.
4-Iodo-2,3-dimethylphenol, CAS: 17938-69-1, stock: 6.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₉OI.
5-Hydroxy Acetate Omeprazole, CAS: /, stock: 7.7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₁N₃O₅S.
5-Hydroxy Acetate Omeprazole-d3, CAS: /, stock: 3.4g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₁₈D₃N₃O₅S.
2-Aminooxazole-4-carbonitrile, CAS: 1240598-27-9, stock: 4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₃N₃O.
2-Aminooxazole-4-carboxylic acid, CAS: 944900-52-1, stock: 4.4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₄N₂O₃.
4-Iodo-2,6-dimethylphenol, CAS: 10570-67-9, stock: 4.8g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₉OI.
4-Iodo-2-methoxyphenol, CAS: 203861-62-5, stock: 6.6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₇O₂I.
5-Hydroxy Omeprazole Sodium Salt, CAS: 1215629-45-0, stock: 7.2g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₈N₃NaO₄S.
2-Aminooxazole-5-carboxylic acid, CAS: 881637-11-2, stock: 8.5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₄N₂O₃.
4-Iodo-2-methylphenol, CAS: 60577-30-2, stock: 9.6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₇OI.
4-Iodo-2-nitrophenol, CAS: 21784-73-6, stock: 8.4g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₄NO₃I.
5-Hydroxy Omeprazole Sulfone, CAS: 151602-51-6, stock: 1.7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₉N₃O₅S.
4-Iodo-3-isopropylphenol, CAS: 1017608-20-6, stock: 5.3g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₁OI.
4-Iodo-3-methylphenol, CAS: 133921-27-4, stock: 8.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₇OI.
5-Hydroxy Omeprazole-d3 Sodium Salt, CAS: /, stock: 5.7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₅D₃N₃NaO₄S.
5-Hydroxymethyl-2,3-dimethylpyridine, CAS: 857146-29-3, stock: 8.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₁NO.
2-Bromo-4-methyloxazole-5-carboxylic Acid, CAS: 1140626-96-5, stock: 2.3g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₄NO₃Br.
2-Bromo-5-methyl-oxazole, CAS: 129053-67-4, stock: 6.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₄BrNO.
4-Iodo-3-nitrophenol, CAS: 113305-56-9, stock: 7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₄NO₃I.
4-Iodophenol, CAS: 540-38-5, stock: 4.6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₅IO.
2-Bromo-5-methyl-oxazole-4-carbaldehyde, CAS: 1240598-14-4, stock: 2.4g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₄NO₂Br.
2-Bromo-5-phenyl-1,3-oxazole, CAS: 129053-70-9, stock: 4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₆BrNO.
4-Isopropoxy-3-methylphenol, CAS: 1216201-65-8, stock: 9.6g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₄O₂.
5-O-Desmethyl Omeprazole, CAS: 151602-49-2, stock: 6.9g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₇N₃O₃S.
2-Bromooxazole-4-carbonitrile, CAS: 1240608-82-5, stock: 4.8g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄HBrN₂O.
2-Bromooxazole-4-carboxylic Acid, CAS: 1167055-73-3, stock: 9.1g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₂BrNO₃.
4-Isopropylphenol, CAS: 99-89-8, stock: 1.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₂O.
4-Isothiocyanatophenol, CAS: 2131-60-4, stock: 1.2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₅NOS.
5-O-Desmethyl Omeprazole-d3, CAS: 1189679-99-9, stock: 3.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₄D₃N₃O₃S.
2-Butyl-6-nitro-1,3-benzoxazole, CAS: 886360-96-9, stock: 5.8g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁ H₁₂ N₂ O₃.
2-Chloro-4,5-diphenyloxazole, CAS: 49656-04-4, stock: 7.6g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₀ClNO.
2-Chloro-4-fluorobenzo[d]oxazole, CAS: 1163123-39-4, stock: 8.3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₃NOFCl.
2-Chloro-4-isopropylpyrimidine, CAS: 941294-36-6, stock: 9.1g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₉N₂Cl.
Octylonium Bromide, CAS: 26095-59-0, stock: 3.1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₉H₄₃BrN₂O₄.
2-Chloro-4-methyloxazole, CAS: 1060816-10-5, stock: 8.2g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₄ClNO.
2-Chloro-4-nitro-benzoyl chloride, CAS: 7073-36-1, stock: 1.8g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₃Cl₂NO₃.
Octylonium-d3 Bromide, CAS: /, stock: 2.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₉H₄₀D₃ BrN₂O₄.
4-Mercaptobenzyl Alcohol, 90%, CAS: 53339-53-0, stock: 2.3g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₈OS.
2-Chloro-4-phenyloxazole, CAS: 445470-08-6, stock: 3.7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₆ClNO.
2-Chloro-5-(trifluoromethyl)benzo[d]oxazole, CAS: 114997-91-0, stock: 5.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₃ClF₃NO.
4-Methoxy-2-nitrophenol, CAS: 1568-70-3, stock: 2.8g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₇NO₄.
2-Chloro-5-fluoro-1,3-benzoxazole, CAS: 135533-78-7, stock: 9.8g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₃ClFNO.
4-Methoxy-3-(trifluoromethyl)phenol, CAS: 53903-59-6, stock: 1.1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₇O₂F₃.
4-Methoxy-3-nitrophenol, CAS: 15174-02-4, stock: 7.5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₇NO₄.
8(9)-Methoxy-1,3-dimethyl-12-thioxopyrido[1’,2’:3,4]imidazo[1,2-a]benzimidazol-2-(12H)-one(Mixture of Regioisomers), CAS: /, stock: 9.9g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₃N₃O₂S.
2-Chloro-6-fluorobenzo[d]oxazole, CAS: 153403-53-3, stock: 7.4g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₃ClFNO.
4-Methoxy-5-benzoyloxy-2-bis-benzylethanonephenol, CAS: 1346600-17-6, stock: 9.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₀H₂₉O₄.
Desulfoxide 4-Demethyl Omeprazole, CAS: 1384163-92-1, stock: 2.3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₇N₃O₂.
Desulfoxide O-Desmethyl Omeprazole, CAS: /, stock: 6.8g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₇N₃O₂.
2-Chlorobenzoxazole, CAS: 615-18-9, stock: 6.1g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₄ClNO.
2-Chlorooxazole-4-carbonitrile, CAS: 1240598-38-2, stock: 1.4g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄HClN₂O.
4-Methoxyphenol Cyanate Ester, CAS: 2983-74-6, stock: 2.8g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₇NO₂.
4-Methoxyphenylacetic Acid, CAS: 104-01-8, stock: 4.6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₀O₃.
Diethyl 4-Chloro-3,5-dimethylpyridine-2,6-dicarboxylate, CAS: /, stock: 1.2g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₆ClNO₄.
Esomeprazole Magnesium, CAS: 161973-10-0, stock: 6.9g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₄H₃₆MgN₆O₆S₂.
2-Chlorooxazole-4-carboxylic Acid, CAS: 706789-07-3, stock: 1.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₂ClNO₃.
2-Cyclobutyl-4-oxazolecarboxylic Acid, CAS: 1190314-33-0, stock: 5.5g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₉NO₃.
Ethyl 2-Chloro-5,6-dimethylnicotinate, CAS: 1159977-35-1, stock: 4.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₂ClNO₂.
2-Cyclohexyl-1,3-benzoxazole-6-carboxylic Acid, CAS: 1181353-33-2, stock: 6.5g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₅NO₃.
2-Cyclopentyl-4-oxazolecarboxylic Acid, CAS: 1247889-30-0, stock: 1.4g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₁NO₃.
4-Methyl-2-(piperazine-1-sulfonyl)phenol, CAS: 1193387-51-7, stock: 7.6g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₆N₂O₃S.
4-Methyl-2-(thiomorpholine-4-carbonyl)phenol, CAS: 1042634-26-3, stock: 2g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₅NO₂S.
Ethyl 4-Chloro-3,5-dimethylpicolinate, CAS: 187222-17-9, stock: 4.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₂ClNO₂.
Ethyl 5,6-Dimethylnicotinate, CAS: 77629-53-9, stock: 8.8g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₃NO₂.
2-Cyclopropyl-5-(piperazin-1-yl)-1,3-oxazole-4-carbonitrile, CAS: 1050910-59-2, stock: 8.9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₄N₄O.
4-Methylamino-phenol Hydrobromide, CAS: 33576-77-1, stock: 1.1g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₉NO • HBr.
4,5-Bis(chloromethyl)-1,3-dioxol-2-one, CAS: 1443544-27-1, stock: 4.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₄Cl₂O₃.
Methyl 4-Chloro-3,5-dimethylpicolinate, CAS: 1781867-59-1, stock: 8g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₀ClNO₂.
Mixture of N-(4-Methoxy-3,5-dimethyl-2-pyridinyl)methyl Omeprazole and N’-(4-Methoxy-3,5-dimethyl-2-pyridinyl)methyl Omeprazole, CAS: /, stock: 1.6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₃₀N₄O₄S.
2-Ethenyl-4,5-dihydrooxazole Polymer with Ethenylbenzene, CAS: 27341-52-2, stock: 5.2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₅NO.
2-Ethoxy-4-oxazolecarboxylic Acid, CAS: 706789-09-5, stock: 1.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₇NO₄.
2-Ethyl-1,3-benzoxazole-5-sulfonyl Chloride, CAS: 1183262-68-1, stock: 8.1g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₈NO₃SCl.
2-Ethyl-4-methyl-1,3-oxazole-5-carboxylic Acid, CAS: 113366-51-1, stock: 4.4g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₉NO₃.
4-Methylpyrogallol, CAS: 3955-29-1, stock: 4.1g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₈O₃.
2-Ethyl-5-methyl-1,3-oxazole-4-carboxylic Acid, CAS: 113366-77-1, stock: 9.5g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₉NO₃.
2-Ethyl-6-nitro-1,3-benzoxazole, CAS: 13243-39-5, stock: 9.5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉ H₈ N₂ O₃.
4-N-Boc-Aminophenol, CAS: 54840-15-2, stock: 1.8g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₅NO₃.
4-N-Trifluoroacetamidophenol, CAS: 2709-93-5, stock: 6.4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₆F₃NO₂.
4-Chloro-4-methyl-5-methylene-1,3-dioxolan-2-one (~90%), CAS: 95579-71-8, stock: 5.4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₅ClO₃.
2-Ethyl-oxazole-4-carboxylic Acid Methyl Ester, CAS: 1126634-42-1, stock: 1.3g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₉NO₃.
4-Nitro Propofol, CAS: 1576-14-3, stock: 4.3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₇NO₃.
4-Nitro-2-(trifluoromethyl)phenol, CAS: 1548-61-4, stock: 2.2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₄F₃NO₃.
2-Fluoro-4-oxazolecarboxylic Acid, CAS: 1167056-76-9, stock: 1.8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₂FNO₃.
2-Hydrazino-1,3-benzoxazole, CAS: 15062-88-1, stock: 7.9g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₇N₃O.
4-Nitro-3-(trifluoromethyl)phenol, CAS: 88-30-2, stock: 5.1g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₄F₃NO₃.
2-Hydroxy-1,3-oxazole-5-carboxylic acid, CAS: 1407858-88-1, stock: 4.3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₃NO₄.
4-Nitrophenol, CAS: 100-02-7, stock: 8.5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₅NO₃.
4-Nitrophenol 2-Acetamido-2-deoxy-6-O-(α-L-fucopyranosyl)-β-D-glucopyranoside, CAS: 81340-02-5, stock: 1.6g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₈N₂O₁₂.
2-Isopropenylbenzoxazole, CAS: 61841-34-7, stock: 8.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₉NO.
4-Nitrophenol-1,2,6-13C3, CAS: 93628-02-5, stock: 8.9g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃¹³C₃H₅NO₃.
2-Mercaptobenzoxazole, CAS: 2382-96-9, stock: 1.3g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₅NOS.
2-Methyl-1,3-benzoxazole-5-carboxylic acid, CAS: 90322-32-0, stock: 6.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₇NO₃.
4-Nitrophenol-15N, CAS: 103427-15-2, stock: 4.9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₅¹⁵NO₃.
2-Methyl-1,3-benzoxazole-6-carboxylic Acid, CAS: 13452-14-7, stock: 3.7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₇NO₃.
2-Methyl-1,3-oxazole-4-carbohydrazide, CAS: 500341-65-1, stock: 4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₇N₃O₂.
4-Nitrophenol-d4, CAS: /, stock: 3.7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆HD₄NO₃.
4-Nitrophenolate;tetrabutylazanium, CAS: 3002-48-0, stock: 7.5g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₄₀N₂O₃.
2-Methyl-4,5-diphenyloxazole, CAS: 14224-99-8, stock: 3.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₃NO.
2-Methyl-5-nitro-1,3-benzoxazole, CAS: 32046-51-8, stock: 7.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₆N₂O₃.
4-Nitrophenyl Acetate, CAS: 830-03-5, stock: 5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₇NO₄.
4-Nitrophenyl Chloroformate >90%, CAS: 7693-46-1, stock: 8.5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₄ClNO₄.
Omeprazole Acid Disodium Salt, CAS: 120003-84-1, stock: 6.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₅N₃Na₂O₅S.
Omeprazole Acid Methyl Ester, CAS: 120003-83-0, stock: 6.2g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₉N₃O₅S.
2-Methyl-5-phenylbenzoxazole, CAS: 61931-68-8, stock: 6.8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₁NO.
2-Methyl-6-benzoxazolemethanol, CAS: 136663-40-6, stock: 5.1g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₉NO₂.
4-Nitrophenyl Phosphorodichloridate, CAS: 777-52-6, stock: 3.9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₄Cl₂NO₄P.
4-Nitroresorcinol, CAS: 03/07/3163, stock: 1.9g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₅NO₄.
N-Trityl Ethyl Olmesartan Acid Ethyl Ester, CAS: /, stock: 3.7g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₆H₄₆N₆O₃.
Omeprazole Acid Methyl Ester Sulfide, CAS: 120003-82-9, stock: 2.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₉N₃O₄S.
Omeprazole Acid-d3 Methyl Ester Sulfide, CAS: 1329797-04-7, stock: 9.6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₆D₃N₃O₄S.
2-Methyl-6-nitro-1,3-benzoxazole, CAS: 5683-43-2, stock: 5.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₆N₂O₃.
2-Methyl-L-cysteine Hydrochloride, CAS: 148766-37-4, stock: 9.2g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₉NO₂S•HCl.
4-Nitroso-3,5-xylenol, CAS: 19628-76-3, stock: 8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₉NO₂.
4-Nitroso-3,5-xylenol-d6, CAS: /, stock: 1.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₃D₆NO₂.
2-Methylbenzoxazole, CAS: 95-21-6, stock: 9.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₇NO.
2-Methylnaphth[1,2-d]oxazole, CAS: 85-15-4, stock: 4.4g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₉NO.
4-Nonyl Phenol, CAS: 104-40-5, stock: 4.2g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₂₄O.
Omeprazole Sodium Hydrate, CAS: /, stock: 7.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₈N₃O₃NaS • H₂O.
2-Methylnaphth[2,1-d]oxazole, CAS: 20686-65-1, stock: 3.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₉NO.
2-Methylnaphth[2,3-d]oxazole, CAS: 20686-66-2, stock: 3.5g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₉NO.
N-Trityl Olmesartan Methyl Ketone, CAS: /, stock: 5.3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₄H₄₂N₆O₂.
2-Methyloxazole-4-carboxaldehyde, CAS: 113732-84-6, stock: 4.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₅NO₂.
2-N,2-N-Dimethyl-1,3-benzoxazole-2,5-diamine, CAS: 1175645-00-7, stock: 1.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₁N₃O.
4-Nonyl Phenol-13C6, CAS: 211947-56-7, stock: 1.3g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉¹³C₆H₂₄O.
Omeprazole Sulfone 3-Methyl Acetate, CAS: /, stock: 4.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₁N₃O₆S.
2-Nitrophloroglucinol, CAS: 16600-92-3, stock: 9.3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₅NO₅.
2-Oxazoleacetonitrile, CAS: 809533-78-6, stock: 5.7g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₄N₂O.
2-Oxazolecarboxylic Acid Ethyl Ester, CAS: 33036-67-8, stock: 6.7g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₇NO₃.
4-Nonyl Phenol-d15, CAS: /, stock: 3.5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₉D₁₅O.
4-Nonyl Phenol-glucuronide, CAS: 207725-23-3, stock: 9g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₃₂O₇.
2-Oxo-2,3-dihydro-1,3-benzoxazole-5-carboxylic Acid, CAS: 65422-72-2, stock: 6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₅NO₄.
4-O-(E)-Feruloylquinic Acid (~90%), CAS: 96646-16-1, stock: 2.5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₂₀O₉.
4-O-Benzyl Dopamine, CAS: 94026-91-2, stock: 8.2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₇NO₂.
Olmesartan Acid Ethyl Ester, CAS: 144689-23-6, stock: 3.4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₃₀N₆O₃.
Omeprazole-d3 Acid Disodium Salt, CAS: /, stock: 9.3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₂D₃N₃Na₂O₅S.
2-Oxo-2,3-dihydro-4-benzoxazole Carboxylic Acid, CAS: 100960-55-2, stock: 4.8g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₅NO₄.
2-Phenyl-1,3-oxazole-4-carbonyl Chloride, CAS: 1204-70-2, stock: 9.9g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₆NO₂Cl.
4-O-Benzyl-3-hydroxy Tyrosol α-Acetate 3’-Glucuronide Methyl Ester, CAS: /, stock: 8.5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₀H₃₄O₁₃.
4-Octanoylphenol, CAS: 2589-73-3, stock: 8.7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₂₀O₂.
2-Phenyl-4,5-dihydrooxazole, CAS: 7127-19-7, stock: 7.1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₉NO.
4-Octylphenol Diethoxylate, CAS: 51437-90-2, stock: 3.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₃₀O₃.
Olmesartan Bis-medoxomil(1H-1-Medoxomil + 2H-2-Medoxomil Mixture), CAS: /, stock: 2.8g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₄H₃₄N₆O₉.
Olmesartan Ethyl Ester Methyl N2-Glucuronide Triacetate, CAS: /, stock: 9.1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₉H₄₆N₆O₁₂.
2-Phenyl-5-methyloxazole-4-carboxylic Acid, CAS: 18735-74-5, stock: 1.9g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₉NO₃.
2-Phenyl-d5-4,4-dimethyl-4,5-dihydrooxazole, CAS: 639516-58-8, stock: 4.6g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₈D₅NO.
S-Deoxy-5-Hydroxy Acetate Omeprazole, CAS: /, stock: 8.4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₁N₃O₄S.
S-Deoxy-5-Hydroxy Acetate Omeprazole-d3, CAS: /, stock: 1.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₁₈D₃N₃O₄S.
2-Phenylbenzoxazole, CAS: 833-50-1, stock: 8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₉NO.
2-Phenyloxazole-5-carboxylic Acid, CAS: 106833-79-8, stock: 5.9g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₇NO₃.
4-Octylphenol-d4 Diethoxylate, CAS: 1346599-54-9, stock: 9g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₆D₄O₃.
2-Piperazin-1-yl-1,3-benzoxazole, CAS: 111628-39-8, stock: 5.8g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₃N₃O.
4-Pentadecylresorcinol, CAS: 16825-54-0, stock: 5.8g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₃₆O₂.
4-Pentylphenol, CAS: 14938-35-3, stock: 6.5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₆O.
2-Piperazin-1-yl-1,3-benzoxazole-5-sulfonamide, CAS: 1035840-39-1, stock: 7.8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₄N₄O₃S.
2-Piperidin-3-yl-1,3-benzoxazole, CAS: 754126-86-8, stock: 3.8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₄N₂O.
4-Phenolsulfonic Acid Sodium Salt Dihydrate, CAS: 10580-19-5, stock: 5.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₅NaO₄S • 2H₂O.
Olmesartan N1-Glucuronide, CAS: /, stock: 3g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₀H₃₄N₆O₉.
Olmesartan N2-Glucuronide Sodium Salt Hydrate, CAS: /, stock: 8.6g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₀H₃₄N₆O₉ • xH₂O • xNa.
3-Des(2-methoxyethyl) 3-(1-Methylethyl) Ester Nimodipine, CAS: 21881-78-7, stock: 9.6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₆N₂O₆.
2-Propyl-4-oxazolecarboxylic Acid, CAS: 36190-03-1, stock: 4.2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₉NO₃.
2-Sulfanyl-1,3-benzoxazole-6-carboxylic Acid, CAS: 108085-62-7, stock: 7.6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₅NO₃S.
4-Phenylazophenol, CAS: 1689-82-3, stock: 8.6g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₀N₂O.
2-tert-Butyl-oxazole-4-carboxylic Acid, CAS: 1060816-08-1, stock: 7.5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₁NO₃.
2-[4-(Bromomethyl)-3-fluorophenyl]-1,3-oxazole, CAS: 1245651-29-9, stock: 7.4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₇NOFBr.
4-Piperazinophenol Dihydrobromide, CAS: 38869-37-3, stock: 8.3g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₄N₂O • 2HBr.
4-Piperidin-3-ylmethyl-phenol Hydrochloride, CAS: 1170102-51-8, stock: 4.1g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₇NO • HCl.
2-[4-[Acetyl[[2-(acetylamino)-3,4-dihydro-4-oxo-6-pteridinyl]methyl]amino]phenyl]-4,5-dihydro-5-oxo-4-oxazolepropanoic Acid, CAS: 78168-20-4, stock: 5.5g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₁N₇O₇.
2-[7-(Diethylamino)-2-oxo-2H-1-benzopyran-3-yl]-5-benzoxazolesulfonamide, CAS: 68427-35-0, stock: 8.8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₁₉N₃O₅S.
4-Piperidin-4-ylmethyl-phenol Hydrochloride, CAS: 1171849-90-3, stock: 5.3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₇NO • HCl.
2-[7-(Diethylamino)-2-oxo-2H-1-benzopyran-3-yl]-5-benzoxazolesulfonic Acid Sodium Salt, CAS: 93859-23-5, stock: 9.2g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₁₇N₂NaO₆S.
4-Propoxyphenol, CAS: 18979-50-5, stock: 4.8g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₂O₂.
4-Propylphenol, CAS: 645-56-7, stock: 4.8g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₂O.
21-Deacetoxy 11-Oxodeflazacort, CAS: 13649-83-7, stock: 9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₇NO₄.
4-tert-Amylphenol, CAS: 80-46-6, stock: 3.8g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₆O.
4-tert-Butyl-2,6-diformylphenol, CAS: 84501-28-0, stock: 9.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₄O₃.
21-Deacetoxy Deflazacort, CAS: 13649-88-2, stock: 4.6g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₉NO₄.
4-tert-Butyl-2,6-dinitrophenol, CAS: 4097-49-8, stock: 6.4g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₂N₂O₅.
4-tert-Butyl-2-chlorophenol (Technical Grade), CAS: 98-28-2, stock: 9.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₃ClO.
21-Deacetoxy Deflazacort-d3 (Major), CAS: /, stock: 5.5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₆D₃NO₄.
21-Desacetyl Deflazacort, CAS: 13649-57-5, stock: 5.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₉NO₅.
4-tert-Butyl-2-chlorophenol-d9, CAS: /, stock: 6g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₄D₉ClO.
4-tert-Butyl-2-nitrophenol, CAS: 3279-07-0, stock: 8.8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₃NO₃.
21-Desacetyl Deflazacort-d3 (Major), CAS: /, stock: 3.8g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₆D₃NO₅.
4-tert-Butylphenol, CAS: 98-54-4, stock: 3.9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₄O.
4-tert-Butylphenol-d9 (Major), CAS: 358730-87-7, stock: 1.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₅D₉O.
3,3’-Bis(3-sulfopropyl)-5,5’-diphenyl-9-ethyloxacarbocyanine Betaine Sodium Salt, CAS: 33628-03-4, stock: 6.3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₇H₃₆N₂O₈S₂ • Na.
3,3’-Iminobis(N,N-dimethylpropylamine), CAS: 6711-48-4, stock: 6.1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₂₅N₃.
4-tert-Butylthiophenol, CAS: 2396-68-1, stock: 6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₄S.
3,5-Bis(1,1-dimethylethyl)-1-hydroxy-4-oxo-2,5-cyclohexadiene-1-propanoic Acid, CAS: 83237-15-4, stock: 2.7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₂₆O₄.
3,5-Dichlorophenol, CAS: 591-35-5, stock: 9.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₄Cl₂O.
3,5-Dimethyl-4,5-dihydroisoxazole-5-carboxylic Acid, CAS: 908248-87-3, stock: 5.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₉NO₃.
3,5-Dimethyl-4-iodoisoxazole, CAS: 10557-85-4, stock: 1.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₆NOI.
3,5-Dimethyl-4-isoxazolecarbaldehyde, CAS: 54593-26-9, stock: 3.5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₇NO₂.
3,5-Dimethyl-4-nitroisoxazole, CAS: 1123-49-5, stock: 3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₆N₂O₃.
3,5-Dimethyl-4-pyrrolidin-2-ylisoxazole, CAS: 1018128-26-1, stock: 5.6g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₄N₂O.
3,5-Dimethyl-isoxazole-4-carboxylic Acid Methoxy-methyl-amide, CAS: 1223452-45-6, stock: 5.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₂N₂O₃.
3,5-Dimethylisoxazole, CAS: 300-87-8, stock: 3.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₇NO.
4-tert-Octylphenol-glucuronide, CAS: 309257-29-2, stock: 2.9g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₃₀O₇.
3,5-Dimethylisoxazole-4-boronic acid, CAS: 16114-47-9, stock: 8.3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₈BNO₃.
7-HC-γ-linolenate, CAS: 161180-12-7, stock: 5.3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₃₄O₄.
4-Thiophenyl-β-lactoside, CAS: /, stock: 7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₆O₁₁S.
4-Tritylphenol, CAS: 978-86-9, stock: 7.3g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₂₀O.
3,5-Dimethylisoxazole-4-boronic acid, pinacol ester, CAS: 832114-00-8, stock: 7.7g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₈BNO₃.
3,5-Dimethylisoxazole-4-carbonyl Chloride, CAS: 31301-45-8, stock: 7.4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₆ClNO₂.
9-OxoOTrE, CAS: 125559-74-2, stock: 6.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₈O₃.
4-Vinylphenol, 10 wt.% In propylene glycol, CAS: 2628-17-3, stock: 7.5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₈O.
4-[(1-Methyl-1H-pyrazol-4-yl)methoxy]phenol, CAS: 1152531-66-2, stock: 7.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₂N₂O₂.
3,5-Dimethylisoxazole-4-carboxylic acid, CAS: 2510-36-3, stock: 8.2g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₇NO₃.
3,5-Dimethylisoxazole-4-sulfonamide, CAS: 175136-83-1, stock: 9.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₈N₂O₃S.
4-[(1E)-1-[4-[2-(Dimethylamino)ethoxy]phenyl]-2-[4-(1-methylethyl)phenyl]-1-buten-1-yl]-phenol, CAS: 115767-71-0, stock: 7.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₉H₃₅NO₂.
3,5-Dimethylisoxazole-4-sulfonyl Chloride, CAS: 80466-79-1, stock: 1.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₆ClNO₃S.
3-(1,3-Dimethyl-1H-pyrazol-4-yl)-5-methylisoxazole-4-carboxylic Acid, CAS: 1171972-67-0, stock: 4.4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₁N₃O₃.
4-[(1R,2S)-rel-2-Aminocyclopropyl]phenol, CAS: 104777-77-7, stock: 6g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₁NO.
4-[(1S)-1-Amino-2-methylpropyl]phenol, CAS: 1213469-19-2, stock: 2.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₅NO.
3-(1,5-Dimethyl-1H-pyrazol-4-yl)-4,5-dihydroisoxazole-5-carboxylic Acid, CAS: 1006496-70-3, stock: 5.9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₁N₃O₃.
3-(1-Methyl-4-piperidinyl)-1,2-benzisoxazole Hydrochloride, CAS: 84163-12-2, stock: 9g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₇ClN₂O.
4-[(1S)-1-Amino-2-methylpropyl]phenol-d6, CAS: /, stock: 1.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₉D₆NO.
3-(1H-Tetrazol-5-yl)piperidine, CAS: 112626-96-7, stock: 8.4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₁₁N₅.
4-[(2,2,2-Trifluoroethyl)amino]phenol, CAS: 1011805-88-1, stock: 6.3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₈NOF₃.
4-[(2,2,3,3-Tetrafluoropropyl)amino]phenol, CAS: 1365808-22-5, stock: 3.6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₉NOF₄.
5,6,7,8-Tetrahydro-4-methoxy-6-methyl-1,3-dioxolo[4,5-g]isoquinolin-8-ol, CAS: 108261-07-0, stock: 6.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₅NO₄.
5,6,7,8-Tetrahydro-4-methoxy-6-methyl-1,3-dioxolo[4,5-g]isoquinolin-8-ol 8-Acetate, CAS: 108434-79-3, stock: 3.8g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₇NO₅.
3-(2,4-Dichlorophenyl)-4,5-dihydro-1,2-oxazole-5-carboxylic Acid, CAS: 1038696-41-1, stock: 9.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₇NO₃Cl₂.
3-(2,4-Dihydroxyphenyl)-2-propenal, CAS: 79407-66-2, stock: 8.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₈O₃.
4-[(2-Aminophenyl)methyl]phenol Hydrochloride, CAS: 1193388-60-1, stock: 4.5g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₃NO • HCl.
4-[(2-hydroxy-6-methylphenyl)methyl]-2-(methoxymethyl)-3-methyl-phenol, CAS: 2194580-67-9, stock: 2g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₂₀O₃.
3-(2,5-Difluorophenyl)-4,5-dihydro-1,2-oxazole-5-carboxylic Acid, CAS: 1096348-81-0, stock: 6.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₇NO₃F₂.
4-[(2-Methyl-1-isopropyl)pentyl]phenol(Mixture of Diastereomers), CAS: 1158978-65-4, stock: 8.1g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₂₄O.
Cotarnine, CAS: 82-54-2, stock: 6.1g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₅NO₄.
Cotarnine Chloride, CAS: 10018-19-6, stock: 4.1g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₄ClNO₃.
3-(2,5-Dimethoxyphenyl)-4,5-dihydroisoxazole-5-carboxylic Acid, CAS: 1018143-27-5, stock: 5.6g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₃NO₅.
4-[(2-Methyl-1-isopropyl-d6)pentyl]phenol(Mixture of Diastereomers), CAS: 1285987-04-3, stock: 4.2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₈D₆O.
4-[(3-Ethyl-1,2,4-oxadiazol-5-yl)methoxy]phenol, CAS: 1152531-58-2, stock: 2.8g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₂N₂O₃.
Cotarnine Iodide, CAS: 30936-27-7, stock: 5g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₄INO₃.
3-(2,6-Dichlorophenyl)-5-methyl-4-isoxazolylcarboxylic Acid Ethyl Ester, CAS: 24248-21-3, stock: 3.5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₁Cl₂NO₃.
3-(2,6-Dichlorophenyl)-5-methylisoxazole-4-carbonyl Chloride, CAS: 4462-55-9, stock: 4.9g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₆Cl₃NO₂.
4-[(3-Methyl-1,2,4-oxadiazol-5-yl)methoxy]phenol, CAS: 1094409-91-2, stock: 5.2g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₀N₂O₃.
4-[(4,6-Dimethylpyrimidin-2-yl)thio]phenol, CAS: 107718-34-3, stock: 9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₂N₂OS.
3-(2,6-Difluorophenyl)-1,2-oxazole-5-carboxylic Acid, CAS: 1152531-95-7, stock: 9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₅NO₃F₂.
3-(2-Chloro-6-fluorophenyl)-5-methylisoxazole-4-carbonitrile, CAS: 175204-41-8, stock: 2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₆ClFN₂O.
4-[(4-Methoxyphenyl)amino]phenol, CAS: 27151-54-8, stock: 7.4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₃NO₂.
4-[(7-Chloroquinolin-4-yl)sulfanyl]phenol, CAS: 1183785-49-0, stock: 4.1g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₀NOSCl.
3-(2-Chloro-6-fluorophenyl)-5-methylisoxazole-4-carbonyl Chloride, CAS: 69399-79-7, stock: 5.6g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₆Cl₂FNO₂.
Methyl Linolenate, CAS: 301-00-8, stock: 3.2g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₃₂O₂.
Methyl-d3 Linolenate, CAS: /, stock: 9.2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₉D₃O₂.
4-[(Cyclopropylamino)methyl]-2-methoxyphenol Hydrochloride, CAS: 1197796-77-2, stock: 3.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₅NO₂ • HCl.
Pinolenic Acid, CAS: 16833-54-8, stock: 4.8g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₃₀O₂.
Pinolenic Acid Ethyl Ester, CAS: 493015-74-0, stock: 8.7g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₃₄O₂.
4-[(E)-(1-methyl-4-piperidyl)iminomethyl]phenol, CAS: /, stock: 7.1g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₈N₂O.
4-[(E)-[1,1-Dioxo-1,2-benzothiazol-3-yl)-methyl-hydrazono]methyl]-2-methoxy-phenol, CAS: 2095165-70-9, stock: 9.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₅N₃O₄S.
Pinolenic Acid Ethyl-d5 Ester, CAS: /, stock: 4.9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₉D₅O₂.
Pinolenic Acid Methyl Ester, CAS: 38406-57-4, stock: 1.7g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₃₂O₂.
4-[(Ethylamino)methyl]phenol, CAS: 45966-19-6, stock: 2.7g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₃NO.
4-[(Methylamino)methyl]phenol, CAS: 78507-19-4, stock: 5.9g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₁NO.
3-(2-Chlorophenyl)-5-methylisoxazole-4-carbonyl Chloride, CAS: 25629-50-9, stock: 3.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₇Cl₂NO₂.
Pinolenic Acid Methyl-d3 Ester, CAS: /, stock: 3.5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₉D₃O₂.
Pinolenic Acid-d6, CAS: /, stock: 8.2g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₄D₆O₂.
4-[(Methylamino)methyl]phenol Hydrobromide, CAS: 1177277-31-4, stock: 4.7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₁NO • HBr.
4-[(Pyridin-3-yl)methoxy]phenol, CAS: 1094283-57-4, stock: 8.2g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₁NO₂.
Noscapinic Acid Sodium Salt, CAS: 143976-78-7, stock: 7.5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₄NNaO₈.
3-(2-Fluoro-4-hydroxyphenyl)-5-(trifluoromethyl)-4-Isoxazolecarboxylic Acid Methyl Ester, CAS: 219939-04-5, stock: 9.8g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₇F₄NO₄.
3-(2-Hydroxyphenyl)-4,5-dihydroisoxazole-5-carboxylic Acid, CAS: 712347-85-8, stock: 2.9g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₉NO₄.
rac 1-Linolenoyl-3-chloropropanediol, CAS: 74875-99-3, stock: 6.2g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₃₅ClO₃.
rac 1-Linolenoyl-3-chloropropanediol-d5, CAS: /, stock: 5.1g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₃₀D₅ClO₃.
4-[(tert-Butoxycarbonyl)oxy]-2-methylphenol, CAS: 457634-20-7, stock: 8.9g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₆O₄.
4-[(tert-Butylamino)methyl]-2-methoxyphenol Hydrochloride, CAS: 1193389-31-9, stock: 3.7g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₉NO₂ • HCl.
3-(2-Thienyl)-5-isoxazolecarboxylic Acid, CAS: 204910-49-6, stock: 9.4g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₅NO₃S.
3-(3,4-Dichlorophenyl)-isoxazole-5-amine, CAS: 501902-20-1, stock: 9.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₆N₂OCl₂.
rac 2-Linolenoyl-3-chloropropanediol, CAS: 1470161-30-8, stock: 4.9g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₃₅ClO₃.
rac 2-Linolenoyl-3-chloropropanediol-13C3, CAS: /, stock: 5.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈¹³C₃H₃₅ClO₃.
4-[(tert-Butylamino)methyl]phenol Hydrochloride, CAS: 1197950-06-3, stock: 9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₇NO • HCl.
3-(3-Bromophenyl)-1,2-oxazole-5-carboxylic Acid, CAS: 1152531-91-3, stock: 7.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₆NO₃Br.
3-(3-Chloro-2-fluorophenyl)isoxazole-5-carboxylic Acid, CAS: 1126636-81-4, stock: 6.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₅NO₃FCl.
rac 2-Linolenoyl-3-chloropropanediol-d5, CAS: 1331666-89-7, stock: 5.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₃₀D₃ClO₃.
rac-1,2-Dilinolenoyl-3-chloropropanediol, CAS: 74875-97-1, stock: 3.2g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₉H₆₃ClO₄.
4-[1-(Methylamino)ethyl]phenol Hydrobromide, CAS: 1093390-65-8, stock: 7.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₃NO • HBr.
4-[2,2-Dichloro-1-(4-hydroxyphenyl)ethenyl]phenol, CAS: 14868-03-2, stock: 7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₀Cl₂O₂.
3-(3-Chlorophenyl)-1,2-oxazole-5-carboxylic Acid, CAS: 100517-43-9, stock: 6.8g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₆NO₃Cl.
3-(3-Cyanophenyl)-1,2-oxazole-5-carboxylic Acid, CAS: 1152531-77-5, stock: 1.9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₆N₂O₃.
rac-1,2-Dilinolenoyl-3-chloropropanediol-d5, CAS: /, stock: 7.5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₉H₅₈D₅ClO₄.
4-[2-(2-Pyridinyl)vinyl]phenol, CAS: 77377-07-2, stock: 3.5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₁NO.
4-[2-(2-Pyridinyloxy)propoxy]phenol, CAS: 142346-93-8, stock: 5.5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₅NO₃.
3-(3-Methoxyphenyl)-4,5-dihydroisoxazole-5-carboxylic Acid, CAS: 1018143-20-8, stock: 9.5g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₁NO₄.
3-(4-(4-Bromophenoxy)phenyl)-5-methylisoxazole-4-carboxylic Acid, CAS: 1159981-31-3, stock: 4.5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₂NO₄Br.
4-[2-(4-Hydroxyphenyl)-4-methylpentan-2-yl]phenol, CAS: 6807-17-6, stock: 6.9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₂O₂.
4-[2-(4-Methylpiperazin-1-yl)ethoxy]phenol, CAS: 100221-01-0, stock: 5.4g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₂₀N₂O₂.
3-(4-(4-Chlorophenoxy)phenyl)-5-methylisoxazole-4-carboxylic Acid, CAS: 1159981-30-2, stock: 6.8g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₂NO₄Cl.
3-(4-(4-Fluorophenoxy)phenyl)-5-methylisoxazole-4-carboxylic Acid, CAS: 1159981-32-4, stock: 4.1g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₂NO₄F.
rac-1-Linoleoyl-3-linolenoyl-propanetriol, CAS: 126374-41-2, stock: 6.6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₉H₆₆O₅.
rac-1-Palmitoyl-2-linolenoyl-3-chloropropanediol, CAS: 1246833-14-6, stock: 2.1g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₇H₆₅ClO₄.
4-[2-(Morpholin-4-yl)ethoxy]phenol Hydrochloride, CAS: 1181457-78-2, stock: 2.5g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₇NO₃ • HCl.
3-(4-(4-Methoxyphenoxy)phenyl)-5-methylisoxazole-4-carboxylic Acid, CAS: 1159981-33-5, stock: 9.6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₅NO₅.
3-(4-(p-Tolyloxy)phenyl)-5-methylisoxazole-4-carboxylic Acid, CAS: 1159981-29-9, stock: 9.2g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₅NO₄.
rac-1-Palmitoyl-2-linolenoyl-3-chloropropanediol-d5, CAS: 1246834-24-1, stock: 6.1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₇H₆₀D₅ClO₄.
4-[2-Amino-2-(1H-1,3-benzodiazol-2-yl)ethyl]phenol, CAS: 108787-14-0, stock: 1.1g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₅N₃O.
4-[3-(4-Hydroxyphenylethylamino)butyl]phenol, CAS: 1797103-75-3, stock: 7.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₃NO₂.
3-(4-Bromophenyl)-4,5-dihydro-1,2-oxazole, CAS: 51067-06-2, stock: 5.5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₈BrNO.
3-(4-Bromophenyl)-5-(trifluoromethyl)isoxazole-4-carboxylic Acid, CAS: 1159978-82-1, stock: 9.2g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₅NO₃F₃Br.
4-[3-(4-Morpholinyl)propoxy]-phenol, CAS: 93759-97-8, stock: 9.1g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₉NO₃.
3-(4-Bromophenyl)-5-methylisoxazole-4-carboxaldehyde, CAS: 1119449-35-2, stock: 9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₈BrNO₂.
3-(4-Bromophenyl)isoxazole, CAS: 13484-04-3, stock: 6.5g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₆NOBr.
4-[3-(N,N-Dimethylaminocarbonyl)phenyl]phenol, CAS: 1261896-44-9, stock: 8.4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₅NO₂.
4-[3-(N-Ethylaminocarbonyl)phenyl]phenol, CAS: 1261947-44-7, stock: 6.8g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₅NO₂.
3-(4-Chlorophenyl)-1,2-oxazole-4-carboxylic Acid, CAS: 1048922-51-5, stock: 3.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₆NO₃Cl.
3-(4-Chlorophenyl)-4,5-dihydroisoxazole-5-carboxylic Acid, CAS: 109888-59-7, stock: 8.6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₈NO₃Cl.
4-[3-(N-Methylaminocarbonyl)phenyl]phenol, CAS: 1261943-49-0, stock: 4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₃NO₂.
4-[4-(2-Hydroxypropoxy)phenoxy]phenol, CAS: 159600-64-3, stock: 3g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₆O₄.
3-(4-Chlorophenyl)-5-(trifluoromethyl)isoxazole-4-carboxylic Acid, CAS: 1159978-81-0, stock: 1.8g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₅NO₃F₃Cl.
4-[4-(4-Aminophenyl)-1-piperazinyl]phendiamineol, CAS: 74853-08-0, stock: 1.1g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₉N₃O.
3-(4-Chlorophenyl)isoxazole, CAS: 31301-39-0, stock: 3.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₆NOCl.
4-[4-(4-Trifluoromethoxyphenoxy)piperidin-1-yl]phenol, CAS: 681482-81-5, stock: 5.2g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₈F₃NO₃.
4-[4-(Ethylcarbamoyl)-3-fluorophenyl]phenol, CAS: 1261894-26-1, stock: 1.2g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₄FNO₂.
3-(4-Chlorophenyl)isoxazole-5-carbaldehyde, CAS: 121769-18-4, stock: 3.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₆NO₂Cl.
3-(4-Fluorophenyl)-5-methylisoxazole-4-carboxylic Acid, CAS: 1736-21-6, stock: 1.4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₈NO₃F.
4-[4-(N,N-Dimethylaminocarbonyl)phenyl]phenol, CAS: 1159944-09-8, stock: 7.5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₅NO₂.
4-[4-(Piperidine-1-carbonyl)phenyl]phenol, CAS: 1125430-43-4, stock: 2.9g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₉NO₂.
3-(4-Methoxyphenyl)-1,2-oxazole-5-carbaldehyde, CAS: 933709-27-4, stock: 8.6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₉NO₃.
3-(4-Methoxyphenyl)-5-isoxazolecarboxylic acid, CAS: 618383-47-4, stock: 6.2g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₉NO₄.
4-[4-(Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]phenol, CAS: 760989-91-1, stock: 4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₁BO₃.
4-[4-[2-(2-Pyridinyloxy)propoxy]phenoxy]phenol, CAS: 159600-61-0, stock: 9.7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₁₉NO₄.
3-(4-Methoxyphenyl)isoxazol-5-amine, CAS: 86685-98-5, stock: 7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₀N₂O₂.
3-(4-Piperidinyl)-1,2-benzisoxazole Hydrochloride, CAS: 84163-22-4, stock: 1.5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₅ClN₂O.
4-[5-(1-Methyl-1H-pyrazol-4-yl)-1,2,4-oxadiazol-3-yl]phenol, CAS: 1152513-70-6, stock: 4.2g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₀N₄O₂.
4-[5-(2-Cyclopentylethyl)-1,2,4-oxadiazol-3-yl]phenol, CAS: 1038982-33-0, stock: 3.3g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₈N₂O₂.
3-(4-Piperidinyl)-1,2-benzisoxazole N-Carbamic Acid Phenyl Ester, CAS: 84163-21-3, stock: 6.5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₁₈N₂O₃.
3-(5-Chlorothiophen-2-yl)-4,5-dihydro-1,2-oxazole-5-carboxylic Acid, CAS: 1094380-46-7, stock: 4.1g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₆NO₃SCl.
4-[5-(3-Bromophenyl)-1,2,4-oxadiazol-3-yl]phenol, CAS: 1038981-90-6, stock: 3.8g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₉N₂O₂Br.
4-[5-(Oxolan-2-yl)-1,2,4-oxadiazol-3-yl]phenol, CAS: 1152506-99-4, stock: 2.2g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₂N₂O₃.
4-[5-(Trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenol, CAS: 118828-15-2, stock: 8.6g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₅N₂O₂F₃.
3-(Boc-amino)-5-tert-butylisoxazole-4-carboxylic Acid, CAS: 1065075-72-0, stock: 4.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₂₀N₂O₅.
3-(Bromomethyl)-1,2-benzisoxazole, CAS: 37924-85-9, stock: 5.1g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₆BrNO.
4-{1-Hydroxy-2-[3-(4-benzylphenyl)-5-methylcyclohexylamino]ethyl}phenol, CAS: /, stock: 4.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₃₃NO₃.
3-(Bromomethyl)-5-methylisoxazole, CAS: 130628-75-0, stock: 8.7g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₆BrNO.
3-(Chloromethyl)-5-cyclopropylisoxazole, CAS: 1060817-59-5, stock: 1.6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₈NOCl.
4-{1-Hydroxy-2-[3-(4-hydroxyphenyl)-5-methylcyclohexylamino]ethyl}phenol Hydrochloride(Mixture of Diastereomers), CAS: /, stock: 1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₈ClNO₃.
4-{2,4-Diaza-3-boratricyclo[7.3.1.0^{5,13}]trideca-1(13),5,7,9,11-pentaen-3-yl}phenol, CAS: 1492899-94-1, stock: 5.8g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₃BN₂O.
3-(Chloromethyl)-5-isobutylisoxazole, CAS: 1142210-99-8, stock: 3.1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₂NOCl.
3-(Chloromethyl)-5-isopropylisoxazole, CAS: 1018128-18-1, stock: 5.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₁₀NOCl.
4-{4H,5H,6H,7H-Thieno[3,2-c]pyridine-5-carbonyl}phenol, CAS: 1019376-54-5, stock: 3.2g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₃NO₂S.
4-{5H,6H,7H,8H-[1,2,4]Triazolo[4,3-a]pyridin-3-yl}phenol, CAS: 1040326-87-1, stock: 1.2g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₃N₃O.
3-(Chloromethyl)-5-Methylisoxazole, CAS: 35166-37-1, stock: 8.5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₆NOCl.
3-(Dibromomethyl)-1,2-benzisoxazole, CAS: 867040-02-6, stock: 2.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₅Br₂NO.
4-{6-[(3-Hydroxypropyl)amino]imidazo[1,2-b]pyridazin-3-yl}phenol, CAS: 1012344-09-0, stock: 2.6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₆N₄O₂.
4-{[(4-Methylphenyl)amino]methyl}phenol, CAS: 107455-66-3, stock: 6.1g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₅NO.
3-(Methoxymethyl)-1,2-oxazole-4-carboxylic Acid, CAS: 1076245-90-3, stock: 4.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₇NO₄.
3-(Pyridin-4-yl)-4,5-dihydro-1,2-oxazole-5-carboxylic Acid, CAS: 1038311-80-6, stock: 3.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₈N₂O₃.
4-{[(5-Methyl-1H-pyrazol-4-yl)methyl]amino}phenol, CAS: 1157551-02-4, stock: 5.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₃N₃O.
4-{[(Cyclopropylmethyl)amino]methyl}phenol Hydrochloride, CAS: 1221722-75-3, stock: 6g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₅NO • HCl.
3-(Trifluoromethyl)isoxazole-4-carboxylic Acid, CAS: 1076245-98-1, stock: 9.3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₂NO₃F₃.
4-{[(Furan-2-ylmethyl)amino](phenyl)methyl}phenol Hydrochloride, CAS: 1208889-22-8, stock: 6.9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₇NO₂ • HCl.
4-{[(p-Fluorophenyl)imino]methyl}phenol, CAS: 3382-63-6, stock: 9.1g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₀FNO.
3-Amino-1,2-benzisoxazole-6-carbonitrile, CAS: 229623-53-4, stock: 2.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₅N₃O.
3-Amino-4-bromo-5-methylisoxazole, CAS: 5819-40-9, stock: 9.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₅N₂OBr.
4-{[(p-Fluorophenyl)imino]methyl}phenol-d4, CAS: 1185243-77-9, stock: 3.8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₆D₄FNO.
4-{[4,6-Bis(octylsulfanyl)-1,3,5-triazin-2-yl]amino-2,6-di-tert-butylphenol, CAS: 991-84-4, stock: 6.1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₃H₅₆N₄OS₂.
3-Amino-5-ethoxyisoxazole, CAS: 32326-26-4, stock: 3.6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₈N₂O₂.
3-Amino-5-methylisoxazole, CAS: 1072-67-9, stock: 4.3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₆N₂O.
3-Amino-5-nitro-1,2-benzisoxazole, CAS: 89793-82-8, stock: 5.5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₅N₃O₃.
3-Amino-5-tert-butylisoxazole, CAS: 55809-36-4, stock: 6.5g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₁₂N₂O.
4’-Desacetoxy-2’-Acetoxy Bisacodyl, CAS: 111664-35-8, stock: 3.8g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₁₉NO₄.
3-Aminobenzo[d]isoxazole-4-carboxylic Acid, CAS: 1104505-81-8, stock: 4.7g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₆N₂O₃.
3-Amino-4-hydroxy-benzeneacetic acid methyl ester, CAS: 78587-72-1, stock: 4g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₁NO₃.
3-Aminoisoxazole, CAS: 1750-42-1, stock: 1.6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃H₄N₂O.
4’-Hydroxy Ospemifene (Ospemifene Impurity), CAS: 341525-22-2, stock: 5.5g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₃ClO₃.
4’-Hydroxy Pyrimethanil, CAS: 81261-84-9, stock: 4.9g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₃N₃O.
3-Bromo-4,5-dihydroisoxazole-5-carboxylic acid amide, CAS: 1030613-69-4, stock: 3.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₅BrN₂O₂.
3-Bromo-4-iodotoluene, CAS: 71838-16-9, stock: 8.2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₆BrI.
4’-Hydroxy Pyrimethanil-d4, CAS: 1794897-91-8, stock: 6.8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₉D₄N₃O.
3-Bromo-5-(4-fluorophenyl)isoxazole, CAS: 903130-97-2, stock: 7.3g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₅BrFNO.
3-Bromo-5-(chloromethyl)isoxazole, CAS: 124498-15-3, stock: 2.6g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₃NOClBr.
3-Bromo-5-cyclohexyl-4,5-dihydroisoxazole, CAS: 1120214-99-4, stock: 1.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₄BrNO.
3-Bromo-5-hydroxymethylisoxazole, CAS: 25742-00-1, stock: 7.5g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₄BrNO₂.
4’-Hydroxy Toremifene(~8% E isomer), CAS: 352233-94-4, stock: 6.5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₂₈ClNO₂.
3-Bromo-5-isoxazolecarboxaldehyde, CAS: 220780-57-4, stock: 6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₂BrNO₂.
3-Bromo-5-isoxazoleethanol, CAS: 105175-00-6, stock: 9.4g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₆BrNO₂.
4’-Hydroxy Toremifene-d6, CAS: 1795138-08-7, stock: 6.1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₂₂D₆ClNO₂.
3-Bromo-5-phenyl-1,2-oxazole, CAS: 10557-74-1, stock: 5.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₆BrNO.
3-Bromo-5-phenyl-4,5-dihydroisoxazole, CAS: 86256-88-4, stock: 1.7g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₈BrNO.
3-Bromoisoxazole, CAS: 111454-71-8, stock: 8.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃H₂BrNO.
3-Bromoisoxazole-5-carbonitrile, CAS: 1241897-95-9, stock: 6.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄HN₂OBr.
3-Bromoisoxazole-5-carboxylic Acid, CAS: 6567-35-7, stock: 2.4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₂BrNO₃.
3-Chloro-1,2-benzisoxazole, CAS: 16263-52-8, stock: 2.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₄ClNO.
4’-Hydroxy-PhIP, CAS: 126861-72-1, stock: 5.5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₂N₄O.
3-Chloro-6-(trifluoromethyl)pyridazine, CAS: 258506-68-2, stock: 7.5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₂ClF₃N₂.
3-Cyclopropyl-5-methyl-1,2-oxazole-4-carboxylic Acid, CAS: 1082420-70-9, stock: 6.3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₉NO₃.
4’-Hydroxychalcone, CAS: 2657-25-2, stock: 3.5g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₂O₂.
3-Ethyl-5-methyl-1,2-oxazole-4-carboxamide, CAS: 1098356-48-9, stock: 5.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₁₀N₂O₂.
3-Ethyl-5-methyl-1,2-oxazole-4-carboximidamide Hydrochloride, CAS: 1170453-95-8, stock: 3.8g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₁₁N₃O • HCl.
3-Ethyl-5-methylisoxazole-4-carboxylic Acid, CAS: 17147-85-2, stock: 7.7g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₉NO₃.
3-Ethylisoxazole-5-carbonitrile, CAS: 1215295-98-9, stock: 8.4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₆N₂O.
3-Ethylisoxazole-5-carboxylic Acid, CAS: 14633-21-7, stock: 3.3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₇NO₃.
3-Hydroxy-5-methylisoxazole, CAS: 10004-44-1, stock: 5.4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₅NO₂.
3-Isobutylisoxazole-5-carboxylic Acid, CAS: 910321-93-6, stock: 7.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₁NO₃.
3-Isopropyl-4,5-dihydroisoxazole-5-carboxylic Acid, CAS: 1177346-52-9, stock: 6.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₁₁NO₃.
3-Isopropylisoxazole-5-carbaldehyde, CAS: 121604-54-4, stock: 3.9g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₉NO₂.
3-Isopropylisoxazole-5-carbonitrile, CAS: 1217862-28-6, stock: 9.6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₈N₂O.
3-Isopropylisoxazole-5-carboxylic Acid, CAS: 14633-22-8, stock: 3.5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₉NO₃.
3-Isoxazolecarboxylic acid, 4-(1h-imidazol-1-ylmethyl)-5-methyl hydrochloride, CAS: 1177339-58-0, stock: 7g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₉N₃O₃.HCl.
4’-Pivaloyloxy Toremifene, CAS: 1798397-87-1, stock: 7.1g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₁H₃₆ClNO₃.
3-Methoxyazetidine Hydrochloride, CAS: 148644-09-1, stock: 2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₁₀ClNO.
3-Methoxyisoxazole-5-carboxylic acid, CAS: 13626-59-0, stock: 2.9g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₅NO₄.
4’-Pivaloyloxy Toremifene-d6, CAS: /, stock: 6.6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₁H₃₀D₆ClNO₃.
3-Methyl-1,2-benzisoxazole, CAS: 4825-75-6, stock: 2.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₇NO.
3-Methyl-1,2-benzisoxazole-d4, CAS: 1189967-37-0, stock: 4.6g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₃D₄NO.
3-Methyl-1,2-oxazole-4-carbaldehyde, CAS: 1064458-79-2, stock: 6.9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₅NO₂.
3-Methyl-1,3-benzoxazole-2(3H)-thione, CAS: 13673-63-7, stock: 6g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₇NOS.
5-((2-Hydroxyethyl)amino)-2-methylphenol, CAS: 55302-96-0, stock: 6.6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₃NO₂.
3-Methyl-5-isoxazoleacetic Acid, CAS: 19668-85-0, stock: 8.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₇NO₃.
3-Methyl-5-phenylisoxazole, CAS: 1008-75-9, stock: 7.4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₉NO.
5-(2-Carboxythiophene-4-yl)-3-chlorophenol, CAS: 1262003-03-1, stock: 7.4g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₇ClO₃S.
5-(2-Carboxythiophene-4-yl)-3-fluorophenol, CAS: 1261936-09-7, stock: 3.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₇FO₃S.
3-Methyl-5-phenylisoxazole-4-carboxylic Acid, CAS: 17153-21-8, stock: 9.2g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₉NO₃.
3-Methyl-5-propyl-1,2-oxazole-4-carboxylic Acid, CAS: 1094382-34-9, stock: 9.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₁NO₃.
5-(2-Nitroethenyl)-2-(benzyloxy)phenol, CAS: /, stock: 3.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₃NO₄.
5-(3,5-Dichlorophenyl)-2-formylphenol, CAS: 1262003-94-0, stock: 9.3g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₈Cl₂O₂.
3-Methyl-N-(piperidin-4-yl)-1,2-oxazole-5-carboxamide Hydrochloride, CAS: 1235440-82-0, stock: 6.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₅N₃O₂ • HCl.
5-(3-Aminophenyl)-3-cyanophenol, CAS: 1261900-78-0, stock: 9.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₀N₂O.
3-Methylisoxazole-5-carbonyl chloride, CAS: 49783-72-4, stock: 3.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₄ClNO₂.
5-(3-Cyanophenyl)-3-methylphenol, CAS: 1261896-62-1, stock: 9.6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₁NO.
3-Methylisoxazole-5-carboxylic Acid, CAS: 4857-42-5, stock: 3.5g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₅NO₃.
3-Phenyl-4-(4-aminosulfonylbenzyl)-5-methylisoxazole, CAS: 1391052-01-9, stock: 4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₆N₂O₃S.
5-(4-Carboxy-3-fluorophenyl)-2-cyanophenol, CAS: 1261964-35-5, stock: 4.8g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₈FNO₃.
3-Phenyl-4-(4-chlorosulfonylbenzyl)-5-methylisoxazole, CAS: 1391051-82-3, stock: 8.3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₄ClNO₃S.
3-Phenyl-4-benzyl-5-methylisoxazole, CAS: 139395-94-1, stock: 6.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₅NO.
5-(Aminomethyl)-2-methoxyphenol Hydrochloride, CAS: 42365-68-4, stock: 5.4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₁NO₂ • (HCl).
5-(Benzyloxy)-2-methoxyphenol, CAS: 84354-17-6, stock: 8.4g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₄O₃.
3-Phenylisoxazole, CAS: 1006-65-1, stock: 8.3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₇NO.
3-Phenylisoxazole-5-carboxylic Acid, CAS: 14442-12-7, stock: 9.9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₇NO₃.
5-(Chloromethyl)-2,3-dimethyl-4-nitrophenolate, CAS: /, stock: 2.1g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₉ClN₂O₃.
5-(Chloromethyl)-2,3-dimethylphenolate, CAS: /, stock: 5.1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₀ClNO.
3-tert-Butylisoxazole-4-carboxylic Acid, CAS: 1217047-14-7, stock: 4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₁NO₃.
3-[2-(3-Fluorophenyl)pyrrolidine-1-carbonyl]-5-methyl-1,2-oxazole, CAS: 1031615-08-3, stock: 3.3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₅N₂O₂F.
5-(Hydroxymethyl)-2-iodophenol, CAS: 773869-57-1, stock: 8.2g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₇O₂I.
5-Acetamido-2-chlorophenol, CAS: 28443-52-9, stock: 3.5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₈ClNO₂.
3’-Amino-4’-methoxy-phenyl-2-(p-phenyl)-benzoxazole, CAS: 599201-51-1, stock: 7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₁₆N₂O₂.
5-Amino-2,4-di-tert-butylphenol, CAS: 873055-58-4, stock: 8.7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₂₃NO.
5-Amino-2,4-di-tert-butylphenol-d9, CAS: 1577233-54-5, stock: 9.4g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₄D₉NO.
5-Amino-2,4-dichlorophenol, CAS: 39489-79-7, stock: 8.3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₅NOCl₂.
5-Amino-2,4-difluorophenol, CAS: 113512-71-3, stock: 1.9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₅NOF₂.
4,4-Dimethyl-2-(4-bromophenyl)-2-oxazoline, CAS: 32664-14-5, stock: 4.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₂BrNO.
4,4’-Azoxybis[N-(5-methyl-3-isoxazolyl)-benzenesulfonamide, CAS: 119403-03-1, stock: 5.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₁₈N₆O₇S₂.
5-Amino-2-chloro-4-fluorophenol, CAS: 84478-72-8, stock: 2.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₅ClFNO.
5-Amino-2-chlorophenol, CAS: 01/06/6358, stock: 6.1g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₆ClNO.
4,5,6,7-Tetrahydro-1,2-benzisoxazol-3-amine, CAS: 1004-64-4, stock: 1.9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₁₀N₂O.
4,5,6,7-Tetrahydro-1,2-benzisoxazole-3-carboxamide, CAS: 1008-50-0, stock: 6.2g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₀N₂O₂.
5-Amino-2-fluorophenol, CAS: 100367-48-4, stock: 7.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₆FNO.
5-Amino-2-methoxyphenol, CAS: 1687-53-2, stock: 2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₉NO₂.
4,5-Dibromo-1H-1,2,3-triazole, CAS: 15294-81-2, stock: 6.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂HBr₂N₃.
4,5-Dihydro-2-(2-naphthalenyl)oxazole, CAS: 10431-96-6, stock: 2.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₁NO.
5-Amino-2-trifluoromethyl-phenol, CAS: 106877-47-8, stock: 6.6g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₆NOF₃.
5-Amino-4-chloro-2-methylphenol, CAS: 110102-86-8, stock: 6.8g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₈ClNO.
4,5-Dihydro-2-methyl-4-[2-(4-octylphenyl)ethyl]-4-oxazolemethanol, CAS: 402616-28-8, stock: 5.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₃₃NO₂.
4,5-Dihydro-2-methyl-4-[2-(4-octylphenyl)ethyl]-4-oxazolemethanol-d4, CAS: /, stock: 8.5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₉D₄NO₂.
5-Amino-4-fluoro-2-methylphenol Sulfate, CAS: 350482-02-9, stock: 9.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₁₀FNO₅S.
4,5-Dihydro-2-[2-methyl-3-(1H-imidazol-5-ylmethyl)phenyl]-4,4-dimethyl-oxazole, CAS: 1797883-60-3, stock: 5.9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₉N₃O.
5-Bromo-2,3,4-trifluorophenol, CAS: 1073339-19-1, stock: 7.8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₂OF₃Br.
4,5-Dimethyl-2-oxazolecarboxylic Acid, CAS: 1240605-72-4, stock: 2.1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₇NO₃.
4,5-Dimethyl-2-Oxazolecarboxylic Acid Ethyl Ester, CAS: 33123-73-8, stock: 6.6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₁NO₃.
5-Bromo-2,3-difluorophenol, CAS: 186590-26-1, stock: 6.7g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₃BrF₂O.
5-Bromo-2,4-difluorophenol, CAS: 355423-48-2, stock: 1.8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₃BrF₂O.
4,5-Dimethyl-3-isoxazolamine, CAS: 13999-39-8, stock: 4.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₈N₂O.
4,5-Dimethylisoxazole-3-carboxylic Acid, CAS: 100047-61-8, stock: 2.2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₇NO₃.
5-Bromo-2-(1-(4-chlorophenyl)-1H-pyrazol-5-yl)phenol, CAS: 1202028-77-0, stock: 8.1g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₀N₂OClBr.
5-Bromo-2-(1-(4-fluorophenyl)-1H-pyrazol-5-yl)phenol, CAS: 1202029-81-9, stock: 4.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₀N₂OFBr.
4,5-Diphenyl-2,3-dihydro-1,3-oxazole-2-thione, CAS: 6670-13-9, stock: 6.9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₁NOS.
5-Bromo-2-(1-(4-methoxyphenyl)-1H-pyrazol-5-yl)phenol, CAS: 1202029-16-0, stock: 5.4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₃N₂O₂Br.
5-Bromo-2-(1-p-tolyl-1H-pyrazol-5-yl)phenol, CAS: 1202029-99-9, stock: 5.5g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₃N₂OBr.
4,6-Diaminoresorcinol Dihydrochloride, CAS: 16523-31-2, stock: 5.3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₁₀Cl₂N₂O₂.
4,5-Dihydro-4,4-dimethyl-2-(2-methylphenyl)oxazole, CAS: 71885-44-4, stock: 4.9g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₅NO.
5-Bromo-2-(1-phenyl-1H-pyrazol-5-yl)phenol, CAS: 1202029-83-1, stock: 5.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₁N₂OBr.
5-Bromo-2-(1H-pyrazol-5-yl)phenol, CAS: 114486-00-9, stock: 1.3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₇N₂OBr.
4-(2-Azidoethyl)-3,5-dimethylisoxazole, CAS: 1005901-00-7, stock: 6.5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₁₀N₄O.
4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole-1-ethanol, CAS: 1040377-08-9, stock: 2.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₉BN₂O₃.
5-Bromo-2-(hydroxymethyl)phenol, CAS: 170434-11-4, stock: 2.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₇O₂Br.
5-Bromo-2-(trifluoromethoxy)phenol, CAS: 1048963-39-8, stock: 4.1g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₄BrF₃O₂.
4-(Bromomethyl)-3-(4-chlorophenyl)-5-methylisoxazole, CAS: 1159981-13-1, stock: 3.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₉NOClBr.
4-(Bromomethyl)-3-methyl-5-phenylisoxazole, CAS: 113841-59-1, stock: 4.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₀NOBr.
5-Bromo-2-(trifluoromethyl)phenol, CAS: 1121585-15-6, stock: 8g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₄OF₃Br.
5-Bromo-2-chloro-4-fluorophenol, CAS: 148254-32-4, stock: 7.9g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₃BrClFO.
4-(Bromomethyl)-5-methyl-3-p-tolylisoxazole, CAS: 1159981-12-0, stock: 9.7g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₂NOBr.
4-(Bromomethyl)-5-phenyl-1,3-oxazole, CAS: 368869-94-7, stock: 7.2g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₈BrNO.
5-Bromo-2-chlorophenol, CAS: 183802-98-4, stock: 1.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₄BrClO.
5-Bromo-2-ethenylphenol, CAS: 1510865-23-2, stock: 3.1g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₇BrO.
4-(Bromomethyl)oxazole, CAS: 1065073-37-1, stock: 6.9g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₄NOBr.
4-(Chloromethyl)-2-(2,6-difluorophenyl)-1,3-oxazole, CAS: 1183584-82-8, stock: 5.2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₆NOF₂Cl.
5-Bromo-2-Fluoro-3-Methylphenol, CAS: 1351668-25-1, stock: 5.7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₆OFBr.
5-Bromo-2-fluoro-4-methoxyphenol, CAS: 1111096-08-2, stock: 4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₆BrFO₂.
4-(Chloromethyl)-2-(2-methoxyphenyl)-1,3-oxazole, CAS: 1038708-65-4, stock: 4.6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₀NO₂Cl.
4-(Chloromethyl)-2-(3,4-difluorophenyl)-1,3-oxazole, CAS: 1005336-42-4, stock: 9.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₆NOF₂Cl.
5-Bromo-2-fluoro-4-methylphenol, CAS: 1111096-04-8, stock: 5.3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₆OFBr.
5-Bromo-2-fluorophenol, CAS: 112204-58-7, stock: 8.5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₄BrFO.
4-(Chloromethyl)-2-(4-ethoxyphenyl)-1,3-oxazole, CAS: 1184380-08-2, stock: 5.3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₂NO₂Cl.
5-bromo-2-iodophenol, CAS: 858855-11-5, stock: 4.1g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₄BrIO.
4-(Chloromethyl)-2-(4-methoxyphenyl)-5-methyl-1,3-oxazole, CAS: 122994-69-8, stock: 4.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₂ClNO₂.
4-(Chloromethyl)-3,5-dimethylisoxazole, CAS: 19788-37-5, stock: 3.8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₈ClNO.
4-(Chloromethyl)-5-cyclopropyl-3-(2,6-dichlorophenyl)-1,2-oxazole, CAS: 1268245-50-6, stock: 4.9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₀NOCl₃.
4-(Chloromethyl)-5-methyl-1,2-oxazole, CAS: 104988-43-4, stock: 3.6g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₆NOCl.
5-Bromo-2-methoxyphenol, CAS: 37942-01-1, stock: 4.2g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₇BrO₂.
5-Bromo-2-methylphenol, CAS: 36138-76-8, stock: 8.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₇BrO.
4-(Chloromethyl)-5-methyl-1,3-oxazole, CAS: 1240612-11-6, stock: 7.3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₆NOCl.
4-(Chloromethyl)-5-methyl-2-(3-methylphenyl)-1,3-oxazole, CAS: 521266-92-2, stock: 3.4g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₂ClNO.
5-Bromo-2-nitrophenol, CAS: 27684-84-0, stock: 7.7g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₄BrNO₃.
5-Bromo-3-chloro-2-fluorophenol, CAS: 1305322-97-7, stock: 6.4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₃BrClFO.
4-(Chloromethyl)-5-methyl-2-(4-methylphenyl)-1,3-oxazole, CAS: 137090-44-9, stock: 8.3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₂NOCl.
4-(Chloromethyl)-5-methyl-2-(thiophen-3-yl)-1,3-oxazole, CAS: 1107663-77-3, stock: 2.4g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₈NOSCl.
5-Bromo-4-chloro-2-nitrophenol, CAS: 855400-82-7, stock: 6.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₃BrClNO₃.
4-(Hydroxymethyl)-5-methylisoxazole-3-carboxylic Acid, CAS: 1134333-99-5, stock: 7.6g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₇NO₄.
5-Chloro-2-(1H-pyrazol-5-yl)phenol, CAS: 114485-99-3, stock: 7.1g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₇N₂OCl.
4-(Piperazin-1-yl)benzo[d]oxazole, CAS: 105684-82-0, stock: 2.8g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₃N₃O.
4-(tert-Butoxycarbonyl)-5-methylisoxazole-3-carboxyic Acid, CAS: 135401-79-5, stock: 5.7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₃NO₅.
5-Chloro-2-(isoxazol-5-yl)phenol, CAS: 107825-97-8, stock: 5.4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₆NO₂Cl.
4-Aminoisoxazole, CAS: 108511-97-3, stock: 4.5g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃H₄N₂O.
4-Aminoisoxazole Hydrochloride, CAS: 108511-98-4, stock: 2.3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃H₄N₂O•HCl.
5-Chloro-2-(pentachlorophenoxy)phenol, CAS: /, stock: 4.8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₄Cl₆O₂.
5-Chloro-2-(Trifluoromethyl)Phenol, CAS: 106877-35-4, stock: 9.6g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₄OF₃Cl.
4-Aminomethyl-2-(4-fluorophenyl)oxazole Hydrochloride, CAS: 1187933-51-2, stock: 7.9g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₉N₂OF • HCl.
4-Isoxazoleboronic Acid Pinacol Ester, CAS: 928664-98-6, stock: 9.4g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₄BNO₃.
5-Chloro-2-fluorophenol, CAS: 186589-76-4, stock: 1g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₄ClFO.
4-Benzyloxy-2-methylphenylboronic Acid, CAS: 847560-49-0, stock: 5.8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₅BO₃.
4-Bromo-2-fluoro-3-(trifluoromethyl)aniline, CAS: 159329-03-0, stock: 1.7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₄BrF₄N.
5-Chloro-2-iodophenol, CAS: 136808-72-5, stock: 8.5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₄OClI.
5-Chloro-2-methylamino-phenol, CAS: 1243357-05-2, stock: 2.8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₈NOCl.
4-Bromo-2-methyl-1,3-benzoxazole, CAS: 217326-69-7, stock: 7.3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₆BrNO.
4-Bromo-3,5-dimethylisoxazole, CAS: 10558-25-5, stock: 9.5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₆BrNO.
5-Chloro-2-methylthiophenol, CAS: 18858-06-5, stock: 1g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₇ClS.
4-Bromo-5-(4-bromophenyl)isoxazole, CAS: 1159981-76-6, stock: 2.1g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₅NOBr₂.
4-Bromo-5-(4-fluorophenyl)isoxazole, CAS: 1159981-77-7, stock: 8.1g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₅NOFBr.
5-Chloro-2-nitrophenol, CAS: 611-07-4, stock: 6.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₄ClNO₃.
4-Bromo-5-(4-methoxyphenyl)isoxazole, CAS: 1159981-74-4, stock: 3.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₈NO₂Br.
4-Bromo-5-bromomethyl-3-(3-chloro-phenyl)-isoxazole, CAS: 1158735-39-7, stock: 5.6g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₆NOClBr₂.
5-Chloro-4-fluoro-2-nitrophenol, CAS: 65001-79-8, stock: 3.3g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₃NO₃FCl.
5-Chloro-4-hydroxy-1,3-benzenedisulfonyl Dichloride, CAS: /, stock: 3.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: ¹³C₆H₃Cl₃O₅S₂.
4-Bromo-5-bromomethyl-3-(4-chloro-phenyl)-isoxazole, CAS: 1158735-42-2, stock: 2.4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₆NOClBr₂.
4-Bromo-5-isoxazolecarboxylic Acid, CAS: 893638-85-2, stock: 8.7g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₂BrNO₃.
5-Fluoro-2-(1-(4-fluorophenyl)-1H-pyrazol-5-yl)phenol, CAS: 1202029-60-4, stock: 6.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₀N₂OF₂.
4-Bromo-5-p-tolylisoxazole, CAS: 1159981-73-3, stock: 7.4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₈NOBr.
4-Bromo-5-phenylisoxazole, CAS: 10557-73-0, stock: 1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₆NOBr.
5-Fluoro-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol, CAS: 1038828-32-8, stock: 7.8g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₆BO₃F.
5-Fluoro-2-(methylthio)phenol, CAS: 1243442-20-7, stock: 2.7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₇OFS.
4-Bromo-A23187, CAS: 76455-48-6, stock: 7.2g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₉H₃₆BrN₃O₆.
5-Fluoro-2-(trifluoromethyl)phenol, CAS: 243459-91-8, stock: 4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₄F₄O.
5-Fluoro-2-iodophenol, CAS: 186589-87-7, stock: 2.4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₄OFI.
4-Bromobenzo[d]isoxazole, CAS: 1126848-34-7, stock: 6.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₄BrNO.
4-Bromobenzo[d]oxazole, CAS: 217326-65-3, stock: 2.1g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₄BrNO.
5-fluoro-2-methoxyphenol, CAS: 72955-97-6, stock: 2.8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₇FO₂.
5-Fluoro-2-methylphenol, CAS: 452-85-7, stock: 8.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₇FO.
4-Bromoisoxazole, CAS: 97925-43-4, stock: 9.1g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃H₂NOBr.
4-Chloro-3,5-dimethylisoxazole, CAS: 10557-86-5, stock: 3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₆NOCl.
5-Fluoro-2-nitrophenol, CAS: 446-36-6, stock: 2.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₄FNO₃.
5-Fluoro-4-methyl-2-nitrophenol, CAS: 83341-28-0, stock: 9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₆FNO₃.
4-Chloromethyl-2-(2-fluorophenyl)-5-methyloxazole, CAS: 671215-76-2, stock: 2.5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₉NOFCl.
5-Hydroxyisophthalic Acid, CAS: 618-83-7, stock: 2.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₆O₅.
4-Chloromethyl-5-methyl-2-phenyl-oxazole, CAS: 103788-61-0, stock: 2.8g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₀NOCl.
4-Cyano-2-cyclobutyl Oxazole, CAS: 1190314-22-7, stock: 4.6g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₈N₂O.
4-Cyano-2-cyclopropyl Oxazole, CAS: 1159734-36-7, stock: 1.3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₆N₂O.
5-Iodo-2-methylphenol, CAS: 183803-06-7, stock: 2.5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₇IO.
4-Fluoro-3-(4-piperidinyl)-1,2-benzisoxazole Hydrochloride, CAS: 95742-19-1, stock: 1.7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₄ClFN₂O.
4-Hydroxy-3,5-isoxazoledicarboxylic Acid 3,5-Diethyl Ester, CAS: 23468-99-7, stock: 9.1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₁NO₆.
5-Methoxy-2-(trifluoromethyl)phenol, CAS: 106877-40-1, stock: 9.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₇O₂F₃.
4-Hydroxy-5-methyl-2-oxazolecarboxylic Acid Methyl Ester, CAS: 1379247-69-4, stock: 3.5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₇NO₄.
4-Iodo-3-methyl-5-phenylisoxazole, CAS: 16114-53-7, stock: 6.1g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₈INO.
5-Methoxy-2-methylphenol, CAS: 20734-74-1, stock: 5.8g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₀O₂.
5-Methoxy-2-nitrophenol, CAS: 704-14-3, stock: 7.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₇NO₄.
4-Iodo-5-methyl-3-phenylisoxazole, CAS: 31295-66-6, stock: 10g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₈NOI.
4-Iodoisoxazole, CAS: 847490-69-1, stock: 9.6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃H₂NOI.
5-Methyl-2-(trifluoromethyl)phenol, CAS: 106877-38-7, stock: 3.8g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₇OF₃.
4-Isopropyl-2-oxazolecarboxylic Acid, CAS: 1187172-65-1, stock: 2.2g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₉NO₃.
4-Methoxy-5-methyl-2-oxazolecarboxylic Acid, CAS: 143033-58-3, stock: 4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₉NO₄.
5-Methylcyclohex-2-en-1-one, CAS: 7214-50-8, stock: 3.7g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₁₀O.
4-Methoxy-TEMPO, CAS: 95407-69-5, stock: 7.8g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₂₀NO₂.
5-O-(E)-Feruloylquinic Acid, CAS: 87099-72-7, stock: 9.3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₂₀O₉.
4-Methyl-1,3-oxazole-5-carbonitrile, CAS: 1003-52-7, stock: 3.8g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₄N₂O.
4-Methyl-2-(trifluoromethyl)-5-oxazolecarboxylic Acid, CAS: 1384265-64-8, stock: 1.2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₄F₃NO₃.
4-Methyl-2-phenyl-1,3-thiazole-5-carboxylic Acid, CAS: 33763-20-1, stock: 7.5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₉NO₂S.
4-Methyl-2-propyl-1,3-oxazole-5-carboxylic Acid, CAS: 113366-52-2, stock: 9.4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₁NO₃.
5-O-Feruloylquinic Acid (E/Z Mixture), CAS: 40242-06-6, stock: 9.9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₂₀O₉.
5-Pentadecylresorcinol, CAS: 3158-56-3, stock: 2.2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₃₆O₂.
4-Methylbenzoxazole, CAS: 107165-67-3, stock: 7.6g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₇NO.
5-Pentadecylresorcinol-d29, CAS: /, stock: 8.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₇D₂₉O₂.
4-Methyloxazole-2-carboxylic Acid, CAS: 1196151-81-1, stock: 6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₅NO₃.
4-Nitro Sulfamethoxazole, CAS: 29699-89-6, stock: 8.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₉N₃O₅S.
5-[(1R)-1,5-Dimethyl-5-hexen-1-yl]-2-methylphenol, CAS: /, stock: 3g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₂₂O.
4-Nitro-1,3-benzoxazole, CAS: 163808-13-7, stock: 9.1g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₄N₂O₃.
4-Nitroisoxazole, CAS: 1121-13-7, stock: 3.4g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃H₂N₂O₃.
5-[(7-Chloro-4-quinolinyl)amino]-2-[[(1,1-dimethylethyl)amino]methyl]phenol Hydrochloride, CAS: 1010411-21-8, stock: 6.5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₄Cl₃N₃O.
5-[2-[4-(1,2-Benzisothiazol-3-yl)-1-piperazinyl]ethyl-4-chloro-2-nitrophenol, CAS: 1797879-13-0, stock: 6.1g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₁₉ClN₄O₃S.
4-Nitroso Sulfamethoxazole, > 90%, CAS: 131549-85-4, stock: 2.3g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₉N₃O₄S.
4-O-Desmethyl 4-O-Ethyl Trimethoprim, CAS: 78025-68-0, stock: 1.6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₂₀N₄O₃.
4-Oxazolemethanol, CAS: 155742-48-6, stock: 4.3g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₅NO₂.
6,6’-((1E,1’E)-((2,3-Dimethylbutane-2,3-diyl)bis(azanylylidene))bis(methanylylidene))bis(2,4-di-tert-butylphenol), CAS: 351498-10-7, stock: 8.8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₆H₅₆N₂O₂.
6,6’-Methylenebis(2-(tert-butyl)-4-ethylphenol), CAS: 88-24-4, stock: 1.4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₃₆O₂.
4-Phenyloxazole, CAS: 20662-89-9, stock: 9.2g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₇NO.
4-Phenyloxazole-5-carboxylic Acid, CAS: 1240599-64-7, stock: 8.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₇NO₃.
6-(2-Fluoro-5-methoxycarbonylphenyl)-2-formylphenol, CAS: 1261919-29-2, stock: 4.1g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₁FO₄.
4-Pyrazolecarboxylic Acid, CAS: 37718-11-9, stock: 2g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₄N₂O₂.
4-Pyrazolecarboxylic Acid Ethyl Ester, CAS: 37622-90-5, stock: 8.4g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₈N₂O₂.
6-(2-Hydroxybenzylamino)-2-(3-hydroxypropylamino)-9-isopropylpurine, CAS: 471270-60-7, stock: 6.6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₄N₆O₂.
4-[(2-Chlorophenoxy)methyl]-5-methylisoxazole-3-carboxylic acid, CAS: 905810-50-6, stock: 8.5g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₀ClNO₄.
4-[(3-Chlorophenoxy)methyl]-5-methylisoxazole-3-carboxylic acid, CAS: 905811-21-4, stock: 3.9g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₀ClNO₄.
6-Amino-2,3-difluorophenol, CAS: 115551-33-2, stock: 4.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₅F₂NO.
6-Amino-2,3-dimethylphenol Hydrochloride, CAS: 131142-40-0, stock: 5.2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₁NO • HCl.
4-[(3-Methoxyphenoxy)methyl]-5-methylisoxazole-3-carboxylic acid, CAS: 905808-61-9, stock: 9.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₃NO₅.
4-[(4-Chlorophenoxy)methyl]-5-methylisoxazole-3-carboxylic acid, CAS: 905809-09-8, stock: 9.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₀ClNO₄.
6-Amino-2,4-dibromo-3-fluorophenol, CAS: 344-10-5, stock: 1.7g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₄Br₂FNO.
6-Amino-2,4-dichloro-3-methylphenol hydrochloride, CAS: 39549-31-0, stock: 3.9g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₇NOCl₂ • HCl.
4-[(4-Fluorophenoxy)methyl]-5-methylisoxazole-3-carboxylic acid, CAS: 931377-09-2, stock: 3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₀FNO₄.
4-[4-Tert-butyl-2-(2-hydroxyethoxy)phenyl]-2-(2,6-difluorophenyl)-4,5-dihydrooxazole, CAS: /, stock: 4.1g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₃F₂NO₃.
6-Amino-4-chloro-2-nitrophenol, CAS: 03/08/6358, stock: 6.9g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₅ClN₂O₃.
6-Bromo-2,3-difluorophenol, CAS: 186590-23-8, stock: 2.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₃BrF₂O.
4’-[(4,5-Dimethyl-3-isoxazolyl)sulfamoyl]acetanilide, CAS: 91960-06-4, stock: 7.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₅N₃O₄S.
6-Bromo-2-chloro-3-methoxyphenol, CAS: 1228957-06-9, stock: 4.9g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₆BrClO₂.
6-Bromo-2-chloro-3-methylphenol, CAS: 1226808-67-8, stock: 8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₆BrClO.
4’-[(4,5-Dimethyl-3-isoxazolyl)sulfamoyl]acetanilide-d4, CAS: /, stock: 6.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₁D₄N₃O₄S.
5,6,7,8-Tetradehydro Risperidone, CAS: 108855-18-1, stock: 1.3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₃FN₄O₂.
6-Bromo-2-Fluoro-3-Methoxyphenol, CAS: 1784923-61-0, stock: 9.4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₆O₂FBr.
6-Bromo-3-fluoro-2-nitrophenol, CAS: 872363-59-2, stock: 7.1g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₃BrFNO₃.
5,6-Dichloro-2(3H)-benzoxazolethione, CAS: 71865-29-7, stock: 4.7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₃Cl₂NOS.
6-Chloro-2-fluoro-3-methoxyphenol, CAS: 1017777-74-0, stock: 4.9g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₆O₂FCl.
5-(1-Ethyl-1H-pyrazol-3-yl)isoxazole-3-carboxylic Acid, CAS: 1006484-70-3, stock: 5.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₉N₃O₃.
5-(1-Piperidinylmethyl)-isoxazole-3-carboxylic Acid Hydrobromide, CAS: 1177299-39-6, stock: 8.8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₄N₂O₃ • HBr.
5-(1H-Pyrazol-1-ylmethyl)-1,2-oxazole-3-carboxylic Acid, CAS: 1007303-85-6, stock: 5.4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₇N₃O₃.
5-(2,3-Dichlorophenyl)oxazole-4-carboxylic acid, CAS: 951885-34-0, stock: 1.4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₅Cl₂NO₃.
6-Methoxy-2-(4-hydroxyphenyl)benzo[b]thiophene, CAS: 175460-94-3, stock: 5.9g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₂O₂S.
5-(2,3-Dihydro-1,4-benzodioxin-6-yl)-1,3-oxazole-4-carboxylic Acid, CAS: 1240165-83-6, stock: 5.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₉NO₅.
5-(2,4-Dichloro-5-fluorophenyl)isoxazole-3-carboxylic Acid, CAS: 763109-73-5, stock: 8.2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₄NO₃FCl₂.
5-(2,4-Dichlorophenyl)isoxazole-3-carboxylic acid, CAS: 712348-40-8, stock: 6.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₅Cl₂NO₃.
5-(2,4-Dichlorophenyl)oxazole-4-carboxylic acid, CAS: 255876-52-9, stock: 2.9g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₅Cl₂NO₃.
5-(2,4-Difluorophenyl)Isoxazole, CAS: 138716-46-8, stock: 8.3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₅NOF₂.
5-(2,4-Difluorophenyl)isoxazole-3-carboxylic Acid, CAS: 1083224-23-0, stock: 8.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₅NO₃F₂.
5-(2,6-Dichlorophenoxymethyl)-1,2-oxazole-3-carboxylic Acid, CAS: 1225900-23-1, stock: 2.9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₇NO₄Cl₂.
6-[(2-Hydroxy-6-methylphenyl)methyl]-2-(methoxymethyl)-3-methyl-phenol, CAS: 2194580-70-4, stock: 5.5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₂₀O₃.
6-[N,N-Di(2-hydroxybenzyl)amino]-2-[(3-hydroxypropyl)amino]-9-isopropylpurine, CAS: 1076200-04-8, stock: 3.3g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₃₀N₆O₃.
5-(2-Bromoethyl)-3-(2-bromophenyl)isoxazole, CAS: 1231243-94-9, stock: 8.8g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₉NOBr₂.
5-(2-Bromoethyl)-3-(4-bromophenyl)isoxazole, CAS: 1199773-55-1, stock: 3.8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₉NOBr₂.
6’-Hydroxy Secophenol, CAS: 2168-61-8, stock: 5.1g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₄O₄.
5-(2-Bromoethyl)-3-(5-bromopyridin-3-yl)isoxazole, CAS: 1231244-48-6, stock: 4.9g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₈N₂OBr₂.
5-(2-Bromophenyl)-2-(chloromethyl)-1,3-oxazole, CAS: 1094318-23-6, stock: 7.9g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₇NOClBr.
5-(2-Bromophenyl)oxazole, CAS: 328270-70-8, stock: 5.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₆NOBr.
5-(2-Chlorophenyl)isoxazole-3-carboxylic acid, CAS: 334017-34-4, stock: 4.4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₆ClNO₃.
5-(2-Fluoro-6-(pyrrolidin-1-yl)pyridin-4-yl)-oxazole, CAS: 1228665-97-1, stock: 6.4g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₂FN₃O.
5-(2-Fluorophenyl)oxazole-4-carboxylic acid, CAS: 347187-18-2, stock: 2.6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₆FNO₃.
5-(2-Nitrophenyl)isoxazole-3-carboxylic Acid, CAS: 1232028-11-3, stock: 3.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₆N₂O₅.
5-(2-Nitrophenyl)oxazole, CAS: 89808-75-3, stock: 3.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₆N₂O₃.
8-L-Lysinevasopressin Tannate, CAS: 1407-40-5, stock: 5.5g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂₂H₁₁₇N₁₃O₅₈S₂.
5-(2-Pyridinyl)-2-oxazolecarboxylic Acid, CAS: 1220039-53-1, stock: 8.4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₆N₂O₃.
5-(2-Pyridyl)isoxazole-3-carboxylic Acid, CAS: 893638-37-4, stock: 7.5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₆N₂O₃.
AC 186, CAS: 1421854-16-1, stock: 4.7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₇F₃O.
5-(3,4,5-Trimethoxyphenyl)isoxazole-3-carboxylic Acid, CAS: 1105193-41-6, stock: 2.6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₃NO₆.
5-(3,4-Difluorophenyl)-1,2-oxazole-3-carboxylic Acid, CAS: 1017513-51-7, stock: 5.6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₅NO₃F₂.
AC 45594, CAS: 13037-86-0, stock: 3.8g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₂₀O₂.
5-(3,4-Difluorophenyl)-4,5-dihydroisoxazole-3-carboxylic Acid, CAS: 1018170-52-9, stock: 2.6g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₇NO₃F₂.
5-(3-Bromophenyl)-1,3-oxazole, CAS: 243455-57-4, stock: 5.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₆BrNO.
5-(3-Bromophenyl)isoxazole, CAS: 7064-33-7, stock: 9.2g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₆BrNO.
5-(3-Chlorophenyl)isoxazole, CAS: 7064-34-8, stock: 2.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₆NOCl.
5-(3-Chlorophenyl)oxazole, CAS: 89808-76-4, stock: 6.3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₆NOCl.
5-(3-Chlorophenyl)oxazole-4-carboxylic acid, CAS: 255876-54-1, stock: 4.7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₆ClNO₃.
5-(3-Chloropropyl)-3-methylisoxazole, CAS: 130800-76-9, stock: 2g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₁₀ClNO.
5-(3-Fluoro-phenyl)-oxazole-4-carboxylic Acid, CAS: 1083401-22-2, stock: 6.5g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₆NO₃F.
5-(3-Fluorophenyl)-3-isoxazolecarboxylic Acid, CAS: 1188032-12-3, stock: 9.2g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₆FNO₃.
5-(3-Nitrophenyl)isoxazole-3-carboxylic Acid, CAS: 199601-80-4, stock: 5.7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₆N₂O₅.
Alfrutamide, CAS: 66648-43-9, stock: 8.5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₉NO₄.
5-(3-Nitrophenyl)oxazole, CAS: 89808-77-5, stock: 4.8g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₆N₂O₃.
5-(3-Nitrophenyl)oxazole-4-carboxylic Acid, CAS: 951885-28-2, stock: 7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₆N₂O₅.
Aloisine A RP107, CAS: 496864-16-5, stock: 1.8g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₇N₃O.
AMI-193, CAS: 510-74-7, stock: 5.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₆FN₃O₂.
5-(3-Pyridinyl)-2-oxazolecarboxylic Acid, CAS: 857521-74-5, stock: 4.8g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₆N₂O₃.
5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)oxazole, CAS: 942070-84-0, stock: 2.9g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₄BNO₃.
Ammonium Cerium(IV) Nitrate, CAS: 16774-21-3, stock: 5.2g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: CeH₈N₈O₁₈.
5-(4-Bromo-phenyl)-3-methyl-isoxazole-4-carboxylic Acid Methyl Ester, CAS: 1228689-61-9, stock: 4.2g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₀NO₃Br.
5-(4-Bromophenyl)-1,3-oxazole, CAS: 72571-06-3, stock: 3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₆BrNO.
Ammonium Hexafluorophosphate, CAS: 16941-11-0, stock: 3.1g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: F₆H₄NP.
5-(4-Bromophenyl)-3-methylisoxazole-4-carboxylic Acid, CAS: 91182-60-4, stock: 2g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₈BrNO₃.
5-(4-Bromophenyl)isoxazole, CAS: 7064-31-5, stock: 9.6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₆BrNO.
5-(4-bromophenyl)isoxazole-3-carbohydrazide, CAS: 870703-96-1, stock: 9.9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₈N₃O₂Br.
Amopyroquine N-Oxide, CAS: 172476-17-4, stock: 6.1g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₀ClN₃O₂.
5-(4-Bromophenyl)isoxazole-3-carboxylic Acid, CAS: 33282-23-4, stock: 5.4g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₆NO₃Br.
5-(4-Chlorophenyl)isoxazole-3-carboxaldehyde, CAS: 763109-09-7, stock: 1.5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₆NO₂Cl.
5-(4-Chlorophenyl)oxazole-2-propionic Acid, CAS: 23464-95-1, stock: 6.3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₀NO₃Cl.
5-(4-Chlorophenyl)oxazole-4-carboxylic acid, CAS: 143659-14-7, stock: 6g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₆ClNO₃.
Ardisiphenol A, CAS: 387816-66-2, stock: 4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₃₈O₄.
5-(4-Fluorophenyl)-1,3-oxazole-4-carboxylic Acid, CAS: 1083246-33-6, stock: 1.1g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₆NO₃F.
5-(4-Fluorophenyl)isoxazole, CAS: 138716-37-7, stock: 9.5g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₆FNO.
5-(4-Fluorophenyl)isoxazole-3-carboxylic Acid, CAS: 33282-24-5, stock: 7.7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₆NO₃F.
Batatasin III, CAS: 56684-87-8, stock: 1.5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₆O₃.
Belamcandol B, CAS: 137786-94-8, stock: 7.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₃₆O₂.
5-(4-Hydroxyphenyl)isoxazole-3-carboxylic Acid, CAS: 33282-15-4, stock: 2.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₇NO₄.
5-(4-Methoxyphenyl)-1,3-oxazole-4-carboxylic Acid, CAS: 89205-07-2, stock: 2.6g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₉NO₄.
Bemotrizinol, CAS: 187393-00-6, stock: 5.4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₈H₄₉N₃O₅.
Bendiocarb, CAS: 22781-23-3, stock: 2.7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₃NO₄.
5-(4-Methoxyphenyl)isoxazole-3-carboxaldehyde, CAS: 870703-95-0, stock: 1.4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₉NO₃.
5-(4-Methoxyphenyl)isoxazole-3-carboxylic Acid, CAS: 33282-16-5, stock: 5.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₉NO₄.
Benzoestrol, CAS: 85-95-0, stock: 8.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₆O₂.
5-(4-Methylphenyl)-1,3-oxazole, CAS: 143659-19-2, stock: 7.4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₉NO.
5-(4-Methylphenyl)-4,5-dihydroisoxazole-3-carboxylic acid, CAS: 1018170-48-3, stock: 7.3g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₁NO₃.
5-(4-Methylphenyl)isoxazole-3-carboxaldehyde, CAS: 640292-02-0, stock: 2.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₉NO₂.
5-(4-Methylphenyl)isoxazole-3-carboxylic Acid, CAS: 33282-21-2, stock: 7.6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₉NO₃.
5-(4-Nitrophenyl)isoxazole-3-carboxylic Acid, CAS: 33282-25-6, stock: 6.5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₆N₂O₅.
Benzotriazole BT, CAS: 70321-86-7, stock: 6.7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₀H₂₉N₃O.
5-(4-Nitrophenyl)oxazole, CAS: 1014-23-9, stock: 4g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₆N₂O₃.
5-(4-Pyridinyl)-2-oxazolecarboxylic Acid, CAS: 857521-75-6, stock: 2.2g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₆N₂O₃.
Benzotriazole BT-d10, CAS: /, stock: 3.1g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₀H₁₉D₁₀N₃O.
5-(5-(Benzyloxy)-6-bromopyridin-2-yl)oxazole, CAS: 1228666-35-0, stock: 4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₁BrN₂O₂.
5-(5-Fluoro-2-hydroxyphenyl)isoxazole, CAS: 288401-62-7, stock: 4.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₆NO₂F.
5-(Aminomethyl)isoxazole-3-carboxylic Acid Hydrochloride, CAS: 1235441-71-0, stock: 8.2g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₆N₂O₃ • HCl.
Bis(1-chloroprop-2-yl) (1-Hydroxyprop-2-yl) Phosphate, CAS: 1477495-11-6, stock: 5.3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₉Cl₂O₅P.
Bis(1-chloroprop-2-yl) (1-Hydroxyprop-2-yl-d6) Phosphate, CAS: /, stock: 3.1g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₃D₆Cl₂O₅P.
5-(Azidomethyl)-3-methyl-1,2-oxazole, CAS: 1237772-60-9, stock: 8.1g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₆N₄O.
5-(Bromoacetyl)-3-phenylisoxazole, CAS: 14731-14-7, stock: 4.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₈NO₂Br.
Bis(2,4-dichloro-5-nitrophenyl) Carbonate, CAS: 39489-75-3, stock: 9.8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₄Cl₄N₂O₇.
5-(Bromomethyl)-3-(6-bromopyridin-3-yl)isoxazole, CAS: 1231244-56-6, stock: 2.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₆N₂OBr₂.
5-(Chloromethyl)-3-phenylisoxazole, CAS: 1011-37-6, stock: 6.9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₈NOCl.
Bis(2,4-dichlorophenyl) Chlorophosphate, CAS: 14254-41-2, stock: 3.1g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₆Cl₅O₃P.
5-(Chloromethyl)-4-methyl-2-propyl-1,3-oxazole, CAS: 1206979-65-8, stock: 8.8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₂NOCl.
5-(Difluoromethyl)-3-methylisoxazole-4-carboxylic Acid, CAS: 1018166-17-0, stock: 9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₅NO₃F₂.
Bis(2-hydroxy-5-nitrophenol)disulfide Disodium Salt, CAS: /, stock: 5.8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₆N₂Na₂O₆S₂.
5-(Methoxymethyl)-3-isoxazolecarboxylic Acid, CAS: 95312-32-6, stock: 2.1g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₇NO₄.
Bis(3,5-di-tert-butylphen-4-ol) Disulfide, CAS: 6386-58-9, stock: 8.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₄₂O₂S₂.
5-(Methoxymethyl)-3-methylisoxazole-4-carboxylic Acid, CAS: 1108712-48-6, stock: 4.2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₉NO₄.
5-(Phenylmethyl)-2-oxazolecarboxylic Acid, CAS: 1357955-62-4, stock: 6.6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₉NO₃.
Bis(4-hydroxyphenyl) Sulfone, CAS: 80-09-1, stock: 4g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₀O₄S.
5-(tert-Butoxycarbonyl)-5,6-dihydro-4H-pyrrolo[3,4-d]oxazole-2-carboxylic Acid, CAS: 1211529-82-6, stock: 9.8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₄N₂O₅.
5-(tert-Butyl)-2-methylbenzoxazole, CAS: 40874-54-2, stock: 6.8g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₅NO.
Bis(4-hydroxyphenyl) Sulfone (d4 major), CAS: /, stock: 4.7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₆D₄O₄S.
Bis(4-hydroxyphenyl) Sulfone -13C12, CAS: /, stock: 6.2g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: ¹³C₁₂H₁₀O₄S.
5-(tert-Butyl)isoxazole-3-carboxylic Acid, CAS: 90607-21-9, stock: 2.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₁NO₃.
5-(Thiophen-2-yl)-1,2-oxazole-3-carboxamide, CAS: 1019656-18-8, stock: 6.9g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₆N₂O₂S.
Bis(4-hydroxyphenyl) Sulfone O-β-D-Glucuronide Sodium Salt, CAS: /, stock: 7.4g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₇NaO₁₀S.
Bis(4-hydroxyphenyl) Sulfone O-β-D-Glucuronide-13C12, CAS: /, stock: 3.8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆¹³C₁₂H₁₈O₁₀S.
5-(Trifluoromethyl)-2-[4-(trifluoromethyl)phenyl]-1,3-oxazole-4-carboxylic Acid, CAS: 886497-47-8, stock: 9.9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₅F₆NO₃.
5-(Trifluoromethyl)-3-(4-fluorophenyl)isoxazole-4-carboxylic Acid, CAS: 1159600-73-3, stock: 4.4g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₅NO₃F₄.
Bis(4-hydroxyphenyl) Sulfone O-β-D-Glucuronide-d8 Sodium Salt, CAS: /, stock: 2.6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₉D₈NaO₁₀S.
Bis(4-hydroxyphenyl) Sulfone-d8, CAS: /, stock: 9.9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₂D₈O₄S.
5-(Trifluoromethyl)-3-(4-methoxyphenyl)isoxazole-4-carboxylic Acid, CAS: 1159978-83-2, stock: 3.5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₈NO₄F₃.
5-(Trifluoromethyl)-3-p-tolylisoxazole-4-carboxylic Acid, CAS: 1159978-80-9, stock: 5.5g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₈NO₃F₃.
Bis(4-octylphenyl) Phosphate, CAS: 34332-95-1, stock: 9.5g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₄₃O₄P.
5-(Trifluoromethyl)isoxazole-4-carboxylic Acid, CAS: 1094702-34-7, stock: 1.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₂NO₃F₃.
5-Amino-2-(3-aminophenyl)benzoxazole, CAS: 13676-48-7, stock: 4.3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₁N₃O.
Bis(4-octylphenyl) Phosphate-d8, CAS: /, stock: 1.6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₃₅D₈O₄P.
Bis(5-amino-2-hydroxyphenyl)methan Dihydrochloride, CAS: 27311-52-0, stock: 2.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₆Cl₂N₂O₂.
5-Amino-2-(4-aminophenyl)benzoxazole, CAS: 13676-47-6, stock: 9.2g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₁N₃O.
5-Amino-2-cyclopropyl-4-oxazolecarboxylic Acid Ethyl Ester, CAS: 1260743-08-5, stock: 8.8g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₂N₂O₃.
Bis-desisopropyl Tolterodine, CAS: 1203453-90-0, stock: 9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₉NO.
5-Amino-3,4-dimethylisoxazole, CAS: 19947-75-2, stock: 4.9g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₈N₂O.
5-Amino-3-(2-bromophenyl)isoxazole, CAS: 119162-51-5, stock: 9.5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₇N₂OBr.
5-Amino-3-(3,5-dichlorophenyl)isoxazole, CAS: 1020997-14-1, stock: 3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₆N₂OCl₂.
5-Amino-3-(3-bromophenyl)isoxazole, CAS: 119162-52-6, stock: 6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₇N₂OBr.
5-Amino-3-(3-fluorophenyl)isoxazole, CAS: 119162-50-4, stock: 6.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₇N₂OF.
5-Amino-3-(3-methoxyphenyl)isoxazole, CAS: 119162-46-8, stock: 5.9g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₀N₂O₂.
5-Amino-3-methylisoxazole, CAS: 14678-02-5, stock: 3.8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₆N₂O.
5-Amino-3-methylisoxazole-4-carbonitrile, CAS: 35261-01-9, stock: 3.6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₅N₃O.
5-Amino-3-[3-(trifluoromethyl)phenyl]isoxazole, CAS: 82360-94-9, stock: 1.9g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₇F₃N₂O.
5-Amino-3-[4-(trifluoromethyl)phenyl]isoxazole, CAS: 81465-84-1, stock: 8.2g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₇N₂OF₃.
5-Amino-benzooxazole-2-carboxylic Acid Methyl Ester, CAS: 1035093-77-6, stock: 5.2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₈N₂O₃.
5-Aminoisoxazole-4-carboxamide Hydrogensulfate, CAS: 1273577-24-4, stock: 6.6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₇N₃O₆S.
5-Aminovaleric Acid Hydrochloride, CAS: 627-95-2, stock: 9.1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₁₁NO₂ • HC l.
5-Bromo-4-methyloxazole, CAS: 929094-30-4, stock: 6.9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₄BrNO.
5-Bromo-1,2-benzisoxazole, CAS: 837392-65-1, stock: 3.1g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₄BrNO.
5-Bromo-1,3-benzoxazole, CAS: 13222-31-6, stock: 3.7g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₄BrNO.
5-Bromo-2-(chloromethyl)-1,3-benzoxazole, CAS: 110704-48-8, stock: 3.5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₅NOClBr.
5-Bromo-2-(pyridin-4-yl)-1,3-benzoxazole, CAS: 1192018-93-1, stock: 1.8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₇N₂OBr.
5-Bromo-2-chlorobenzo[d]oxazole, CAS: 1030377-54-8, stock: 5.5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₃BrClNO.
5-Bromo-2-ethylbenzo[d]oxazole, CAS: 938458-80-1, stock: 7.8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₈NOBr.
5-Bromo-2-methyl-7-nitro-1,3-benzoxazole, CAS: 1226072-60-1, stock: 9.6g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₅N₂O₃Br.
5-Bromo-2-methylbenzooxazole, CAS: 5676-56-2, stock: 4.8g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₆BrNO.
5-Bromo-2-methyloxazole-4-carboxylic acid, CAS: 1209573-86-3, stock: 7.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₄BrNO₃.
5-Bromo-2-phenyloxazole, CAS: 92629-11-3, stock: 6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₆BrNO.
5-Bromo-3-methoxyisoxazole, CAS: 1369096-82-1, stock: 1.2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₄BrNO₂.
5-Bromo-7-chloro-1,3-benzoxazole, CAS: 1226072-26-9, stock: 7.2g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₃NOClBr.
5-Bromo-7-chloro-2-methyl-1,3-benzoxazole, CAS: 1226070-17-2, stock: 7.2g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₅NOClBr.
5-Bromo-benzo[d]isoxazole-3-carboxylic Acid, CAS: 1123169-28-7, stock: 3.4g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₄NO₃Br.
5-Bromo-benzo[d]isoxazole-3-carboxylic Acid Methyl Ester, CAS: 1123169-30-1, stock: 6.1g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₆NO₃Br.
5-Bromobenzooxazole, CAS: 132244-31-6, stock: 6.1g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₄BrNO.
5-Bromobenzo[d]oxazole-2-thiol, CAS: 439607-87-1, stock: 9.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₄NOSBr.
5-Bromomethyl-3-(2-nitrophenyl)-isoxazole, CAS: 1231243-92-7, stock: 4.4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₇N₂O₃Br.
5-Bromomethyl-3-(3-bromophenyl)-isoxazole, CAS: 1158735-27-3, stock: 5.8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₇NOBr₂.
5-Bromooxazole-4-carboxylic Acid, CAS: 1240611-09-9, stock: 6.7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₂NO₃Br.
5-Chloro-2-(chloromethyl)-1,3-benzoxazole, CAS: 63842-22-8, stock: 1.9g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₅NOCl₂.
5-Chloro-2-chloromethyl-6-nitro-benzooxazole, CAS: 1126637-40-8, stock: 3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₄N₂O₃Cl₂.
5-Chloro-2-methyl-6-nitro-1,3-benzoxazole, CAS: 13452-16-9, stock: 3.9g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₅N₂O₃Cl.
5-Chloro-3-(2-methoxyphenyl)-1,2-oxazole, CAS: 1188091-06-6, stock: 6.5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₈NO₂Cl.
5-Chloro-3-(4-hydroxyphenyl)-2,1-benzisoxazole, CAS: 67445-85-6, stock: 8.4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₈ClNO₂.
5-Chloro-3-phenyl-2,1-benzisoxazole, CAS: 719-64-2, stock: 3.1g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₈ClNO.
5-Chloro-6-nitro-1,3-benzoxazole, CAS: 116549-11-2, stock: 5.2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₃N₂O₃Cl.
5-Chlorobenzoxazole, CAS: 17200-29-2, stock: 3.2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₄NOCl.
5-Chlorobenzo[d]oxazole-2(3H)-thione, CAS: 22876-19-3, stock: 5.3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₄CINSO.
5-Cyclobutyl-1,3-oxazole-4-carboxylic Acid, CAS: 1083274-51-4, stock: 3.4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₉NO₃.
5-Cyclopropyl-2-phenyl-1,3-oxazole-4-carboxylic Acid, CAS: 1016761-70-8, stock: 8.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₁NO₃.
5-Cyclopropyl-3-methyl-1,2-oxazole-4-carboxylic Acid, CAS: 1082329-71-2, stock: 3.2g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₉NO₃.
5-Cyclopropylisoxazole-3-carboxylic Acid, CAS: 110256-15-0, stock: 7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₇NO₃.
5-Cyclopropylisoxazole-4-carboxylic Acid, CAS: 124845-04-1, stock: 5.6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₇NO₃.
5-Ethoxy-2-oxazolecarboxylic Acid, CAS: 68208-10-6, stock: 4.1g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₇NO₄.
5-Ethoxy-2-Oxazolecarboxylic Acid Ethyl Ester, CAS: 68208-09-3, stock: 5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₁NO₄.
5-Ethoxy-4-methoxazole, CAS: 5006-20-2, stock: 2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₉O₂.
5-Ethylisoxazole-3-carboxylic Acid, CAS: 52320-59-9, stock: 6.1g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₇NO₃.
5-Fluoro-1,3-benzoxazole, CAS: 221347-71-3, stock: 5.7g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₄FNO.
5-Fluoro-2-Methylbenzoxazole, CAS: 701-16-6, stock: 7.1g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₆NOF.
5-Fluoro-3-(4-piperidinyl)-1,2-benzisoxazole Hydrochloride, CAS: 84163-16-6, stock: 6.3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₄ClFN₂O.
5-Fluoro-3H-1,3-benzoxazole-2-thione, CAS: 13451-78-0, stock: 3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₄FNOS.
5-Furan-2-yl-isoxazole-3-carboxylic acid, CAS: 98434-06-1, stock: 7.9g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₅NO₄.
5-Isopropyl-3-pyrrolidin-2-ylisoxazole, CAS: 1018126-16-3, stock: 1.2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₆N₂O.
Bisphenol F Mono-β-D-glucuronide, CAS: /, stock: 6g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₀O₈.
Bisphenol F Monosulfate Sodium Salt, CAS: 54172-90-6, stock: 2.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₂O₅S.
5-Isopropylisoxazole-3-carboxylic acid, CAS: 89776-74-9, stock: 2g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₉NO₃.
5-Isoxazoleacetonitrile, CAS: 854137-77-2, stock: 3.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₄N₂O.
5-Isoxazolecarboxylic Acid Methyl Ester, CAS: 15055-81-9, stock: 2.6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₅NO₃.
5-Methoxy-1,3-benzoxazole-2-thiol, CAS: 49559-83-3, stock: 2.1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₇NO₂S.
5-Methoxy-2-(methylthio)-1,3-benzoxazole, CAS: 1071329-05-9, stock: 3.9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₉NO₂S.
5-Methoxy-2-benzoxazolecarboxylic Acid, CAS: 49559-68-4, stock: 7.8g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₇NO₄.
5-Methoxy-benzodisoxazole-3-carboxylic Acid, CAS: 108805-39-6, stock: 4.4g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₇NO₄.
5-Methoxyoxazole-2-carboxylic Acid, CAS: 439109-82-7, stock: 3.9g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₅NO₄.
5-Methoxyoxazole-2-carboxylic Acid Methyl Ester, CAS: 477870-14-7, stock: 7.3g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₇NO₄.
5-Methyl-1,3-benzoxazole-2(3H)-thione, CAS: 22876-22-8, stock: 5.4g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₇NOS.
Bisphenol S Monosulfate Disodium Salt, CAS: /, stock: 8.2g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₀Na₂O₇S₂.
Bisphenol TMC, CAS: 129188-99-4, stock: 1.8g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₆O₂.
5-Methyl-1,3-oxazole-2-carbaldehyde, CAS: 1030585-89-7, stock: 1.2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₅NO₂.
5-Methyl-1,3-oxazole-4-carbonitrile, CAS: 1240598-07-5, stock: 1.5g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₄N₂O.
5-Methyl-1,3-oxazole-4-carboxylic Acid, CAS: 103879-58-9, stock: 5.9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₅NO₃.
5-Methyl-2-(thiophen-2-yl)-1,3-oxazole-4-carboxylic Acid, CAS: 1016526-89-8, stock: 1.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₇NO₃S.
5-Methyl-2-oxo-2,3-dihydro-1,3-benzoxazole-6-sulfonyl Chloride, CAS: 1227465-58-8, stock: 8.7g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₆NO₄SCl.
5-Methyl-2-phenyloxazole-4-carboxylic Acid Methyl Ester, CAS: 100063-41-0, stock: 5.5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₁NO₃.
Bisphenol Z-d8-Phosgene Copolymer, CAS: /, stock: 6.8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: (C₂₁H₁₆D₈O₃)n . (HCl)n.
5-Methyl-3,4-diphenylisoxazole, CAS: 37928-17-9, stock: 7.4g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₃NO.
5-Methyl-3-(4-phenoxyphenyl)isoxazole-4-carboxylic Acid, CAS: 1159981-28-8, stock: 5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₃NO₄.
Bisphenol Z-Phosgene Copolymer, CAS: 25134-45-6, stock: 7.9g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: (C₂₁H₂₄O₃)n . (HCl)n.
5-Methyl-3-(pyrrolidin-2-yl)-1,2-oxazole, CAS: 1000932-34-2, stock: 1.3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₂N₂O.
5-Methyl-3-isoxazolecarboxylic Acid Benzylidenehydrazide, CAS: 91397-11-4, stock: 8g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₁N₃O₂.
5-Methyl-3-isoxazolecarboxylic Acid Hydrazide, CAS: 62438-03-3, stock: 8g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₇N₃O₂.
5-Methyl-3-phenyl-4-isoxazolecarboxylic Acid, CAS: 1136-45-4, stock: 8.4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₉NO₃.
bis[2-(2-Benzothiazolyl)phenolato]zinc(II), 98%, CAS: 58280-31-2, stock: 1.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₁₆N₂O₂S₂Zn.
5-Methyl-3-phenylisoxazole-4-carboxaldehyde, CAS: 87967-95-1, stock: 1.1g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₉NO₂.
5-Methyl-4-(morpholin-4-ylmethyl)isoxazole-3-carboxylic Acid, CAS: 1177341-15-9, stock: 5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₄N₂O₄ • HCl.
bis[2-(2-Benzoxazolyl)phenolato]zinc(II), CAS: 23467-27-8, stock: 2.5g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₁₆N₂O₄Zn.
5-Methyl-4-(pyrrolidin-1-ylmethyl)isoxazole-3-carboxylic Acid, CAS: 1172847-00-5, stock: 2.6g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₄N₂O₃ • HCl.
5-Methyl-4-isoxazolesulfonyl Chloride, CAS: 321309-26-6, stock: 6.2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₄NO₃SCl.
Bromochlorophenol Blue, CAS: 2553-71-1, stock: 2.2g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₁₀Br₂Cl₂O₅S.
5-Methyl-4-oxazolecarboxylic Acid Methyl Ester, CAS: 41172-57-0, stock: 4.5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₇NO₃.
Bromochlorophenol Blue Sodium Salt, CAS: 102185-52-4, stock: 3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₉Br₂Cl₂O₅SNa.
5-Methyl-4-[(2-methylphenoxy)methyl]isoxazole-3-carboxylic Acid, CAS: 905808-63-1, stock: 2.4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₃NO₄.
5-Methyl-4-[(4-methylpiperidin-1-yl)methyl]isoxazole-3-carboxylic Acid, CAS: 1119452-18-4, stock: 3.9g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₈N₂O₃.
5-Methyl-4-[(4-nitro-1H-pyrazol-1-yl)methyl]isoxazole-3-carboxylic Acid, CAS: 956758-72-8, stock: 2.3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₈N₄O₅.
5-methyl-Isoxazole, CAS: 5765-44-6, stock: 7.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₅NO.
5-Methyl-N-(2-methyl-4-nitrophenyl)-1,2-oxazole-4-carboxamide, CAS: 1050884-58-6, stock: 7.8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₁N₃O₄.
Bromophenol Blue, CAS: 115-39-9, stock: 1.9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₁₀Br₄O₅S.
5-Methyl-N-(3-nitrophenyl)-1,2-oxazole-4-carboxamide, CAS: 1049872-93-6, stock: 5.5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₉N₃O₄.
5-Methyl-N-(piperidin-4-yl)-1,2-oxazole-3-carboxamide Hydrochloride, CAS: 1209330-86-8, stock: 5.2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₅N₃O₂ • HCl.
Bromophenol Red Sodium Salt, CAS: 102185-50-2, stock: 5.8g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₁₁Br₂NaO₅S.
Bromosulfalein, CAS: 71-67-0, stock: 7.8g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₈Br₄Na₂O₁₀S₂.
5-Methyl-N-(piperidin-4-yl)-1,2-oxazole-4-carboxamide Hydrochloride, CAS: 1221722-77-5, stock: 2g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₅N₃O₂ • HCl.
5-Methyl-N-[2-(4-sulfamoylphenyl)ethyl]-1,2-oxazole-3-carboxamide, CAS: 24477-36-9, stock: 7.5g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₅N₃O₄S.
Bromothymol Blue, CAS: 76-59-5, stock: 1.3g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₂₈Br₂O₅S.
Bromothymol Blue Sodium Salt, CAS: 34722-90-2, stock: 5.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₂₈Br₂O₅S • Na.
5-Methylbenzoxazole, CAS: 10531-78-9, stock: 7.5g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₇NO.
5-Methylisoxazole-3-carbonitrile, CAS: 57351-99-2, stock: 9.7g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₄N₂O.
Bromoxylenol Blue, CAS: 40070-59-5, stock: 6.8g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₀Br₂O₅S.
5-Methylisoxazole-3-carboxaldehyde, CAS: 62254-74-4, stock: 9.7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₅NO₂.
5-Methylisoxazole-3-carboxamide, CAS: 3445-52-1, stock: 9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₆N₂O₂.
Bromoxynil, CAS: 1689-84-5, stock: 9.9g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₃Br₂NO.
BSTFA-TMCS, CAS: 152571-61-4, stock: 8.3g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₂₇F₃NOSi₃.
Bufencarb, CAS: 8065-36-9, stock: 6.9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₉NO₂.
Bufencarb-d3, CAS: /, stock: 9.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₆D₃NO₂.
5-Methylisoxazole-3-carboxylic-d4 Acid Methyl Ester, CAS: /, stock: 7.5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₃D₄NO₃.
5-Nitro-1,3-benzoxazole, CAS: 70886-33-8, stock: 5.2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₄N₂O₃.
5-Nitro-1,3-benzoxazole-2-thiol, CAS: 22876-21-7, stock: 5.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₄N₂O₃S.
5-Phenyl-1,3-oxazole-4-carboxylic Acid, CAS: 99924-18-2, stock: 5.6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₇NO₃.
5-Phenyl-4,5-dihydroisoxazole-3-carboxylic Acid, CAS: 10313-27-6, stock: 2g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₉NO₃.
5-Phenylbenzoxazole-2-thiol, CAS: 17371-99-2, stock: 4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₉NOS.
5-Phenylisoxazole, CAS: 1006-67-3, stock: 3.1g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₇NO.
5-Phenylisoxazole-3-carbaldehyde, CAS: 59985-82-9, stock: 1.4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₇NO₂.
5-Phenylisoxazole-3-Carbohydrazide, CAS: 90946-22-8, stock: 3.4g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₉N₃O₂.
Caffeic Acid 3-Sulfate, CAS: 151481-52-6, stock: 3.9g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₈O₇S.
Caffeic Acid 4-Sulfate, CAS: 151481-51-5, stock: 5.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₈O₇S.
5-Phenylisoxazole-3-carboxylic Acid, CAS: 14441-90-8, stock: 6.3g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₇NO₃.
5-Phenyloxazole, CAS: 1006-68-4, stock: 3.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₇NO.
Carbazotic Acid (moistened with water)(Picric Acid), CAS: 88-89-1, stock: 4.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₃N₃O₇.
5-Phenyloxazole-2-carboxaldehyde, CAS: 96829-89-9, stock: 5.1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₇NO₂.
5-tert-Butyl-2-(1-chloroethyl)-1,3-oxazole, CAS: 1133001-05-4, stock: 9.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₄NOCl.
Carnosic Acid, CAS: 07/09/3650, stock: 1.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₈O₄.
Carnosol, CAS: 5957-80-2, stock: 8.5g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₆O₄.
5-tert-Butyl-2-(chloromethyl)oxazole, CAS: 224441-73-0, stock: 9.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₂NOCl.
5-tert-Butyl-2-chloro-1,3-benzoxazole, CAS: 1027076-19-2, stock: 3.9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₂NOCl.
5-tert-Butyl-2-oxazolecarboxylic Acid, CAS: 209531-11-3, stock: 6.6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₁NO₃.
5-tert-Butyl-2-oxazolecarboxylic Acid Ethyl Ester, CAS: 33123-71-6, stock: 4.9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₅NO₃.
5-[(4-Fluorophenoxy)methyl]isoxazole-3-carboxylic acid, CAS: 932917-26-5, stock: 9.6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₈FNO₄.
5-[(4-Methyl-1H-pyrazol-1-yl)methyl]isoxazole-3-carboxylic Acid, CAS: 1170258-35-1, stock: 1.4g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₉N₃O₃.
Cdk9 Inhibitor II, CAS: 140651-18-9, stock: 9.8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₀N₆O.
5-[2-(Trifluoromethyl)phenyl]-1,2-oxazole-4-carboxylic Acid, CAS: 1003561-80-5, stock: 2.6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₆NO₃F₃.
5-[4-(2-Chloroacetyl)piperazin-1-yl]-2-methyl-1,3-oxazole-4-carbonitrile, CAS: 1050910-17-2, stock: 9.9g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₃N₄O₂Cl.
CGP 7930, CAS: 57717-80-3, stock: 7.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₃₂O₂.
6-Amino-2-(3-aminophenyl)benzoxazole, CAS: 313502-13-5, stock: 7.1g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₁N₃O.
6-Amino-2-(4-aminophenyl)benzoxazole, CAS: 16363-53-4, stock: 1.1g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₁N₃O.
Chlorophenol Red, CAS: 4430-20-0, stock: 6.8g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₁₂Cl₂O₅S.
6-Benzoxazolamine, CAS: 177492-52-3, stock: 5.3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₆N₂O.
6-Bromo-1,2-benzisoxazole, CAS: 1060802-88-1, stock: 5.5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₄BrNO.
Chlorophenol Red Sodium Salt, CAS: 123333-64-2, stock: 1.1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₁₂Cl₂NaO₅S.
Chlorophenol Red-β-D-galactopyranoside, CAS: 99792-79-7, stock: 7.1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₂₂Cl₂O₁₀S.
6-Bromo-2-methyl-1,3-benzoxazole, CAS: 151230-42-1, stock: 5.3g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₆BrNO.
6-Bromo-3-chlorobenzo[d]isoxazole, CAS: 1243389-57-2, stock: 9.6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₃NOClBr.
Chloroxylenol, CAS: 88-04-0, stock: 6.9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₉ClO.
Chloroxylenol-d6, CAS: 1407521-66-7, stock: 7.2g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₃D₆ClO.
6-Bromo-4-chloro-1,3-benzoxazole, CAS: 1226067-99-7, stock: 2.3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₃NOClBr.
6-Bromo-benzo[d]isoxazole-3-carboxylic Acid, CAS: 1123169-17-4, stock: 2.1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₄NO₃Br.
Chloroxynil, CAS: 1891-95-8, stock: 3.5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₃Cl₂NO.
Ciramadol, CAS: 63269-31-8, stock: 3.3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₂₃NO₂.
6-Bromobenzoxazole, CAS: 375369-14-5, stock: 4.2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₄BrNO.
6-Bromobenzo[D]isoxazol-3-amine, CAS: 177995-39-0, stock: 2.4g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₅N₂OBr.
cis-3,4’,5-Trimethoxy-3’-hydroxystilbene, CAS: 586410-08-4, stock: 5.2g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₈O₄.
6-Chloro-1,2-benzisoxazol-3(2H)-one, CAS: 61977-29-5, stock: 1.8g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₄ClNO₂.
6-Chloro-2(3H)-benzoxazolethione, CAS: 22876-20-6, stock: 5.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₄ClNOS.
cis-5-(1,1-Dimethylnonyl)-2-(3-hydroxycyclohexyl)phenol, CAS: 70435-08-4, stock: 5.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₃₈O₂.
cis-5-(1,1-Dimethylnonyl)-2-(3-hydroxycyclohexyl)phenol-d5, CAS: /, stock: 9.3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₃₃D₅O₂.
6-Chloro-2-ethyl-benzooxazole, CAS: 1027019-12-0, stock: 6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₈NOCl.
6-Chloro-2-hydrazino-1,3-benzoxazole, CAS: 912773-31-0, stock: 2.3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₆N₃OCl.
cis-9,10-Dihydroxy-9,10-dihydrophenanthrene, CAS: 2510-71-6, stock: 3.9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₂O₂.
cis-Diethyl Stilbestrol, CAS: 22610-99-7, stock: 8.2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₀O₂.
6-Chloro-2-oxo-N-[1-(phenylmethyl)-1H-pyrazol-5-yl]-3(2H)-benzoxazolepropanamide, CAS: 1177727-04-6, stock: 4.9g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₁₇ClN₄O₃.
6-Chloro-4,4-dimethyl-2,3-dihydro-1H-quinoline, CAS: 1187933-22-7, stock: 8.6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₄ClN.
cis-Zeatin-O-glucoside Riboside, CAS: 125225-72-1, stock: 6.9g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₃₁N₅O₁₀.
Citrastadienol, CAS: 474-40-8, stock: 6.1g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₀H₅₀O.
6-Chloro-5-methyl-2-piperidin-4-yl-1,3-benzoxazole, CAS: 1035840-69-7, stock: 6.7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₅N₂OCl.
6-Cyanobenzothiazol, CAS: 58249-61-9, stock: 1.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₄N₂S.
Citrastadienol-d4, CAS: /, stock: 3.9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₀H₄₆D₄O.
Clofoctol, CAS: 37693-01-9, stock: 7.2g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₆Cl₂O.
6-Fluoro-1,3-benzoxazole-2-thiol, CAS: 145096-57-7, stock: 2.1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₄FNOS.
6-Fluoro-3-(1,2,3,6-tetrahydropyridin-4-yl)benzo[d]isoxazole, CAS: 439082-09-4, stock: 2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₁FN₂O.
6-Fluoro-3-(4-piperidinyl)-1,2-benzisoxazole Hydrochloride, CAS: 84163-13-3, stock: 8.9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₄ClFN₂O.
Coniferyl Benzoate, CAS: 4159-29-9, stock: 6.6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₆O₄.
Copper (I) Bromide, CAS: 7787-70-4, stock: 1.2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: CuBr.
6-Fluoro-3-[1-bis-[2-(methyl-6,7,8,9-tetrahydropyridol[1,2,a]pyrimidin-4-one-3-yl)ethyl]piperidinium]benzisoxazole Iodide, CAS: /, stock: 1g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₄H₄₂FIN₆O₃.
6-Fluoro-benzooxazole-2-carboxylic Acid Methyl Ester, CAS: 1086392-62-2, stock: 7.3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₆NO₃F.
Copper (II) Bromide, CAS: 7789-45-9, stock: 2.6g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: Br₂Cu.
Corilagin, CAS: 23094-69-1, stock: 9g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₂₂O₁₈.
6-Methoxy-2-benzoxazolecarboxylic Acid, CAS: 944898-55-9, stock: 2.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₇NO₄.
6-Methoxy-3-(4-piperidinyl)-1,2-benzisoxazole Hydrobromide, CAS: 84163-17-7, stock: 6.1g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₇BrN₂O₂.
6-Methoxy-3-[4-(N-benzyloxycarbonyl)piperidinyl]-1,2-benzisoxazole, CAS: 84163-07-5, stock: 9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₂N₂O₄.
6-Methyl-1,3-benzoxazole, CAS: 10531-80-3, stock: 7.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₇NO.
CP 47497-C6-homolog, CAS: 70435-06-2, stock: 7.1g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₃₂O₂.
6-Nitro-1,3-benzoxazole, CAS: 17200-30-5, stock: 5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₄N₂O₃.
6-Nitrobenzoxazole-2(3H)-one, CAS: 4694-91-1, stock: 1.4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₄N₂O₄.
6α-Hydroxy Deflazacort, CAS: 1262053-48-4, stock: 7.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₃₁NO₇.
6α-Hydroxy-21-desacetyl Deflazacort, CAS: 87539-45-5, stock: 4.1g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₉NO₆.
6β-Hydroxy Deflazacort, CAS: 1262053-48-4, stock: 6.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₃₁NO₇.
CRT 0066101, CAS: 1883545-60-5, stock: 3.1g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₂N₆O • 2(HCl).
CRT-0105950, CAS: 1661845-86-8, stock: 3.8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₁₆ClN₃OS.
6β-Hydroxy-21-desacetyl Deflazacort, CAS: 72099-45-7, stock: 7.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₉NO₆.
7-Bromo-2-methylbenzo[d]oxazole, CAS: 1239489-82-7, stock: 7.2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₆BrNO.
CU-CPT9a, CAS: 2165340-32-7, stock: 6.1g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₅NO₂.
Cupric Nonylphenolsulfonate, CAS: 61607-83-8, stock: 1.8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₀H₄₆O₈S₂.
7-Bromo-5-chloro-2-methyl-1,3-benzoxazole, CAS: 1195693-72-1, stock: 8.6g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₅NOClBr.
7-Bromobenzo[d]oxazole, CAS: 885270-14-4, stock: 4.5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₄BrNO.
7-Chloro-2-(chloromethyl)-1,3-benzoxazole, CAS: 116044-87-2, stock: 6.5g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₅NOCl₂.
7-Chlorobenzo[d]oxazole, CAS: 1243378-99-5, stock: 3.9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₄NOCl.
9-Mesityl-10-methylacridinium Perchlorate, CAS: 674783-97-2, stock: 4.6g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₂ClNO₄.
9-Methyl Risperidone, CAS: 138271-01-9, stock: 1.9g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₉FN₄O₂.
Cyclohexanol, CAS: 108-93-0, stock: 1.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₁₂O.
9-O-Acetyl Paliperidone, CAS: 130049-87-5, stock: 2.2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₂₉FN₄O₄.
Cyclophenol, CAS: 20007-85-6, stock: 1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₁₄N₂O₄.
Acetone Oxime, CAS: 127-06-0, stock: 3.9g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃H₇NO.
D,L-N,N-Didesmethyl-O-desmethyl Venlafaxine Hydrochloride, CAS: 135308-76-8, stock: 1.5g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₂₂ClNO₂.
Acid Ceramidase Inhibitor 17a, CAS: 1644158-57-5, stock: 9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₁FN₂O₃.
Acivicin, CAS: 42228-92-2, stock: 9.8g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₇ClN₂O₃.
D,L-O-Desmethyl Venlafaxine-d10, CAS: 1062607-49-1, stock: 4.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₅D₁₀NO₂.
Acrylonitrile (1 mg/mL in Methanol), CAS: 107-13-1, stock: 5.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃H₃N.
D,L-O-Desmethyl Venlafaxine-d6, CAS: 1062605-69-9, stock: 4.2g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₉D₆NO₂.
Allosamidin, CAS: 103782-08-7, stock: 9g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₄₂N₄O₁₄.
AM 4668, CAS: 1011531-27-3, stock: 9.1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₁₉F₃O₄S.
Ammonium 5-(Carbamoyl)isoxazol-3-olate, CAS: 81965-22-2, stock: 1.7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₇N₃O₃ ₍fₒr.
DDAO, CAS: 118290-05-4, stock: 8.9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₁Cl₂NO₂.
AS 2444697, CAS: 1287665-60-4, stock: 9.4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₀N₆O₄•HCl.
Benoxaprofen, CAS: 51234-28-7, stock: 4.4g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₂ClNO₃.
De((S)-4-(1-bromoethyl)-2-(2-hydroxyethyl)phenol) Bedoradrine-d6, CAS: /, stock: 8.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₄D₆N₂O₂.
Benoxaprofen Glucuronide, CAS: 67472-42-8, stock: 1.8g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₀ClNO₉.
Benoxaprofen-13C,d3, CAS: 1329840-53-0, stock: 4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅¹³CH₉D₃ClNO₃.
Dehydro Oxymetazoline Hydrochloride, CAS: 205035-03-6, stock: 8.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₂₃ClN₂O.
Benzisoxazole Hsp90 Inhibitor, CAS: 1012788-65-6, stock: 2.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₀ClN₃O₄.
Benzooxazole-5-boronic acid pinacol ester, CAS: 936902-12-4, stock: 6.4g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₆BNO₃.
Dehydroxy Ractopamine, CAS: 1246816-72-7, stock: 9.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₃NO₂.
Benzoxazole, CAS: 273-53-0, stock: 8.9g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₅NO.
Dehydroxy Ractopamine Hydrochloride, CAS: 1440291-59-7, stock: 7.2g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₄ClNO₂.
Dehydroxy Ractopamine-d6 (Major) Hydrochloride Salt, CAS: 1346599-88-9, stock: 5.1g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₈D₆ClNO₂.
Delphinidin 3-β-D-Glucoside, CAS: 6906-38-3, stock: 1.8g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₁ClO₁₂.
Benzo[d]isoxazole-3-carboxylic acid, CAS: 28691-47-6, stock: 6.1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₅NO₃.
Benzo[d]isoxazole-3-carboxylic Acid Methyl Ester, CAS: 1082682-56-1, stock: 6.1g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₇NO₃.
Des-N,N-diethylethanamine 4-Hydroxyclomiphene, CAS: 53775-07-8, stock: 3.9g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₁₅ClO.
Benzo[D]oxazole-5-carbaldehyde, CAS: 638192-65-1, stock: 6.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₅NO₂.
Benzo[d]oxazole-5-carboxylic Acid, CAS: 15112-41-1, stock: 5.6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₅NO₃.
Desacetyl Bisacodyl, CAS: 72901-16-7, stock: 5.5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₁₇NO₃.
Benzyl Tetrahydro-1H-pyrrolo[3,4-c]isoxazole-5(3H)-carboxylate, CAS: 1174730-77-8, stock: 7.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₄N₂O₃.
Broxaterol, CAS: 76596-57-1, stock: 6.3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₅BrN₂O₂.
Broxaterol-d9, CAS: /, stock: 6g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₆D₉BrN₂O₂.
Di(4-nitrophenyl)phosphoryl Chloride, CAS: 6546-97-0, stock: 5.6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₈ClN₂O₇P.
CCMI, CAS: 917837-54-8, stock: 8.2g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₁₅Cl₂N₃O₂.
CCT 137690, CAS: 1095382-05-0, stock: 9.9g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₃₁BrN₈O.
Di-sec-butylphenol, mixture of isomers, predom. 2,6-isomer, CAS: 5510-99-6, stock: 6.2g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₂₂O.
Dibenzyl Phenyl Phosphate, CAS: 112507-48-9, stock: 4.3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₁₉O₄P.
Cyclopropanecarboxylic Acid, CAS: 1759-53-1, stock: 7.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₆O₂.
Cyclopropanecarboxylic Acid Hexyl Ester, CAS: 60128-03-2, stock: 5.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₈O₂.
Dibenzyl Phenyl Phosphate-D5, CAS: /, stock: 4.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₁₄D₅O₄P.
CYM 5541, CAS: 945128-26-7, stock: 2.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₈N₂O₂.
D,L-Serine Methyl Ester Hydrochloride, CAS: 05/04/5619, stock: 6.7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₉NO₃•HCl.
Dichloroprop-d7, CAS: /, stock: 7.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉HD₇Cl₂O₃.
Dienestrol, CAS: 84-17-3, stock: 1.5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₈O₂.
De(6-Fluoro-3-(piperidin-4-yl)benzo[d]isoxazole) 9-Hydroxy-1-chloro Risperidone-d4, CAS: /, stock: 5.8g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₇D₄ClN₂O₂.
Deflazacort, CAS: 14484-47-0, stock: 6.3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₃₁NO₆.
Deflazacort-d3, CAS: /, stock: 7.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₂₈D₃NO₆.
Dihydrozeatin-O-Glucoside Riboside, CAS: 62512-95-2, stock: 7.2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₃₃N₅O₁₀.
Deflazacort-d3 (Major), CAS: /, stock: 1.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₂₈D₃NO₆.
Delamanid, CAS: 681492-22-8, stock: 1.6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₂₅F₃N₄O₆.
Dimethyl 2-Hydroxyisophthalate, CAS: 36669-06-4, stock: 10g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₀O₅.
Dimethyl 5-Hydroxyisophthalate, CAS: 13036-02-7, stock: 6.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₀O₅.
Desethylpropionate Fenoxaprop P, CAS: 70217-01-5, stock: 7.8g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₈ClNO₃.
Dibromoformaldoxime, CAS: 74213-24-4, stock: 3.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: CHBr₂NO.
Dihydro-3-[(3-methoxyphenyl)methyl]-2(3H)-furanone, CAS: 187993-26-6, stock: 7.1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₄O₃.
Dinoseb, CAS: 88-85-7, stock: 7.9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₂N₂O₅.
Dinoseb-13C6, CAS: /, stock: 1.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄¹³C₆H₁₂N₂O₅.
Ditazole, CAS: 18471-20-0, stock: 2.1g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₀N₂O₃.
Ditazole-d8, CAS: /, stock: 1.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₁₂D₈N₂O₃.
Dinoterb, CAS: 1420-07-1, stock: 6.6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₂N₂O₅.
Dioxacarb, CAS: 6988-21-2, stock: 5.8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₃NO₄.
Dioxacarb-d3, CAS: 1219795-12-6, stock: 1.3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₀D₃NO₄.
Estra-5(10),9(11)-diene-3,17-dione 3-Ethylene Ketal, CAS: 5571-36-8, stock: 6.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₆O₃.
Ethyl (S)-2-Ethoxy-3-(4-hydroxyphenyl)propionate, CAS: 222555-06-8, stock: 3.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₈O₄.
Ethyl 2,5-dibromo-1,3-oxazole-4-carboxylate, CAS: 460081-22-5, stock: 9.9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₅Br₂NO₃.
Ethyl 2,5-Dimethyl-1,3-oxazole-4-carboxylate, CAS: 23000-15-9, stock: 6.8g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₁NO₃.
Dirhodium(II) Tetrakis[ε-caprolactamate] Acetonitrile Solvate, CAS: 935529-75-2, stock: 8.8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₄₆N₆O₄Rh₂.
ethyl 2-(2-aminophenyl)-1,3-oxazole-4-carboxylate, CAS: 885274-55-5, stock: 2.6g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₂N₂O₃.
Ethyl 2-(4-Fluorophenyl)-3-(trifluoromethyl)pyrazole-4-carboxylate, CAS: 175137-38-9, stock: 3.1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₀N₂O₂F₄.
Ethyl 2-(t-butoxycarbonylamino)oxazole-5-carboxylate, CAS: 941294-50-4, stock: 1.2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₆N₂O₅.
Drometrizole Trisiloxane, CAS: 155633-54-8, stock: 8.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₃₉N₃O₃Si₃.
Ethyl 2-(Trifluoromethyl)-1,3-oxazole-4-carboxylate, CAS: 1060815-99-7, stock: 3.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₆NO₃F₃.
Ethyl 2-amino-4-methyloxazole-5-carboxylate, CAS: 79221-15-1, stock: 9.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₁₀N₂O₃.
E,E-Dienestrol, CAS: 13029-44-2, stock: 9.7g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₈O₂.
Ethyl 2-amino-5-bromo-1,3-oxazole-4-carboxylate, CAS: 914347-40-3, stock: 5.4g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₇BrN₂O₃.
Ethyl 2-Aminooxazole-5-carboxylate, CAS: 113853-16-0, stock: 8.6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₈N₂O₃.
E,E-Dienestrol-d6, CAS: /, stock: 1.1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₂D₆O₂.
Eckol, CAS: 88798-74-7, stock: 7.8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₂O₉.
Ethyl 2-bromo-1,3-oxazole-5-carboxylate, CAS: 1060816-22-9, stock: 5.6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₆BrNO₃.
Ethyl 2-Bromo-4-(trifluoromethyl)oxazole-5-carboxylate, CAS: 1227934-69-1, stock: 1.1g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₅NO₃F₃Br.
Ellagic Acid, CAS: 476-66-4, stock: 8.9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₆O₈.
Ethyl 2-Bromo-5-methyloxazole-4-carboxylate, CAS: 1187582-59-7, stock: 2.9g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₈NO₃Br.
Ethyl 2-Bromooxazole-4-carboxylate, CAS: 460081-20-3, stock: 8.3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₆BrNO₃.
Ethyl 2-chlorooxazole-4-carboxylate, CAS: 460081-18-9, stock: 7.5g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₆ClNO₃.
Erianin, CAS: 95041-90-0, stock: 4.1g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₂O₅.
Ethyl 2-Chlorooxazole-5-carboxylate, CAS: 862599-47-1, stock: 2g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₆NO₃Cl.
Ethyl 2-Cyclopropyl-1,3-oxazole-4-carboxylate, CAS: 1060816-03-6, stock: 4.4g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₁NO₃.
Ethiofencarb Sulfone, CAS: 53380-23-7, stock: 5.1g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₅NO₄S.
Ethiofencarb Sulfoxide, CAS: 53380-22-6, stock: 9.9g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₅NO₃S.
Ethyl 2-Cyclopropyl-4-methyl-1,3-oxazole-5-carboxylate, CAS: 1030014-04-0, stock: 6.6g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₃NO₃.
Ethyl 2-Methyloxazole-4-carboxylate, CAS: 10200-43-8, stock: 1.4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₉NO₃.
Ethiofencarb-d3 Sulfone, CAS: /, stock: 3.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₂D₃NO₄S.
Ethyl 2-oxo-2,3-dihydrooxazole-4-carboxylate, CAS: 874827-32-4, stock: 4.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₇NO₄.
Ethyl 2-oxo-2,3-dihydrooxazole-5-carboxylate, CAS: 1150271-25-2, stock: 3.5g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₇NO₄.
Ethyl 3-Ethyoxypropionate, CAS: 763-69-9, stock: 4.6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₁₄O₃.
Ethyl 2-Phenyloxazole-4-carboxylate, CAS: 39819-39-1, stock: 5.4g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₁NO₃.
Ethyl 2-Pyrrol-1-yl-benzate, CAS: 78540-08-6, stock: 9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₃NO₂.
Ethyl 3,5-Dimethylisoxazole-4-carboxylate, CAS: 17147-42-1, stock: 8.2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₁NO₃.
Ethyl 3-(4-Bromophenyl)-5-(trifluoromethyl)isoxazole-4-carboxylate, CAS: 1159978-86-5, stock: 5.8g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₉NO₃F₃Br.
Ethyl 3-(4-Chlorophenyl)-5-(trifluoromethyl)isoxazole-4-carboxylate, CAS: 1159978-85-4, stock: 5.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₉NO₃F₃Cl.
Ethyl 3-(4-Hydroxyphenyl)-5-methylisoxazole-4-carboxylate, CAS: 1071788-87-8, stock: 7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₃NO₄.
Ethyl 3-Bromoisoxazole-4-carboxylate, CAS: 111303-36-7, stock: 9.2g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₆NO₃Br.
Ethyl 3-bromoisoxazole-5-carboxylate, CAS: 105174-97-8, stock: 2.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₆BrNO₃.
Ethyl Paraben-d4, CAS: 1219795-53-5, stock: 2.3g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₆D₄O₃.
Ethyl 3-Methylisoxazole-5-carboxylate, CAS: 63366-79-0, stock: 9.8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₉NO₃.
Ethyl 3-Phenylisoxazole-5-carboxylate, CAS: 13599-24-1, stock: 6.6g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₁NO₃.
Ethyl 4,5,6,7-Tetrahydrobenzo[d]isoxazole-3-carboxylate, CAS: 1013-14-5, stock: 3.1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₃NO₃.
Ethyl 4-(2-Bromoacetyl)-5-methylisoxazole-3-carboxylate, CAS: 115697-68-2, stock: 5.4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₀NO₄Br.
Ethyl 4-(Trifluoromethyl)oxazole-5-carboxylate, CAS: 1126633-32-6, stock: 6.4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₆NO₃F₃.
Ethyl 4-Acetyl-5-methylisoxazole-3-carboxylate, CAS: 15911-11-2, stock: 2.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₁NO₄.
Ethyl 4-bromo-1,3-oxazole-5-carboxylate, CAS: 1258283-17-8, stock: 3.8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₆BrNO₃.
Ethyl 4-Methyloxazole-5-carboxylate, CAS: 20485-39-6, stock: 6.1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₉NO₃.
Ethyl 5-(1-hydroxyethyl)-1,2-oxazole-3-carboxylate, CAS: 78934-71-1, stock: 1.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₁NO₄.
Ethyl 5-(1H-Pyrazol-3-yl)Isoxazole-3-Carboxylate, CAS: 264226-03-1, stock: 8.9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₉N₃O₃.
Evodol, CAS: 22318-10-1, stock: 8.2g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₂₈O₉.
Ethyl 5-(2,3-dichlorophenyl)oxazole-4-carboxylate, CAS: 951885-31-7, stock: 4.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₉Cl₂NO₃.
Ethyl 5-(2,4-dichlorophenyl)oxazole-4-carboxylate, CAS: 254749-13-8, stock: 6.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₉Cl₂NO₃.
Fenobucarb, CAS: 3766-81-2, stock: 2.6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₇NO₂.
Ethyl 5-(2-bromoacetyl)isoxazole-3-carboxylate, CAS: 104776-74-1, stock: 9.4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₈BrNO₄.
Ethyl 5-(2-Furyl)isoxazole-3-carboxylate, CAS: 33545-40-3, stock: 2.7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₉NO₄.
Ethyl 5-(3-Nitrophenyl)isoxazole-3-carboxylate, CAS: 866040-66-6, stock: 3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₀N₂O₅.
Ethyl 5-(3-nitrophenyl)oxazole-4-carboxylate, CAS: 916674-05-0, stock: 3.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₀N₂O₅.
Ethyl 5-(4-chlorophenyl)oxazole-4-carboxylate, CAS: 127919-28-2, stock: 4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₀ClNO₃.
Ethyl 5-(4-Methoxyphenyl)-isoxazole-3-carboxylate, CAS: 925006-96-8, stock: 1.9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₃NO₄.
Ferulic Acid 4-O-Sulfate Disodium Salt, CAS: /, stock: 7.7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₈Na₂O₇S.
Ethyl 5-(4-nitrophenyl)oxazole-4-carboxylate, CAS: 72030-87-6, stock: 9.1g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₀N₂O₅.
Ethyl 5-(Hydroxymethyl)isoxazole-3-carboxylate, CAS: 123770-62-7, stock: 4.8g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₉NO₄.
Ferulic Acid-d3 4-O-Sulfate Disodium Salt, CAS: /, stock: 6.2g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₅D₃Na₂O₇S.
Folin and Ciocalteu’s Phenol Reagent, CAS: /, stock: 7.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: N/A.
Ethyl 5-(n-boc)aminomethylisoxazole-3-carboxylate, CAS: 253196-37-1, stock: 1.5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₈N₂O₅.
Ethyl 5-(tert-Butyl)isoxazole-3-carboxylate, CAS: 91252-54-9, stock: 3g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₅NO₃.
Fosfestrol Tetrasodium Salt, CAS: 4719-75-9, stock: 9.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₈Na₄O₈P₂.
Furcatin, CAS: 499-33-2, stock: 2.5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₈O₁₀.
Ethyl 5-(Trifluoromethyl)-3-p-tolylisoxazole-4-carboxylate, CAS: 1159978-84-3, stock: 4.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₂NO₃F₃.
Ethyl 5-acetylisoxazole-3-carboxylate, CAS: 104776-70-7, stock: 3.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₉NO₄.
Ethyl 5-Amino-3-methylisoxazole-4-carboxylate, CAS: 25786-72-5, stock: 1.8g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₁₀N₂O₃.
Ethyl 5-Chloro-3-methyl-4-isoxazolecarboxylate, CAS: 3356-94-3, stock: 3.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₈ClNO₃.
Ethyl 5-chloro-4-methylisoxazole-3-carboxylate, CAS: 3356-96-5, stock: 2.7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₈ClNO₃.
Ethyl 5-Methyl-3-phenylisoxazole-4-carboxylate, CAS: 1143-82-4, stock: 4.4g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₃NO₃.
Gallic Acid-d2, CAS: 294660-92-7, stock: 5.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₄D₂O₅.
Ethyl 5-Methyl-4-oxazolecarboxylate, CAS: 32968-44-8, stock: 9g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₉NO₃.
Ethyl 5-Methylisoxazole-3-carboxylate, CAS: 3209-72-1, stock: 3.3g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₉NO₃.
Ethyl 5-Methylisoxazole-4-carboxylate, CAS: 51135-73-0, stock: 1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₉NO₃.
Ethyl 5-phenylisoxazole-3-carboxylate, CAS: 7063-99-2, stock: 4.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₁NO₃.
Gum Rosin, CAS: 07/09/8050, stock: 5.4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: N/A.
Ethyl 5-[2-(Trifluoromethyl)phenyl]-1,2-oxazole-3-carboxylate, CAS: 1188056-68-9, stock: 7.2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₀NO₃F₃.
Ethyl Benzo[d]isoxazole-3-carboxylate, CAS: 57764-49-5, stock: 1.9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₉NO₃.
Ethyl Isoxazol-3-carboxylate, CAS: 3209-70-9, stock: 6.7g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₇NO₃.
Hexestrol, CAS: 84-16-2, stock: 9g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₂₂O₂.
Hexestrol Dipropionate, CAS: 4825-53-0, stock: 2.7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₃₀O₄.
Ethyl isoxazole-4-carboxylate, CAS: 80370-40-7, stock: 8.2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₇NO₃.
Ethyl Oxazole-4-carboxylate, CAS: 23012-14-8, stock: 4.1g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₇NO₃.
Hexestrol-d4, CAS: 1189950-25-1, stock: 1.3g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₈D₄O₂.
Hexestrol-d6, CAS: 1215476-12-2, stock: 9.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₆D₆O₂.
Ethyl Oxazole-5-carboxylate, CAS: 118994-89-1, stock: 2.4g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₇NO₃.
Etoxazole, CAS: 153233-91-1, stock: 7.8g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₂₃F₂NO₂.
Etoxazole-d5, CAS: /, stock: 1.3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₁₈D₅F₂NO₂.
Fluazacort, CAS: 19888-56-3, stock: 9.9g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₅H₃₀FNO₆.
Fmoc-Glu(obzl)-Cl, CAS: 123622-36-6, stock: 2.4g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₂₄NO₅Cl.
Hydrobromic Acid (47-48% in aqueous solution), CAS: 10035-10-6, stock: 7.2g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: HBr.
Hydrobromic Acid Solution (in Acetic Acid), CAS: 37348-16-6, stock: 6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: HBr.
Glisoxepid, CAS: 25046-79-1, stock: 4.7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₇N₅O₅S.
Hydrobromic Acid-d Solution (48 wt. % in D2O), CAS: 13536-59-9, stock: 3.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: DBr.
Glisoxepid-d4, CAS: 1795033-41-8, stock: 6.2g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₃D₄N₅O₅S.
Heptanal, CAS: 111-71-7, stock: 4.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₁₄O.
I-BET 151, CAS: 1300031-49-5, stock: 3.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₁N₅O₃.
Ibotenic Acid Monohydrate, CAS: 60573-88-8, stock: 1.9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₈N₂O₅.
Hydroxy Tyrosol α-Acetate, CAS: 69039-02-7, stock: 7.6g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₂O₄.
ISO 1, CAS: 478336-92-4, stock: 8.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₃NO₄.
Hydroxy Tyrosol α-Acetate-3-Sulfate Sodium Hydrate, CAS: /, stock: 2.6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₃NaO₈S.
Hydroxy Tyrosol-d3, CAS: 294660-90-5, stock: 4.9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₇D₃O₃.
Isocarboxazid, CAS: 59-63-2, stock: 2.8g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₃N₃O₂.
Isocarboxazid (1.0 mg/mL in Acetonitrile), CAS: 59-63-2, stock: 7.1g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₃N₃O₂.
Hydroxy Tyrosol-d5, CAS: /, stock: 6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₅D₅O₃.
IC 87201, CAS: 866927-10-8, stock: 4.1g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₀Cl₂N₄O.
Isosulfamethoxazole, CAS: 17103-52-5, stock: 1.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₁N₃O₃S.
Isoxadifen, CAS: 209866-92-2, stock: 5.6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₃NO₃.
Indophenol, CAS: 500-85-6, stock: 3.8g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₉NO₂.
Isoxazole, CAS: 288-14-2, stock: 4.7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃H₃NO.
Isoxazole-3-carboxylic acid, CAS: 3209-71-0, stock: 6.5g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₃NO₃.
Indophenol Blue, CAS: 132-31-0, stock: 1.7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₆N₂O.
Indophenol-d4, CAS: /, stock: 4.5g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₅D₄NO₂.
Isoxazole-4-boronic acid, CAS: 1008139-25-0, stock: 6.1g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃H₄BNO₃.
Isoxazole-4-carboxylic acid, CAS: 6436-62-0, stock: 1.3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₃NO₃.
Isoxazole-5-carbonyl Chloride, CAS: 62348-13-4, stock: 7.9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₂ClNO₂.
α-Desmethyl Benoxaprofen, CAS: 51234-85-6, stock: 6.1g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₀ClNO₃.
α-Desmethyl Benoxaprofen Methyl Ester, CAS: 1391054-57-1, stock: 7.1g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₂ClNO₃.
α-Hydroxy Trimethoprim (Impurity), CAS: 29606-06-2, stock: 5.1g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₈N₄O₄.
L-741,742 Hydrochloride, CAS: 874882-93-6, stock: 9.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₅ClN₂O • ( HCl).
Isopropylated phenol, phosphate (3:1), CAS: 68937-41-7, stock: 6g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₇H₃₃O₄P.
Isopropylbenzenethiol, CAS: 4946-14-9, stock: 2.2g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₂S.
Merocyanine 540, CAS: 62796-23-0, stock: 8.1g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₃₃N₃O₆S₂ • N a.
Methyl 1,3-benzoxazole-5-carboxylate, CAS: 924869-17-0, stock: 8.5g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₇NO₃.
α,α,α’-Tris(4-hydroxyphenyl)-1-ethyl-4-isopropylbenzene, CAS: 110726-28-8, stock: 7.8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₉H₂₈O₃.
Methyl 1,3-benzoxazole-6-carboxylate, CAS: 1305711-40-3, stock: 4.8g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₇NO₃.
α,α’-Diethyl-4,4’-stilbenediol-d4, CAS: 6898-97-1, stock: 8.9g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₈H₁₆D₄O₂.
Methyl 2-(4-Nitrophenyl)oxazole-4-carboxylate, CAS: 1171126-87-6, stock: 6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₈N₂O₅.
Methyl 2-(Aminomethyl)-1,3-oxazole-4-carboxylate Hydrochloride, CAS: 1006619-33-5, stock: 3.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₈N₂O₃ • HCl.
K 114, CAS: 872201-12-2, stock: 8.5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₁₇BrO₂.
Methyl 2-(Chloromethyl)oxazole-4-carboxylate, CAS: 208465-72-9, stock: 4.5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₆NO₃Cl.
Methyl 2-aminooxazole-4-carboxylate, CAS: 1000576-38-4, stock: 2.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₆N₂O₃.
K02288, CAS: 1431985-92-0, stock: 9.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₀N₂O₄.
KCC 07, CAS: 315702-75-1, stock: 3.3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₁N₃OS.
Methyl 2-Aminooxazole-5-carboxylate, CAS: 934236-40-5, stock: 4.5g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₆N₂O₃.
Methyl 2-bromo-4-oxazolecarboxylate, CAS: 1092351-94-4, stock: 3.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₄BrNO₃.
KRIBB3, CAS: 129414-88-6, stock: 6.8g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₁₉NO₄.
Methyl 2-Bromooxazole-5-carboxylate, CAS: 1092351-96-6, stock: 4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₄BrNO₃.
Methyl 2-chlorobenzo[d]oxazole-4-carboxylate, CAS: 1007112-35-7, stock: 7.7g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₆ClNO₃.
Methyl 2-chlorooxazole-4-carboxylate, CAS: 934236-35-8, stock: 3.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₄ClNO₃.
Methyl 2-Mercaptobenzo[d]oxazole-6-carboxylate, CAS: 72752-81-9, stock: 6.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₇NO₃S.
L-Phenylephrine, CAS: 59-42-7, stock: 8.1g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₃NO₂.
L-Tyrosine Disodium Salt, CAS: 69847-45-6, stock: 2.6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₉NNa₂O₃.
Methyl 2-Methylbenzo[d]oxazole-6-carboxylate, CAS: 136663-23-5, stock: 6.2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₉NO₃.
Methyl 2-Methyloxazole-4-carboxylate, CAS: 85806-67-3, stock: 4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₇NO₃.
Lactyl Phenetidine, CAS: 539-08-2, stock: 4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₅NO₃.
Lanreotide-d8 (95%), CAS: /, stock: 1.1g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅₄H₆₁D₈N₁₁O₁₀S₂.
Methyl 3,5-Dimethylisoxazole-4-carboxylate, CAS: 56328-87-1, stock: 6.9g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₉NO₃.
Lead Dipicrate, CAS: 6477-64-1, stock: 6.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₄N₆O₁₄ •Pb.
Methyl 3-Hydroxyisoxazole-5-carboxylate, CAS: 10068-07-2, stock: 4.6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₅NO₄.
Methyl 3-Methylisoxazole-5-carboxylate, CAS: 1004-96-2, stock: 4.7g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₇NO₃.
Leuco-2,6-dichlorophenolindophenol, CAS: 2099-87-8, stock: 5.8g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₉Cl₂NO₂.
Methyl 4-(4-chlorophenyl)isoxazole-5-carboxylate, CAS: 1072944-87-6, stock: 5.3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₈ClNO₃.
Methyl 4-(Chloromethyl)-5-methylisoxazole-3-carboxylate, CAS: 1177292-31-7, stock: 3.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₇H₈ClNO₃.
Ligustroside Aglycone, CAS: 174511-64-9, stock: 5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₉H₂₂O₇.
Methyl 4-Acetyl-5-methylisoxazole-3-carboxylate, CAS: 104149-61-3, stock: 6.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₉NO₄.
Methyl 4-Benzoyl-5-methyl-1,2-oxazole-3-carboxylate, CAS: 104149-63-5, stock: 5.4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₁NO₄.
LJH685, CAS: 1627710-50-2, stock: 2.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₂H₂₁F₂N₃O.
LJI308, CAS: 1627709-94-7, stock: 1.5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₁₈F₂N₂O₂.
Methyl 5-(2,4-Difluorophenyl)isoxazole-3-carboxylate, CAS: 1105191-49-8, stock: 3.5g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₇NO₃F₂.
Lobetyolin, CAS: 136085-37-5, stock: 3.4g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₀H₂₈O₈.
Lumogallion, CAS: 4386-25-8, stock: 7.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₉ClN₂O₆S.
Methyl 5-(2-chlorophenyl)oxazole-4-carboxylate, CAS: 89204-91-1, stock: 5.5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₈ClNO₃.
Methyl 5-(2-Furyl)isoxazole-3-carboxylate, CAS: 33545-41-4, stock: 3.3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₇NO₄.
LY 231617, CAS: 141545-89-3, stock: 6.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₂₉NO•HCl.
Methyl 5-(2-Nitrophenyl)isoxazole-4-carboxylate, CAS: 1375064-51-9, stock: 8.3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₈N₂O₅.
Methyl 5-(2-Pyridyl)isoxazole-3-carboxylate, CAS: 1375064-64-4, stock: 9.9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₈N₂O₃.
Methyl 5-(2-Thienyl)isoxazole-3-carboxylate, CAS: 517870-23-4, stock: 1.8g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₇NO₃S.
Methyl 5-(3-Bromophenyl)isoxazole-3-carboxylate, CAS: 745078-74-4, stock: 4.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₈BrNO₃.
m-Isobutoxy-phenol, CAS: 91950-13-9, stock: 7.3g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₄O₂.
Methyl 5-(3-chlorophenyl)isoxazole-4-carboxylate, CAS: 1065074-27-2, stock: 4.9g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₈ClNO₃.
Methyl 5-(3-chlorophenyl)oxazole-4-carboxylate, CAS: 89204-92-2, stock: 9.7g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₈ClNO₃.
m-Tyramine, CAS: 588-05-6, stock: 1.5g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₁NO.
Methyl 5-(3-Nitrophenyl)isoxazole-3-carboxylate, CAS: 517870-18-7, stock: 9.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₈N₂O₅.
Methyl 5-(4-Bromophenyl)isoxazole-3-carboxylate, CAS: 517870-15-4, stock: 3.1g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₈NO₃Br.
m-Tyramine Hydrobromide, CAS: 38449-59-1, stock: 9.6g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₂BrNO.
m-Tyramine Hydrochloride, CAS: 3458-98-8, stock: 5.6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₈H₁₁NO •HCl.
Methyl 5-(4-fluorophenyl)oxazole-4-carboxylate, CAS: 89204-90-0, stock: 4.4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₈FNO₃.
Methyl 5-(4-Hydroxyphenyl)isoxazole-3-carboxylate, CAS: 60640-71-3, stock: 8.3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₉NO₄.
Meptazinol Hydrochloride, CAS: 59263-76-2, stock: 9.8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₂₃NO•HCl.
Methyl 5-(4-Nitrophenyl)isoxazole-3-carboxylate, CAS: 487034-01-5, stock: 3.5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₈N₂O₅.
Methyl 5-(Chloromethyl)-1,2-oxazole-4-carboxylate, CAS: 1027781-88-9, stock: 8.3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₆NO₃Cl.
Meptazinol-13C,d3 Hydrochloride, CAS: /, stock: 2.1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄¹³CH₂₀D₃NO•HCl.
meso-Tetra(p-hydroxyphenyl)porphine, CAS: 51094-17-8, stock: 3.4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₄H₃₀N₄O₄.
Methyl 5-(Chloromethyl)-4,5-dihydro-1,2-oxazole-3-carboxylate, CAS: 1193387-44-8, stock: 5.4g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₈NO₃Cl.
Mesurol Phenol Sulfoxide, CAS: 22454-92-8, stock: 7.5g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₂O₂S.
Meta-Topolin, CAS: 75737-38-1, stock: 4.3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₁N₅O.
Methyl 5-Amino-2-(thiophen-2-yl)-1,3-oxazole-4-carboxylate, CAS: 1216295-88-3, stock: 1.1g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₈N₂O₃S.
Methyl 5-Amino-2-phenyl-1,3-oxazole-4-carboxylate, CAS: 1034889-77-4, stock: 5.5g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₀N₂O₃.
Methyl 5-Methylisoxazole-4-carboxylate, CAS: 100047-54-9, stock: 3g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₇NO₃.
Methyl 5-Phenylisoxazole-3-carboxylate, CAS: 51677-09-9, stock: 6.4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₉NO₃.
Methiocarb, CAS: 2032-65-7, stock: 9.6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₅NO₂S.
Methyl Benzo[D]oxazole-2-carboxylate, CAS: 27383-86-4, stock: 8.8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₇NO₃.
Methyl Chloroformate, CAS: 79-22-1, stock: 3.4g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂H₃ClO₂.
Methiocarb Sulfone, CAS: 2179-25-1, stock: 1.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₅NO₄S.
Methiocarb Sulfoxide, CAS: 01/10/2635, stock: 4.5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₅NO₃S.
Methyl Oxazole-5-carboxylate, CAS: 121432-12-0, stock: 7.3g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₅NO₃.
Methiocarb-d3, CAS: 1581694-94-1, stock: 7.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₂D₃NO₂S.
Methiocarb-d3 Sulfone, CAS: /, stock: 9.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₂D₃NO₄S.
Methyl-d3 Chloroformate, CAS: 43049-56-5, stock: 6.4g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂D₃ClO₂.
Methiocarb-d3 Sulfoxide, CAS: /, stock: 5.3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₂D₃NO₃S.
Methost-7-enol, CAS: 481-25-4, stock: 4.9g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₈H₄₈O.
ML115, CAS: 912798-42-6, stock: 8.1g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₅ClN₂O₄.
ML351, CAS: 847163-28-4, stock: 3.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₁₁N₃O.
Methoxamine Hydrochloride (Mixture of Diastereomers), CAS: 61-16-5, stock: 8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₈ClNO₃.
Methoxy-X04, CAS: 863918-78-9, stock: 3.7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₀O₃.
Muscimol, CAS: 2763-96-4, stock: 2.8g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₆N₂O₂.
Muscimol Hydrobromide, CAS: 18174-72-6, stock: 3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₇BrN₂O₂.
Muscimol-15N,d2 Hydrochloride, CAS: 1346602-01-4, stock: 4.5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₅D₂ClN¹⁵NO₂.
N,N’-Diphenylformamidine, CAS: 622-15-1, stock: 8.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₂N₂.
N-(3-Amino-4-chlorophenyl)-5-methyl-1,2-oxazole-4-carboxamide Hydrochloride, CAS: 1193390-10-1, stock: 8.1g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₀N₃O₂Cl • HCl.
N-(3-Amino-4-fluorophenyl)-5-methyl-1,2-oxazole-4-carboxamide Hydrochloride, CAS: 1193389-78-4, stock: 5.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₁FN₃O₂Cl.
N-(3-Aminophenyl)-5-methyl-1,2-oxazole-4-carboxamide Hydrochloride, CAS: 1181867-71-9, stock: 4.8g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₁N₃O₂ • HCl.
N-(3-Hydroxyphenyl)-3-methyl-5-isoxazolecarboxamide, CAS: 64384-94-7, stock: 2.9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₀N₂O₃.
N-(4-Aminobenzenesulfonyl) Sulfamethoxazole, CAS: 135529-16-7, stock: 3.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₆N₄O₅S₂.
N-(4-Aminobenzenesulfonyl) Sulfamethoxazole-d4, CAS: 1346603-52-8, stock: 8.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₂D₄N₄O₅S₂.
N-(4-Aminophenyl)-5-methyl-1,2-oxazole-4-carboxamide Hydrochloride, CAS: 1193388-99-6, stock: 7.8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₁N₃O₂ • HCl.
N-(5-Methyl-3-isoxazolyl)benzenesulfonamide, CAS: 13053-79-7, stock: 3.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₀N₂O₃S.
N-Acetyl Sulfamethoxazole, CAS: 21312-10-7, stock: 6.3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₃N₃O₄S.
N-Acetyl Sulfamethoxazole-13C6, CAS: /, stock: 1.7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆¹³C₆H₁₃N₃O₄S.
N-Acetyl Sulfamethoxazole-d4 (major), CAS: 1215530-54-3, stock: 9.8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₉D₄N₃O₄S.
N-Acetyl Zonisamide, CAS: 68936-43-6, stock: 7.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₀N₂O₄S.
Metipranolol Hydrochloride, CAS: 36592-77-5, stock: 6.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₂₈ClNO₄.
N-Boc-5-(Aminomethyl)-3-bromoisoxazole, CAS: 903131-45-3, stock: 5.6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₃N₂O₃Br.
Miproxifene, CAS: 129612-87-9, stock: 3.7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₉H₃₅NO₂.
N-Cyclopropyl-5-(thiophen-2-yl)isoxazole-3-carboxamide, CAS: 832115-62-5, stock: 1.9g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₀N₂O₂S.
N-Cyclopropyl-5-(thiophen-2-yl)isoxazole-3-carboxamide -d4, CAS: /, stock: 9.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₆D₄N₂O₂S.
Mixture of p-Digallic Acid and m-Digallic AcidReplaces D445920, CAS: /, stock: 1.8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₀O₉.
N-Hydroxy Sulfamethoxazole, CAS: 114438-33-4, stock: 8.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₁N₃O₄S.
Moxisylyte Hydrochloride, CAS: 964-52-3, stock: 4.2g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₂₅NO₃ •HCl.
MPP Dihydrochloride, CAS: 911295-24-4, stock: 3.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₉H₃₁N₃O₃ • 2(HCl).
N-Methyl-3-[3-(5-methoxycarbonylpyridyl)-5-isoxazolecarboxylic Acid Methyl Ester, CAS: 1159977-50-0, stock: 8.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₆N₂O₅.
N-tert-Butoxycarbonyl (5R)-Acivicin, CAS: 1356931-87-7, stock: 3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₅ClN₂O₅.
N-tert-Butoxycarbonyl (βR,5R)-β-Amino-3-chloro-4,5-dihydro-5-isoxazoleethanol, CAS: /, stock: 9.9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₇ClN₂O₄.
N-tert-Butoxycarbonyl (βR,5S)-β-Amino-3-chloro-4,5-dihydro-5-isoxazoleethanol, CAS: 1151863-28-3, stock: 7.5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₇ClN₂O₄.
N-tert-Butoxycarbonyl Acivicin, CAS: 73684-59-0, stock: 4.7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₅ClN₂O₅.
N-[3-[(2,5-Dimethyl-1H-pyrrol-1-yl)sulfonyl]-1-methyl-1H-pyrazol-4-yl]-carbamic Acid tert-Butyl Ester, CAS: 1287670-12-5, stock: 3.5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₂₂N₄O₄S.
N-[4-(Aminocarbonyl)phenyl]-2-methyl-4-oxazolecarboxamide, CAS: 1119444-26-6, stock: 3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₁N₃O₃.
N-[4-Amino-3-(trifluoromethyl)phenyl]-5-methyl-1,2-oxazole-4-carboxamide Hydrochloride, CAS: 1193388-66-7, stock: 2.1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₂H₁₀N₃O₂F₃ • HCl.
N2-Methyl Trimethoprim (Impurity), CAS: 213745-86-9, stock: 8.9g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₅H₂₀N₄O₃.
N4-(2-Bromoethyl)-3-(2,6-dichlorophenyl)-5-methylisoxazole-4-carboxamide, CAS: 218456-06-5, stock: 8.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₃H₁₁N₂O₂Cl₂Br.
NVP-AUY 922, CAS: 747412-49-3, stock: 5.1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₆H₃₁N₃O₅.
O,N-Aminomethanylylidene-β-D-arabinofuranose, CAS: 27963-98-0, stock: 2.7g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₁₀N₂O₄.
O,N-Aminomethanylylidene-β-D-arabinofuranose (Racemic Mixture), CAS: /, stock: 3.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₆H₁₀N₂O₄.
Ocaperidone, CAS: 129029-23-8, stock: 1.5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₂₅FN₄O₂.
OGT 2115, CAS: 853929-59-6, stock: 9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₄H₁₆BrFN₂O₄.
Oxazole, CAS: 288-42-6, stock: 1.5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃H₃NO.
Oxazole-2-carboxamide, CAS: 884539-45-1, stock: 3.4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₄N₂O₂.
Oxazole-4-carbaldehyde, CAS: 118994-84-6, stock: 8.7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₃NO₂.
Oxazole-4-carbohydrazide, CAS: 885274-12-4, stock: 2g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₅N₃O₂.
Oxazole-4-carbonitrile, CAS: 55242-84-7, stock: 1.8g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₂N₂O.
Oxazole-4-carbothioamide, CAS: 118802-31-6, stock: 4.1g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₄N₂OS.
Oxazole-4-carboxylic Acid, CAS: 23012-13-7, stock: 5.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₃NO₃.
N,N-Di-B-butyl-3-aminophenol, CAS: 43141-69-1, stock: 9.1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₂₃NO.
Oxazole-5-carboxylic Acid, CAS: 118994-90-4, stock: 6.9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄H₃NO₃.
Oxazoline, CAS: 504-77-8, stock: 5.5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃H₅NO.
N,N’-Dicyclohexylcarbodiimide Pentachlorophenol Complex, CAS: 15406-98-1, stock: 2.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₃₁H₂₅Cl₁₅N₂O₃.
PF 945863, CAS: 893556-85-9, stock: 1.3g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄₄H₆₅N₅O₁₀.
Potassium 3,5-DImethylisoxazole-4-yl Trifluoroborate, CAS: 1111732-84-3, stock: 6.5g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₆BF₃KNO.
Pyrisoxazole, CAS: 847749-37-5, stock: 9.4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₇ClN₂O.
N,O-Di(2-hydroxyethyl)-2-amino-5-nitrophenol, CAS: 59820-43-8, stock: 3.5g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₄N₂O₅.
N,O-Didesmethyl Tramadol-d3 Hydrochloride, CAS: 1261393-89-8, stock: 7.2g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₄H₁₉D₃ClNO₂.
Risperidone Isoxazole-N-oxide, CAS: 1391053-34-1, stock: 3.8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₇FN₄O₃.
N-(2-Chloroethyl)-N-(2-hydroxyethyl) Methylamine Picrate, CAS: 878762-81-3, stock: 6.4g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₅H₁₂ClNO•C₆H₃N₃O₇.
SAR-20347, CAS: 1450881-55-6, stock: 8.1g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₁H₁₈ClFN₄O₄.
SN 2, CAS: 823218-99-1, stock: 5.6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₇H₂₁NO.
Sodium Sulfamethoxazole, CAS: 4563-84-2, stock: 5.6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₀N₃NaO₃S.
Sulfamethoxazole, CAS: 723-46-6, stock: 6.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₁N₃O₃S.
N-(3-Hydroxypropyl) 4-hydroxy-2-nitroaniline, CAS: 92952-81-3, stock: 4.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₉H₁₂N₂O₄.
Sulfamethoxazole 2,3,4-Tri-O-acetyl-β-D-glucuronide Methyl Ester, CAS: 121364-44-1, stock: 1.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₂₃H₂₇N₃O₁₂S.
Sulfamethoxazole β-D-Glucuronide, CAS: 14365-52-7, stock: 1.2g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₉N₃O₉S.
N-(4-Hydroxyphenyl)piperazine Dihydrobromide, CAS: 38869-37-3, stock: 1.8g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₁₆Br₂N₂O.
N-(4-Hydroxyphenyl)piperazine-d8, Dihydrobromide, CAS: 1329502-88-6, stock: 9.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₈D₈Br₂N₂O₂.
Sulfamethoxazole N4-glucoside (alpha/beta mixture), CAS: 119691-75-7, stock: 6.5g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₂₁N₃O₈S.
Sulfamethoxazole-13C6, CAS: 1196157-90-0, stock: 5g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₄¹³C₆H₁₁N₃O₃S.
Sulfamethoxazole-d4, CAS: 1020719-86-1, stock: 5.2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₀H₇D₄N₃O₃S.
Sulfamethoxazole-d4 β-D-Glucuronide, CAS: /, stock: 4.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₆H₁₅D₄N₃O₉S.
N-Boc-2-aminophenol, CAS: 186663-74-1, stock: 3.1g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula: C₁₁H₁₅NO₃.
